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INTRODUCTION 
 
In 2005, U.S. District Court Judge Janis Jack, presiding over a 
multi-district litigation involving 10,000 claims of injury from exposure 
to silica dust that were  generated by litigation screenings,1 issued a 263 
page opinion rejecting the validity of thousands of medical reports 
generated by those screenings.2  Before issuing her opinion, Judge Jack 
 
 1 In a litigation screening, potential litigants are solicited directly or indirectly by lawyers by 
use of mass mailings, newspaper and circular advertisements, television and radio 
announcements, and “800” telephone numbers.  Those responding to the advertisements come to 
a strip mall, motel room, union hall or lawyer’s office where medical tests, including medical 
exams in some cases, are administered by a doctor or medical technician for the purpose of 
generating results to be used to support claims of injury and qualify the potential litigant for 
compensation.  Litigation screenings were first used to generate nonmalignant asbestos claims in 
the mid-to-late 1980’s; those screenings usually involved use of mobile X-ray vans which were 
brought to the site of the screening. For a more detailed description of asbestos screenings, see 
Lester Brickman, On The Theory Class’s Theories of Asbestos Litigation: The Disconnnect 
Between Scholarship and Reality, 31 PEPP. L. REV. 33, 62 (2004) [hereinafter Brickman, Asbestos 
Litigation].  Litigation screenings, such as those that have been used to generate hundreds of 
thousands of nonmalignant asbestos-related claims, are fundamentally different than medical 
screenings.  Litigation screenings have no intended health benefit and are undertaken for the sole 
purpose of generating claims for compensation.  For a listing of the criteria of a medically sound 
screening program for asbestos related diseases, see The Ass’n of Occupational & Envtl. Clinics, 
Guidance Document: Asbestos Screenings (Spring 2000), available at 
http://www.aoec.org/principles.htm. 
 2 In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563 (S.D. Tex. 2005). About 
10,000 of approximately 20,000 claims based on injury from exposure to crystalline silica (e.g., 
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ordered that a Daubert3 hearing be held to assess the reliability of 
 
sand dust or quartz) that had been filed mostly in state courts in Mississippi and Texas were 
removed to federal court and then transferred by the Judicial Panel on Multi-district Litigation to 
the U.S. District Court in Corpus Christi, Texas for consolidated pretrial proceedings under the 
federal MDL (multidistrict litigation statutes).  28 U.S.C. § 1407(a) (2000).  In order for a case to 
be transferred, the civil actions pending in different judicial districts must have one or more 
questions of fact in common.  Id.  Additionally, the transfer must be convenient for the parties 
and the witnesses and must promote justice and efficiency.  Id.  The MDL process is used to 
manage mass torts.  See James M. Wood, The Judicial Coordination of Drug and Device 
Litigation, 54 FOOD & DRUG L.J. 325, 337 (1999); Desmond T. Barry, Jr., A Practical Guide to 
the Ins and Outs of Multidistrict Litigation, 64 DEF. COUNS. J. 58, 66 (1997) (“[T]he procedures 
are intended only as a guide to promote the fair and efficient resolution of complex litigation.”); 
id. at 59 (noting the purpose of MDL is to “eliminate duplication in discovery, avoid conflicting 
rulings and schedules, reduce litigation cost, and save time and effort on the part of the parties, 
the attorneys, the witness and the courts”).  Transfers are for pretrial management only.  Gregory 
Hansel, Extreme Litigation: An Interview With Judge Wm. Terrell Hodges, 19 ME. B.J. 16, 18 
(2004). 
 3 Daubert v. Merrel Dow Pharm., 509 U.S. 579 (1993). In Daubert, the Court established a 
two-part test for determining the admissibility of scientific evidence under FED R. CIV. P. 702.  
The Court found that (1) the Rule’s requirement of “scientific knowledge” establishes a standard 
of evidentiary reliability, including “trustworthiness” and “scientific validity;” and (2) that the 
Rule requires that the scientific testimony “assist the trier of fact . . . [to make] a valid scientific 
connection of pertinent inquiry as a precondition to admissibility.” Id. at 590 n.9, 591-92.  The 
Court also laid out a flexible, non-exhaustive, four-factor test to determine the reliability of 
scientific expert testimony, examining (1) whether the scientific technique or theory can be or has 
been tested; (2) whether the theory or technique had been subject to peer review and published; 
(3) whether the technique or theory has an established rate of error or is governed by a set of 
established standards; and (4) whether the theory or technique has achieved a status of general 
acceptance in the relevant scientific community. Id. at 593-95; see also Robert J. Berlin, 
Epidemiology as More Than Statistics: A Revised Text for Products Liability, 42 TORT TRIAL & 
INS. PRAC. L.J. 81, 82-83 (2000); Margaret A. Berger, The Supreme Court’s Trilogy on the 
Admissibility of Expert Testimony, in FED. JUDICIAL CTR., REFERENCE MANUAL ON SCIENTIFIC 
EVIDENCE 9, 12-13 (2d ed. 2000) (providing a summary of the four factors). The first factor, 
testability, asks whether the hypothesis can be and has been challenged by conducting appropriate 
scientific testing.  Daubert, 509 U.S. at 593.  The Court described this as a “key question.”  Id.  
The second factor, peer review, examines whether the theory or technique has been examined by 
the relevant scientific community.  Id. at 593-94. 
[S]ubmission to the scrutiny of the scientific community is a component of “good 
science,” in part because it increases the likelihood that substantive flaws in 
methodology will be detected. The fact of publication (or lack thereof) in a peer 
reviewed journal thus will be a relevant, though not dispositive, consideration in 
assessing the scientific validity of a particular technique or methodology on which an 
opinion is premised. 
Id. (citations omitted). The third factor, existence of standards and rate of error, aids in assessing 
whether a scientific technique is likely to yield accurate results.  Id. at 594.  The final factor, 
general acceptance in the scientific community, harkens back to Frye but becomes only one non-
determinative factor in the reliability analysis.  Id.  The Court emphasized that the multi-factor 
reliability standard is a flexible one.  Id.  “The inquiry envisioned by Rule 702 is, we emphasize, 
a flexible one. Its overarching subject is the scientific validity—and thus the evidentiary 
relevance and reliability—of the principles that underlie a proposed submission.”  Id. at 594-95.  
The Court directed judges to employ these factors in a “gatekeeping role” and to exclude 
evidence which lacks reliability and fit.  Id. at 597.  “We recognize that, in practice, a 
gatekeeping role for the judge, no matter how flexible, inevitably on occasion will prevent the 
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thousands of medical reports generated by a handful of doctors.  In 
addition to this unprecedented use of a Daubert hearing in a mass tort 
proceeding,4 Judge Jack compelled the production of a large volume of 
 
jury from learning of authentic insights and innovations.”  Id.  Rule 702 “assigns to the trial judge 
the task of ensuring that an expert’s testimony both rests on a reliable foundation and is relevant 
to the task at hand.”  Id. 
 4 What is unprecedented is Judge Jack’s use of a Daubert hearing to determine the reliability 
of the litigation doctors’ diagnoses of silicosis and, therefore, the admissibility of their testimony.  
To comprehend the significance of Judge Jack’s decision, it is necessary to have some 
understanding of how proof of causation is introduced in a products liability or toxic tort trial.  In 
dealing with such litigation, courts differentiate between general causation and specific causation: 
General causation is established by demonstrating, often through a review of scientific 
and medical literature, that exposure to a substance can cause a particular disease (e.g., 
that smoking can cause lung cancer).  Specific, or individual, causation, however, is 
established by demonstrating that a given exposure is the cause of an individual’s 
disease (e.g., that a specific plaintiff’s lung cancer was caused by his smoking). 
Mary Sue Henifin, Howard M. Kipen, & Susan R. Poulter, Reference Guide on Medical 
Testimony, in REFERENCE MANUAL ON SCIENTIFIC EVIDENCE, supra note 3, at 439, 444  
(footnote  omitted). 
There have been frequent occasions when federal judges have excluded plaintiffs’ medical 
(and scientific) experts in Daubert hearings on the grounds of unreliability or irrelevance of their 
general causation testimony.  See, e.g., Ruggiero v. Warner-Lambert Co., 424 F.3d 249 (2d Cir. 
2005) (excluding expert medical testimony that the diabetes drug, Rezulin, was capable of 
causing or exacerbating cirrhosis of the liver); Gen. Elec. Co. v. Joiner, 522 U.S. 136 (1997) 
(affirming exclusion of physicians’ opinions that PCB exposure can cause small-cell lung 
cancer); see also David Klingsberg & Bert L. Slonin, Physicians’ Differential Diagnoses as 
Causation Proof: Recent Case Law Holds the Line in Requiring Daubert Reliability, 33 
PRODUCTS SAFETY & LIABILITY REP. 1129 (2005) (discussing courts’ rejection of differential 
diagnoses as not satisfying the Daubert reliability requirement with regard to general causation).  
In 1996, in an MDL proceeding, U.S. District Court Judge Robert E. Jones appointed independent 
advisors for the court on scientific issues and on the basis of their reports, held that testimony of 
plaintiffs’ experts that certain alleged diseases were caused by silicone breast implants was not 
based on accepted scientific evidence and would therefore be excluded.  Hall v. Baxter 
Healthcare Corp., 947 F. Supp. 1387 (D. Or. 1996).  
General causation is not an issue in most silica and asbestos litigation because it is indisputable 
that long-term exposure to crystalline silica dust can cause silicosis and that exposure to asbestos 
dust can cause asbestosis (as well as mesothelioma and lung cancer). 
The operative issue in silica litigation is whether there is specific causation, that is, whether a 
plaintiff has silicosis and if so, whether any exposure to silica dusts emanating from use of a 
plaintiff’s products or activity was a substantial factor in causing the silicosis. 
Generally, in personal injury cases, physicians often testify on one or more of the ultimate 
issues in the case such as specific causation.  Henifin, Howard, & Poulter, supra, at 445.  
Depending on the applicable substantive rule on the burden of proof, the physician may testify 
that a plaintiff’s disease is “more likely than not” due to exposure to plaintiff’s product or that 
such causation exists “to a reasonable degree of medical certainty.”  Id. 
A licensed physician who is a B Reader qualified by the National Institute for Occupational 
Safety and Health (NIOSH) to read chest X-rays and grade them on the International Labour 
Organization (ILO) scale or who is a pulmonologist, is qualified to testify as an expert on both 
causation and whether the plaintiff has a silica or asbestos-related disease.  In testifying that the 
plaintiff has silicosis, a plaintiff’s medical expert properly bases the diagnosis on (1) an X-ray 
reading or pathology; (2) a history of occupational or other exposure to crystalline silica dust; (3) 
a sufficient latency period from time of first exposure; and (4) a differential diagnosis in which 
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medical evidence, under threat of contempt, that the screening 
companies and doctors would not have otherwise produced.  In her 
opinion, Judge Jack documented in great detail the existence of a 
fraudulent scheme to create bogus medical evidence that led her to 
conclude that “it is apparent that truth and justice had very little to do 
with these diagnoses. . . . [Indeed] it is clear that lawyers, doctors and 
screening companies were all willing participants” in a scheme to 
“manufacture . . . [diagnoses] for money.”5 
Judge Jack’s findings largely corroborated my own conclusions, 
published a year earlier,6  with regard to the validity of X-ray readings, 
pulmonary function assessments and diagnoses of asbestosis produced 
in the course of litigation screenings.  In that article, I described how an 
illegitimate “entrepreneurial” model had been devised by lawyers, 
doctors and screening companies to screen hundreds of thousands of 
potential litigants for the sole purpose of generating claims of 
nonmalignant injury from asbestos exposure. 
More recently, U.S. District Court Judge James T. Giles, who 
succeeded the late Judge Charles Weiner in presiding over the asbestos 
MDL,7 reached the following conclusion after extensive hearings, 
 
the physician has ruled out other possible causes of the opacities shown on the x-ray, based upon 
a physical examination and pulmonary function tests.  Thus, if there is a positive diagnosis, the 
physician testifies (a) that the plaintiff has silicosis and (b) that the occupational (or other) 
exposure alleged was sufficient to cause the disease.  That testimony may be countered by a 
defendant’s medical expert, resulting in a typical “battle of the experts.” 
What was unprecedented in the silica MDL was Judge Jack’s use of a Daubert proceeding first 
to engage in discovery of the screening companies that had generated the approximately 10,000 
claims in the MDL and of the doctors who had provided most of the diagnoses, and then on the 
basis of the results of that discovery, to conclude that the doctors’ diagnoses were unreliable and 
therefore inadmissible.  Though not unprecedented, Judge Jack’s determination to have the 
screening company principals and diagnosing doctors deposed in her presence and to take an 
active role in the questioning was another key factor in unraveling the fraudulent scheme to 
manufacture diagnoses for money.  Indeed, had she not personally presided over the Daubert 
hearing (and used her knowledge as a nurse and her legal and medical research skills to obtain 
scientific information about silicosis and its incidence), it is doubtful that the fraudulent scheme 
would have been so clearly illuminated. 
 5 MDL 1553, 398 F. Supp. 2d at 635.  The court remanded virtually all of the cases back to 
state courts on the grounds that they had been improperly removed to federal courts. Id. at 567.  
Nevertheless, the court addressed “all of the diagnoses by all of the challenged doctors,” despite 
not having the jurisdiction to issue a ruling on the admissibility of the testimony regarding the 
diagnoses, id. at 637 (emphasis in original), because Judge Jack felt constrained to issue what 
was, in effect, an advisory opinion to state courts.  Since the Mississippi Supreme Court had 
adopted the federal Daubert standards, thus leading to the same standards under which Judge 
Jack reviewed the issues, she wanted to document the results “in hopes that the state courts that 
ultimately must shepherd these cases to their conclusion will not have to re-hear Daubert-type 
challenges to these doctors and their diagnoses.”  Id. 
 6 See Brickman, Asbestos Litigation, supra note 1. 
 7 In re Asbestos Prods. Liab. Litiga. (No. VI) (MDL 875), MDL Docket No. 875, 2002 U.S. 
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discovery, and motion practice: 
Current litigation efforts in this court and in the silica litigation have 
revealed that many mass screenings lack reliability and 
accountability and have been conducted in a manner which failed to 
adhere to certain necessary medical standards and regulations. . . . 
This court will therefore entertain motions and conduct such hearings 
as may be necessary to resolve questions of evidentiary sufficiency 
in non-malignant cases supported only by the results of mass 
screenings which allegedly fail to comport with acceptable screening 
standards.8 
 
A.     The “Entrepreneurial” Model of Litigation Screenings 
 
The core of the “entrepreneurial” model of nonmalignant asbestos 
litigation that I described is an unprecedented-in-scale litigant 
recruitment effort: the litigation screening.9  Entrepreneurial screening 
companies have been hired by lawyers to seek out persons with 
occupational exposure to dusts such as those containing crystalline 
silica or asbestos.  Mobile X-ray vans are brought to local union halls, 
motels, or strip mall parking lots, where X-rays are taken on an 
assembly-line rate of one every five to ten minutes.  In addition to the 
X-rays, most screening companies also administer pulmonary function 
tests (PFTs) to determine lung impairment for the sole purpose of 
generating evidence for litigation purposes.10 
The sole object of these screenings is to generate medical reports to 
be used to support claims of asbestosis, a scarring of the lung tissue 
caused by exposure to asbestos.11  In the 1988-2006 period, well over 
 
Dist. LEXIS 16590 (E.D. Pa. Jan. 14, 2002). 
 8 Administrative Order No. 12, MDL 875, (May 31, 2007). 
 9 Brickman, Asbestos Litigation, supra note 1, at 62-83. 
 10 See id. at 111 (describing pulmonary function tests); see also infra, note 197. 
 11 Prolonged exposure to scores of different dust particles, which penetrate the lung’s forward 
line of defenses, results in the accumulation of macrophages and inflammatory cells in the alveoli 
(the air exchange sacks of the lung), which can lead to a scarring of lung tissue.  See generally 
Ken Donaldson & C. Lang Tran, Inflammation Caused by Particles and Fibers, 14 INHALATION 
TOXICOLOGY 5 (2002).  When that occurs, the condition is termed “interstitial or parenchymal 
fibrosis.”  The ILO adopted the term pneumoconiosis to describe the reaction of lung tissue to the 
accumulation of dust in the lungs at the the Fourth ILO International Conference on 
Pneumoconiosis, in Bucharest in 1971.  See Int’l Labour Org., Pneumoconioses Definition, 
http://www.ilo.org/encyclopedia/?doc&nd=857400196&nh=0 (last visited Feb. 20, 2007).  The 
ILO excludes certain occupational chronic pulmonary diseases from the pneumoconiosis because 
although they develop from the inhalation of dust, the particles are not known to accumulate in 
the lungs.  Id.  If the fibrosis is the result of exposure to crystalline silica (sand dust, quartz, etc.), 
the condition is termed “silicosis”; if it is the result of exposure to asbestos, it is called 
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90% of the approximately 585,000 nonmalignant claims for 
compensation filed with the Manville Trust12 were generated by these 
litigation screenings.13 
To read the hundreds of thousands of chest X-rays and pulmonary 
function tests generated by the litigation screenings and to produce the 
massive numbers of medical reports needed to advance the scheme, 
plaintiffs’ lawyers and the screening companies have hired a small 
number of doctors who share one common characteristic: their apparent 
willingness to enter into business transactions with lawyers and 
screening companies for the sale of tens of thousands of X-ray readings 
and diagnoses in exchange for the payment of millions of dollars.  
These X-ray readers, usually radiologists and pulmonologists, have 
been certified by the National Institute for Occupational Safety and 
 
“asbestosis.”  W. RAYMOND PARKES, OCCUPATIONAL LUNG DISORDER 285, 411 (3d ed. 1994).  
Fibroses caused by exposure to different dusts encountered in occupational settings, as well as by 
numerous other causes, may manifest differently on an X-ray.  See infra notes 162-170.  While 
the determination of the cause of a fibrosis may have a medical purpose, the principal reason for 
determining that the cause is asbestos exposure is a function of the compensation system.  
Whereas a diagnosis of another cause of fibrosis may yield no compensable claim, a diagnosis of 
asbestosis may enable the subject to be eligible for substantial compensation. 
In its mildest form, asbestosis may cause no breathing impairment and is detectable only by 
chest X-ray or high resolution CAT scan.  In more severe cases, significant fibrosis can decrease 
the elasticity of the lungs, and “interfere with the lung’s ability to oxygenate the blood.”  AM. 
BAR ASSOC., COMM’N ON ASBESTOS LITIG., ABA REPORT TO THE HOUSE OF DELEGATES, 
RECOMMENDATION & RESOLUTION 7 (2003) [hereinafter ABA REPORT] (“Asbestotic lungs are 
characterized by reduced capacity, i.e., they can process only a reduced volume of air compared 
to normal lungs.  Workers who suffer from significant asbestosis generally have shortness of 
breath on exertion.”).  In its most severe form, asbestosis is progressive and debilitating and can 
lead to death. 
 12 The Manville Personal Injury Settlement Trust (Manville Trust) is the entity created as a 
consequence of the bankruptcy of the Johns-Manville Corp. in 1982 to which all claims against 
Johns-Manville relating to asbestos exposure were channeled.  Johns-Manville mined most of the 
asbestos used in the United States and was by far the leading manufacturer of asbestos-containing 
materials.  Prior to its bankruptcy filing, the company was the one most frequently sued for 
causing asbestos related injury.  See Brickman, Asbestos Litigation, supra note 1, at 54.  The 
company’s filing for bankruptcy led plaintiffs’ lawyers to develop the “entrepreneurial” model 
described in this Article.  See Lester Brickman, The Asbestos Litigation Crisis:  Is There A Need 
For An Administrative Alternative?, 13 CARDOZO  L. REV. 1819, 1825 (1992) [hereinafter 
Brickman, Administrative Alternative?]. 
 13 See S. COMM. ON THE JUDICIARY, THE FAIRNESS IN ASBESTOS INJURY RESOLUTION ACT 
OF 2003, S. REP. NO. 108-118, at Attachment A (2003) .  The Senate Judiciary Commission cites 
to a letter from Steven Kazan to the Honorable Jack B. Weinstein, which states that David 
Austern reported at a conference that “90% of the [Manville] Trust’s last 200,000 claims have 
come from attorney-sponsored x-ray screening programs, [and] that 91% of all claims allege only 
non-malignant asbestos ‘disease.’”  Id.  Since about 10% of the claims were for malignancies, 
then the reference to 90% of claims generated by screenings is the equivalent of virtually 100% of 
the nonmalignant claims.  See also STEPHEN CARROLL ET AL., ASBESTOS LITIGATION 75 (RAND 
Institute for Civil Justice 2005); Lester Brickman, Ethical Issues In Asbestos Litigation, 33 
HOFSTRA L. REV 833, 834 (2005) [hereinafter Brickman, Ethical Issues]. 
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Health (NIOSH) as B Readers,14 which is an indication of special 
competence in reading chest X-rays and classifying them on the 
International Labour Organization (ILO) scale.15  A small number of B 
Readers, perhaps 4-6% of all certified B Readers,16 are most frequently 
selected by plaintiffs’ lawyers to read most of the hundreds of thousands 
of X-ray films generated by screenings.  These B Readers grade most of 
 
 14  NIOSH, part of the Centers for Disease Control and Prevention (CDC), awards B Reader 
approvals to individuals who meet a specified level of proficiency in classifying chest X-rays 
according to the ILO scale. See infra note 15. These B Readers are usually, but not always, 
licensed physicians and must be re-certified at 4-year intervals.  ABA REPORT, supra note 11, at 
14. 
 15 The degree of fibrosis appearing on a chest X-ray is graded according to a classification 
system developed by the International Labour Organization (ILO) INT’L LABOR ORG., 
GUIDELINES FOR THE USE OF ILO INTERNATIONAL CLASSIFICATION OF RADIOGRAPHS OF 
PNEUMOCONIOSIS (rev. ed. 1980) [hereinafter ILO GUIDELINES]; see also DIV. OF RESPIRATORY 
DISEASE STUDIES, NAT’L INST. FOR OCCUPATIONAL SAFETY & HEALTH & CENTERS FOR 
DISEASE CONTROL AND PREVENTION, THE CLASSIFICATION OF RADIOGRAPHS OF 
PNEUMOCONIOSES, in STUDY SYLLABUS FOR CLASSIFICATION OF RADIOGRAPHS OF 
PNEUMOCONIOSES (2002) (acting as a study guide for the application of the ILO radiographic 
classification system; prepared under contract by the Task Force on Pneumoconioses of the 
American College of Radiology).  The system uses a scale that was developed to systematically 
record the radiographic abnormalities in the chest provoked by the inhalation of dusts.  ILO 
GUIDELINES, supra, at 1, 2.  According to the ILO: 
The object of the Classification is to codify the radiographic abnormalities of 
pneumoconiosis in a simple reproducible manner.  The Classification does not define 
pathological entities, nor take into account working capacity.  The Classification does 
not imply legal definitions of pneumoconiosis for compensation purposes, nor set nor 
imply a level at which compensation is payable. 
The Classification is based on a set of standard radiographs, a written text and a set 
of notes.  In some parts of the scheme the standard radiographs take precedence over 
the text for the definitions; the text makes it clear when this is so. 
Id. 
On the ILO scale, chest X-rays are classified according to the number of abnormalities (termed 
“opacities”) in a given area of the chest film.  A zero corresponds to no abnormalities, one to 
slight, two to moderate, and three to severe.  “Since this process is to some degree inherently 
subjective, readers give two classifications, the category that they think most likely and next most 
likely.  The result is a 12 point scale, with results ranging from 0/0 (normal [X-ray] appearance) 
to 3/3 (severe abnormalities).”  In re Joint E. & S. Dists. Asbestos Litig., 237 F. Supp. 2d 297, 
308.  (E.D.N.Y.& S.D.N.Y. 2002). The vast majority of screening X-rays (for which asbestosis is 
claimed) are read as 1/0, which means the X-ray on first impression is at the lowest level of 
abnormality (1), but may be normal (0).  See infra note 206.  A reading of 1/1 is stronger than a 
1/0 and means that the reader found clear evidence of irregularities.  ABA REPORT, supra note 
11, at 13.  For purposes of identifying and locating opacities, the ILO form divides the lungs into 
six zones, upper, middle, and lower, left and right.  For a diagnosis of asbestosis, the opacities 
should be found bilaterally in the lower zones.  Nonetheless, a B Reader may assign a 1/0 grade 
even if he finds irregular opacities in only one of the six zones. 
 16 As of December 15, 2005, NIOSH listed 387 B Readers on its website.  Nat’l Inst. For 
Occupational Safety & Health, NIOSH B Reader List (2005), 
http://www.cdc.gov/niosh/topics/chestradiography/breader-list.html.  On July 22, 2003, it listed 
431. Id.  On April 25, 2002, it listed 535. Id.  And on February 20, 1998, NIOSH listed 627 B 
Readers.  Id. 
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these X-rays as 1/0 on the ILO scale and describe their findings of 
radiographic evidence of fibrosis as “consistent with asbestosis.”  Along 
with a small number of other doctors, they diagnose the vast majority of 
litigants thus found to have lung profusions of 1/0 or greater as having 
mild asbestosis17  (or silicosis—if that is the purpose of the screening, or 
both asbestos and silicosis18). These B Readers and other doctors, 
numbering approximately twenty-five, have accounted for a 
dramatically disproportionate percentage of the total number of X-ray 
readings and medical reports that have been submitted as evidence in 
support of nonmalignant asbestos personal injury claims.19  Indeed, the 
reliance on a small number of B Readers and diagnosing doctors is a 
defining characteristic of the “entrepreneurial” model.20 
Based on the evidence I examined, I concluded that the majority of 
the hundreds of thousands of medical reports generated by the litigation 
screenings were not the product of good faith medical practice; rather 
they were produced in the course of business transactions involving the 
sale of X-ray readings and diagnoses for tens of millions of dollars in 
fees.  I opined that the vast majority of those diagnosed with asbestosis 
 
 17 A diagnosis of asbestosis, when done in a clinical rather than a litigation setting, is based 
on a chest X-ray, physical exam, including a medical and occupational history, and a 
measurement of lung function. Am. Thoracic Soc’y, Diagnosis and Initial Management of 
Nonmalignant Diseases Related to Asbestos, 170 AM. J. RESPIRATORY CRITICAL CARE MED. 
691, 695-97 (2004) (publishing the official statement of the American Thoracic Society as 
adopted by its Board of Directors on Dec. 12, 2003); see also infra note 141. 
 18 See infra note 219. 
 19 A study of a stratified sample of claims submitted to Owens Corning before its bankruptcy 
filing indicated that just five B Readers (Drs. Raymond Harron, Jay Segarra, Richard Keubler, 
Philip H. Lucas and James W. Ballard) had read over eighty percent of the X-rays, with Dr. 
Harron alone accounting for forty-six percent of the X-ray readings.  Report of Dr. Gary K. 
Friedman Owens Corning Impaired Nonmalignant Claim Submissions 1994-1999 (approx.) at 11, 
18, 21 (c. 2000) (unpublished report, on file with the Cardozo Law Review).  The Manville Trust 
reported that of 199,533 claims it processed in the period January 1, 2002 to June 30, 2004, just 
twenty B Readers accounted for sixty-two percent of the total B Readings.  See David T. Austern, 
Claims Resolution Management Co., 2004 Asbestos Claim Filing Trends 8 (Sept. 2004) 
(Unpublished Power Point Presentation, on file with the Cardozo Law Review).  The Trust 
further reported that as of December 31, 2005 of the many hundreds of B readers in its files, the 
top twenty-five who authored B reads in support of claims submitted to the Trust accounted for 
sixty-six percent (89,092) of the 135,235 B reads in its records.  CRMC Response to Amended 
Notice of Deposition Upon Written Questions at Exh B, In re Asbestos Prods. Liab. Litig. (No. 
VI), Civ. Action No. MDL 875 (E.D. Pa. Mar. 2, 2006) [hereinafter CRMC Response].  Of the 
thousands of doctors who submitted diagnoses, the top twenty-five who were identified in the 
Trust’s records as the primary diagnosing doctor accounted for forty-six percent (255,928) of the 
total of 552,045 claims that permitted such identification.  Id. at exh. C. 
 20 In the silica MDL, Judge Jack noted that “the over 9,000 Plaintiffs who submitted Fact 
Sheets were diagnosed with silicosis by only 12 doctors . . . affiliated with a handful of law firms 
and mobile x-ray screening companies.”  In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. 
Supp. 2d 563, 580 (S.D. Tex. 2005). 
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would not have been found to have an asbestos-related disease if they 
were examined in a clinical setting by doctors without a financial stake 
in the litigation.21  
Subsequent to Judge Jack’s opinion, I published another article in 
which I concluded that Judge Jack’s findings with regard to silica 
claims applied in full measure to nonmalignant asbestos litigation.22 
Judge Jack’s opinion has been widely covered in the news media23 
and is still reverberating around the mass tort world.  Much less 
heralded is the fact that Judge Jack ordered that the X-rays and medical 
records, generated by the unprecedented discovery that she had 
permitted, be placed in a repository where it could be accessed by the 
MDL 1553 parties.24  These records, which include the N&M screening 
company’s files on asbestos screenings, are now being systematically 
examined. 
In addition to the litigation screening files that have been made 
available by Judge Jack, additional such files are being accumulated in 
the course of ongoing discovery in the asbestos MDL—a federal 
proceeding that may include as many as 100,000 plaintiffs that has been 
underway for over fifteen years.25  While this proceeding has been 
largely inactive for the nonmalignant claims for at least the past ten 
years, Judge Jack’s decision in MDL 1553 has motivated defendants to 
seek similar discovery as that permitted by Judge Jack.  These attempts 
are being stoutly resisted by plaintiffs’ counsel.26  While presiding 
Judge James T. Giles has been cautious in permitting discovery,27 he 
 
 21 See Brickman, Asbestos Litigation, supra note 1, at 42-43. 
 22 Lester Brickman, On the Applicability of the Silica MDL Proceeding to Asbestos 
Litigation, 12 CONN. INS. L.J. 289 (2006) [hereinafter Brickman, Silica/Asbestos Litigation].   
 23 See, e.g., Jonathan D. Glater, Reading X-Rays in Asbestos Suits Enriched Doctor, N.Y. 
TIMES, Nov. 29, 2005, at A1; Luke Boggs, Legal Matters: Frivolous Claims Spur Backlash, 
ATLANTA J.-CONST., June 14, 2005, at A11; Mike Tolson, Attorneys Behind Silicosis Suits Draw 
U.S. Judge’s Wrath / Houston Legal Firm Fined; Order From Bench Says Diagnoses Made For 
The Money, HOUSTON CHRON., July 2, 2005, at A1; Peter Geier, Silica Case Seen As 
Breakthrough, NAT’L L.J., Aug. 1, 2005, at 1; The Silicosis Sheriff, WALL ST. J., July 14, 2005, at 
A10. 
 24 See Order: MDL X-Ray Repository in Mississippi, In re Silica Prods. Liab. Litig. (MDL 
1553), 398 F. Supp. 2d 563 (S.D. Tex. 2005) (MDL 1553), available at 
http://docs.mdl1553.com/docs/6055.pdf. 
 25 In re Asbestos Prods. Liab. Litig. (No. VI) (MDL 875), 771 F. Supp. 415, (J.P.M.L. 1991).  
The MDL was transferred to the Eastern District of Pennsylvania on July  29, 1991.  Id. at 417; 
see Judicial Panel On Multi-District Litigation, available at 
www.jpml.uscourts.gov/Pending_MDLs/Products_Liability/MDL-875/mdl-875.html (last visited 
Aug. 18, 2007). 
 26 See, e.g., Plaintiffs’ Motion to Quash the Subpoenas Served By Forman Perry Upon 
Various Diagnosing Physicians and Entities, MDL 875, 771 F. Supp. 415 (E.D. Pa. Mar. 23, 
2007) (MDL 875). 
 27 In response to motions to compel production of documents and countermotions to quash 
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has come to recognize that the medical reports generated by asbestos 
litigation screenings “lack reliability and accountability.”28 Some of the 
documentary evidence that has been ordered to be produced has already 
proved valuable in affording additional insight into litigation screening 
practices.  Like the records produced in MDL 1553, the records being 
produced in MDL 875 are also being systematically examined. 
In this Article, I present some of the findings of these ongoing 
examinations as well as other data which has recently become available 
that addresses the issue of whether a substantial proportion of the 
hundreds of thousands of medical reports generated by asbestos 
litigation screenings have also been “manufactured for money.”  In 
particular, I focus on data indicating the percentage of X-rays read as 
indicating radiographic evidence of pulmonary fibrosis which is 
“consistent with asbestosis” (the “positives” rate or the “percent 
positive”) by the comparative handful of doctors who account for a 
majority of the hundreds of thousands of medical reports produced by 
litigation screenings and, as well, the percentage of these “positives” 
who are then diagnosed with asbestosis “within a reasonable degree of 
medical certainty.”  To understand the significance of this data properly, 
I summarize the results of a review of clinical studies of the prevalence 
of radiographic evidence of fibrosis and diagnoses of asbestosis among 
workers occupationally exposed to asbestos and compare that to the 
prevalence rates of the doctors involved in the asbestos litigation 
screenings (litigation doctors). 
I also summarize the results of seven clinical studies or their 
equivalent in which X-rays generated by litigation screenings and read 
as indicating radiographic evidence of fibrosis, which were “consistent 
with asbestosis,” were re-read by independent medical experts who 
found very high error rates. 
Another comparison presented is that between the ratio of findings 
of pleural plaques to pulmonary fibrosis found in clinical studies to the 
ratio in litigation screenings.  This ratio abruptly changed from one that 
was moderately consistent with clinical studies to one that was widely 
inconsistent when a global settlement (later invalidated by the U.S. 
Supreme Court) significantly devalued pleural plaque claims. 
Another facet of litigation screenings that I examine in this Article 
is the administration of pulmonary function tests to determine the 
degree of lung impairment and qualify the litigant for increased 
 
subpoenas, Judge Giles stated: “This Court . . . is not an investigating Grand Jury. . . . I do not 
presume that there is fraud in mass tort litigation.”  Transcript of Motions Hearing, MDL 875, 771 
F. Supp. 415 (E.D. Pa. Jan. 31, 2007) (MDL 875). 
 28 See Administrative Order No. 12, supra note 8, at ¶ 7.  
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compensation.  Here too, I summarize the findings in medical literature 
which are significantly inconsistent with the outcomes of the pulmonary 
function tests administered in litigation screenings. 
I also compare the pandemic proportions of nonmalignant 
asbestos-related disease claims which were filed in the 1990-2004 
period in the tort system and with asbestos bankruptcy trusts with the 
paucity of hospitalizations primarily for asbestosis in that period. 
I then review some of Judge Jack’s findings in the silica MDL and 
how they bear on the reliability of X-ray readings and diagnoses of 
asbestosis and silicosis generated by litigation screenings.  Evidence 
introduced in the silica MDL indicates that 60-70% of the 10,000 
silicosis claimants had previously filed claims for asbestosis.  Medical 
literature, however, indicates that having both diseases is a clinical 
rarity.  One of the lead plaintiff’s counsel in the silica MDL attempted 
to exonerate his firm’s actions in filing dual disease claims by arguing 
that the previous diagnoses of asbestosis were “wrong” and that his firm 
did not file asbestosis claims.  A careful recitation of the record, 
however, reveals that the firm had formed an affiliate firm which did 
file asbestos claims with the fees shared with the parent firm.  Indeed at 
screenings sponsored by the firm, a litigation doctor made a diagnosis 
of silicosis and forwarded that to the firm and, at the same time and for 
the same litigant, made a diagnosis of asbestosis and forwarded it to the 
affiliate firm. 
Finally, I examine the possibility that the litigation doctors have 
predetermined “signature” percentages of positive X-ray readings and 
diagnoses.  Bearing on this is the detailed record I present of the 
concerted refusal of the litigation doctors to provide records of all of 
their X-ray readings and diagnoses in response to subpoenas and court 
orders—records that may enable calculation of their percent positives 
that could be “smoking gun” evidence of fraud. 
The conclusion I draw from the data and evidence presented is that 
Judge Jack’s findings with regard to the medical reports in the silica 
MDL apply with at least equal force to nonmalignant asbestos litigation: 
the medical reports are mostly “manufactured for money.” 
 
I.     THE PREVALENCE OF FINDINGS OF FIBROSIS “CONSISTENT WITH 
ASBESTOSIS” AND OF DIAGNOSES OF ASBESTOSIS IN LITIGATION 
SCREENINGS 
 
Asbestos litigation screenings are an enormously profitable 
commercial enterprise.  The purpose of these screenings is to identify 
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potential litigants and generate medical reports to support claims for 
compensation.  No health benefits are intended.29  In the 1990-2000 
period, each screened litigant cost attorneys approximately $500-$1000 
and represented a net potential value to the attorney paying for the 
screening of $30,000-$50,000 in the form of fees and expenses.30  To 
assure that a high percentage of those screened become litigants, 
lawyers select B Readers who have demonstrated a great propensity to 
find that a high percentage of the X-rays they are asked to review for 
asbestos litigation purposes are graded as 1/0 or higher on the ILO 
scale.31  ILO guidelines require that the B Reader read all X-rays blind 
to “any information about the individuals other than the radiographs 
themselves.”32  This includes information about an individual’s 
occupational and exposure history.  Leaving nothing to chance, 
however, plaintiffs’ lawyers routinely instruct B Readers that the 
purpose of reading the X-ray is to determine whether the individual has 
a claim for asbestosis or silicosis.  As concluded by Judge Jack: 
[I]n the setting of mass screening and/or mass B-reading for 
litigation, the B-reader is acutely aware of the precise disease he is 
supposed to be finding on the X-rays.  In these cases, the doctors 
repeatedly testified that they were told to look for silicosis, and the 
doctors did as they were told.33 
B Readers’ responsiveness to these directions from the lawyers that 
hired them is indeed impressive.  As noted by Judge Jack: 
[A]fter December 31, 2000 (when N&M changed its focus from 
asbestos to silica litigation), Dr. Harron [working for N&M] found  
[lung] opacities (consistent with silicosis) in 99.6% of the 6,350 B-
reads he performed for MDL Plaintiffs.  But prior to December 31, 
2000 (when N&M focused on asbestos litigation), Dr. Harron 
performed B-reads on 1,807 of the same MDL Plaintiffs for asbestos 
litigation and he found . . . opacities (consistent with asbestosis but 
not silicosis) 99.11% of the time.34 
The “entrepreneurial” business plan for generating claims by use of 
screenings has been highly effective.  My research leads me to conclude 
 
 29 See Brickman, Asbestos Litigation, supra note 1, at 64-65. 
 30 See Thomas Korosec, Enough To Make You Sick, DALLAS OBSERVER, Sept. 26, 2002, at 3 
[hereinafter Korosec, Enough To Make You Sick]; Brickman, Ethical Issues, supra note 13, at 
841-42. 
 31 For an explanation of how a new B Reader was tested to see whether he measured up to the 
standard for selection, see Brickman, Asbestos Litigation, supra note 1, at  86 n.174. 
 32 In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 626 (S.D. Tex. 2005). 
 33 Id. at 627.  It was “the lawyers [who] determined first what disease [the litigation doctors]  
would search for and then what criteria would be used for diagnosing that disease.”  Id. at 634-35. 
 34 Id. at 607-08 (footnote omitted). 
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that the comparative handful of B Readers employed by screening 
companies and plaintiffs’ lawyers are mostly reading 50-90% of the X-
rays generated by screenings as indicating radiographic changes graded 
as 1/0 or higher on the ILO scale which are “consistent with 
asbestosis.”35  A number of these B Readers have testified that their 
 
 35 See Brickman, Asbestos Litigation, supra note 1, at 84-89 nn. 159-64 (concluding on the 
basis of the evidence that I had then examined that 60-80% of the X-rays were being graded as 
1/0 or higher); see also Joseph N. Gitlin et al., Comparison of “B” Readers’ Interpretations of 
Chest Radiographs for Asbestos Related Changes, 11 ACAD. RADIOLOGY 843, 844 (2004). (“A 
small number of B Readers has [sic] made reputations with attorneys by consistently interpreting 
chest radiographs of asbestos claimants as positive [i.e., 1/0 on the ILO scale] in 90-100% of 
cases.”). 
The silica MDL generated a treasure trove of data about the activities of N&M, a screening 
company which did both asbestosis and silicosis screenings and which was responsible for a 
majority of claims included in the silica MDL.  But for Judge Jack’s rulings that N&M and other 
screening companies and doctors submit to examination in her presence and provide extensive 
records under threat of contempt, this inculpatory data would never have seen the light of day.  
N&M was incorporated in Mississippi in 1996 by Heath Mason and Molly Netherland. Transcript 
of Daubert Hearings at 266-67, MDL 1553, 398 F. Supp. 2d  at 563  (testimony of Heath Mason).  
N&M has screened over 47,000 individuals.  Certain Defendants’ First Amended Supplemental 
Brief in Response to Plaintiff’s Challenge to the Constitutionality of Florida’s Asbestos and Silica 
Compensation Fairness Act at 9, Perry v. Am. Optical Corp., No. 99-0869-AI (Fla., Palm Beach 
County Ct., 2006) (citing to N&M records produced in MDL 1553, Sales by Item Summary).  
These screenings were held in Alabama, Arkansas, California, Florida, Hawaii, Illinois, 
Kentucky, Louisiana, Missouri, Mississippi, Ohio, Pennsylvania, Texas, Wisconsin, West 
Virginia, and the Virgin Islands.  Id. at 8.  N&M’s financial records indicate gross receipts 
totaling over $25 million between July 1996 and April 2005.  Id. at 9 (citing to an N&M record, 
Income by Customer Summary). N&M did work for numerous law firms including: Reyes & 
O’Shea; Provost Umphrey; the Ferraro Law Firm; O’Quinn, Laminack & Pirtle; the Foster Law 
Firm; and Campbell, Cherry, Harrison, Davis & Dove.  Id. at 18.  A review of specific screening 
records provided by N&M in the silica MDL indicates that at those specific screenings, N&M’s 
doctors found that between 80% and 95% of the individuals had “positive” ILO profusions of 1/0 
or greater.  Transcript of Daubert Hearings at 302, MDL 1553, 398 F. Supp. 2d 563 (Feb. 17, 
2005) (testimony of Heath Mason).   
One of the principal N&M doctors accounting for this positive rate is Dr. Ray Harron, who 
is the most prolific, by far, of the litigation B Readers.  See CMRC Response, supra note 19, at 
Exh. F.  Dr. Harron’s positive rate for X-ray readings for the West Virginia law firm of Peirce, 
Raimond & Coulter since 2000 was approximately 97.5%.  See Amended Complaint ¶36, CSX 
Transportation, Inc. v. Gilkison et al., Civil Action No. 5:05-cv-202 (N.D. W.Va. July 5, 2007) 
(citing to E-mail dated January 27, 2006 from Robert Potter, former defense counsel for the 
Peirce firm, to J. David Bollen.)  Dr. Harron’s diagnosis rate is set forth in infra note 37.  Dr. 
James Ballard appears to have read 99 of 100 X-rays sent to him by the law firm of Nix, Patterson 
& Roach as positive for asbestosis.  See Dr. Steven E. Haber, Diagnostic Practices in a Litigation 
Context’s Screening Companies and The Doctors they Employed, June 11, 2007, at 25, In re 
W.R. Grace & Co., No. 01-01139 (JFK) (Bankr. D. Del. 2006).  “For another set of X-rays for the 
same law firm, Dr. Ballard invoiced only for positive reads and had a 97% positive rate involving 
1000 films.”  Id.; see also infra note 124 and accompanying text.  
Another source of information about the results of litigation screenings are the records being 
produced in the course of the recent proceedings and discovery in MDL 875.  A review of 
documents and materials produced by Respiratory Testing Services, Inc. (RTS) in MDL 875 
indicates that RTS screened at least 40,507 individuals over the course of 669 days in 35 different 
states.  See Certain Defendants’ Combined Motion and Brief to Exclude Diagnostic Materials 
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Created by Respiratory Testing Services, Inc. and To Dismiss Claims of Plaintiffs Relying On 
Same at 8, MDL 875, 771 F. Supp 415 (E.D. Pa. Apr. 3, 2007) (MDL 875) [hereinafter Motion to 
Exclude RTS Claims] (citing to documents on file in the court’s document depository).  A review 
further indicates that of approximately 25,155 unique ILO forms generated by screenings 
conducted by RTS, 13,941 (55.5%) were graded as 1/0 or higher.  Id.  Charles Foster who 
founded RTS testified in the silica MDL that he had assured plaintiffs’ lawyers when he worked 
at Pulmonary Testing Services prior to forming RTS that he could generate positive findings in 
75% of litigants.  Transcript of Daubert Hearings at 169, MDL 1553, 398 F. Supp. 2d 563 (Feb. 
18, 2005) (testimony of Charles Foster).  However he contends that RTS’s positive rate goal was 
about 40 percent.  Id. at 170.  For a description of RTS, see Brickman, Asbestos Litigation, supra 
note 1, at 81.  The founder of RTS, Charles Foster, has repeatedly pled the Fifth Amendment in 
refusing to testify before Congress and in civil proceedings with regard to the litigation 
screenings he conducted.  See infra note 256. 
In litigation screenings of 700-750 active and retired tire workers done in the late 1980’s, 439 
(58.5%-62.7%) were found to have radiographic evidence of exposure to asbestos and on that 
basis, had filed claims for compensation.  See R.B. Reger et al., Cases of Alleged Asbestos-
Related Disease: A Radiologic Re-Evaluation, 32 J. OCCUPATIONAL MED. 1088 (1990) 
[hereinafter Reger et al., 1990]. 
Other empirical and documentary data that I assembled indicates that PTS, another screening 
company, generated a 70% positive rate on initial X-ray screenings.  See Brickman, Asbestos 
Litigation, supra note 1, at n.164.  Most of PTS’ B readings were done by Dr. Richard Kuebler 
and to a lesser extent, Dr. Philip Lucas, his partner.  Dr. Larry Mitchell testified that for the period 
1990-1995, he had a positive rate of around 60%.  Id.  Other screening companies also generated 
positive rates in the 70-80% range.  Id.  Dr. Barry Levy testified in the silica MDL that he 
reviewed 860 reports in a 72 hour period and concluded that all 860 plaintiffs had silicosis.  
Transcript of Daubert Hearings at 67, MDL 1553, 398 F. Supp. 2d 563 (Feb. 16, 2005) (testimony 
of Dr. Barry Levy). 
Dr. Jay T. Segarra is one of the most prolific B readers and diagnosing doctors in asbestos 
litigation.  According to the Manville Trust, Dr. Segarra provided 38,447 positive reports in 
support of claims submitted to the Trust as of December 31, 2005.  See CRMC Response, supra 
note 19, at Ques. 14(a) and 14(c).  Only two doctors authored more positive reports than did Dr. 
Segarra.  Id.  For these services, Dr. Segarra has been paid “about $10 million.”  Wade Goodwyn, 
Silicosis Ruling Could Revamp Legal Landscape, on All Things Considered (Nat’l Public Radio 
Broadcast, March 6, 2006), 2006 WLNR 22951933, available at 
http://www.npr.org/templates/story/story. php?storyId=5244935.  On one occasion, Dr. Segarra 
testified that he found 20-35% of the X-rays he reviewed positive for asbestosis.  Deposition of 
Dr. Jay T. Segarra at 40, Moorehouse v. N. Am. Refractories Co., No. CI-2002-00253(2), (D. 
Miss. Oct. 14, 2002).  In depositions taken in 2002, 2003, 2004 and 2006, Dr. Segarra variously 
testified that in screenings, his percentage of positive X-ray readings ranged from 10-20% and 10-
40%.  Deposition of Dr. Jay T. Segarra, at 232-37, In re: W.R. Grace & Co., No. 01-1139 (JFK) 
(Bankr. D. Del. Nov. 20, 2006).  On the basis of my own analysis of available data, I previously 
concluded that Dr. Segarra’s positive rate for X-ray readers was at least 40%.  Brickman, 
Asbestos Litigation, supra note 1, at n. 164.  In response to a recent subpoena for his records, Dr. 
Segarra produced a redacted version of the response he had submitted to an August 2, 2005 
request from the House Committee on Energy and Commerce for all records relating to his 
diagnoses of silicosis and to his work for screening companies.  See Deposition of Dr. Jay T. 
Segarra at Exh. No. 28, Ragsdale v. Able Supply Co., No. 2005 -76615 (Tex. Dist. Ct. June 29, 
2006)  Dr. Segarra’s response indicates that he did not turn over the requested records to the 
House Committee.  Instead, he provided only his own statistical analysis of what he alleges his 
records contain—not the actual underlying records, and only for the period January 2003 through 
June 2005, and only for X-ray impressions and diagnoses.  Dr. Segarra began providing litigation 
support for asbestos claims in 1992 for Pulmonary Function Laboratory.  Deposition of Dr. Jay T. 
Segarra, Abernathy v. ACandS, Inc, No. A-290, 967-C. (Tex. Dist. Ct. Aug. 1, 1995) .  Moreover, 
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in responding to the subpoena in Ragsdale, Dr. Segarra deleted information that he had provided 
to the House Committee indicating which lawyers he had done screenings for in the two and a 
half year period.  By limiting his response to January 2003 through June 2005, Dr. Segarra 
omitted, inter alia, providing data as to whatever role he may have played in the phantom 
silicosis epidemic that commenced in 2002, see infra notes 216-224, and his oversight of RTS 
screenings as its de facto medical director from 1995-2000. 
According to the deposition, id., Dr. Segarra states that he reviewed 13,329 X-rays for a variety 
of purposes in the two and a half year period of which 266 were unreadable.  Of the 13,063 films 
which were readable, Dr. Segarra states that he read 46.6% as positive (6,092) and 53.36% 
negative (6,471).  Asbestosis was the most common impression (33%).  Id.  Of the 4,276 relevant 
medical reviews he rendered in this period which could be tabulated, he issued positive diagnoses 
in 82.8% (3,540) and negative findings for disease in 17.2% (736).  Id.  During this period, Dr. 
Segarra provided X-ray impressions and/or diagnoses for approximately 93 different attorneys, 
including Baron & Budd, Brent Coon & Associates, Ness Motley, Hissey Kientz, and Heard, 
Robins and Cloud.  Id.  Dr. Segarra identified three screening companies for which he did these 
readings and reports: N&M, RTS, and Holland & Bieber.  Id.  According to the limited 
information provided, Dr. Segarra invoiced a total of at least $889,220 for X-ray readings and 
diagnoses in 2004 and $380,735 for the first six months of 2005.  Id.  Annualized, this amounts to 
$847,000 per year.  Additional data recently compiled indicates that Dr. Segarra made positive X-
ray findings in 42% of 11,378 X-rays read for RTS, see Certain Defendants’ Combined Motion 
and Brief to Exclude Expert Testimony by Dr. Jay T. Segarra and to Dismiss the Claims of 
Plaintiffs Relying on Same at 23, In re Asbestos Prods. Liab. Litig. (No. IV), MDL Docket No. 
MDL 875  (E.D. Pa. Sept. 7, 2007), and made positive findings in 50% of 18,463 X-rays read for 
Workers’ Disease Detection Service. Id. 
Dr. Segarra’s asserted positive rates of around 47% for thousands of X-ray readings and 83% 
for thousands of diagnoses appear to be attained irrespective of the work histories of those 
screened, their degree of exposure to occupational dust-containing products that allegedly caused 
the opacities or disease or any other factors that would appear relevant to the incidence of disease.  
By failing to turn over the actual records which were requested by the House Committee and 
subpoenaed in Ragsdale, Dr. Segarra has precluded analyses of both the reliability of his 
calculation of 46.6% positive and of whether he has a “signature” percentage of positive readings.  
While these percentages are consistent with the limited empirical data I previously examined, see 
Asbestos Litigation, supra note 1, at 92 n.164, the high degree of self-interest that may have 
motivated Dr. Segarra to understate his “positives” rate should introduce a note of caution with 
regard to the reliability of Dr. Segarra’s responses.  Additional reasons for caution in accepting 
the veracity of Dr. Segarra’s testimony include: (1) the fact that he effectively acknowledges that 
his previous testimony on multiple occasions of a positive rate of 10-40% and averaging 10-20% 
for X-ray readings is not accurate; (2) that his response omitted results for the ten or more years 
prior to 2003 when he was participating in numerous screenings, beginning in the early 1990s, 
when he worked initially for the Pulmonory Function Laboratories, a screening company, see 
Deposition of Jay Segarra, In re W.R. Grace & Co., No. 01-1139 (JFK) (Bankr. D. Del. Nov. 20, 
2006), including the screenings that generated the phantom silicosis epidemic in 2002-2004; his 
role as de facto medical director of RTS in 1995-2000; (3) that he has steadfastly refused to 
supply the underlying records on which he based his calculations for January 2003 through June 
2005, see infra note 253; (4) the fact that in order for Dr. Segarra to even justify his 
acknowledged 47% positive rate, he would have had to have made over 40,000 negative findings 
which would have meant that during his 13 year career as a litigation doctor, he would have had 
to have examined at least 17 screened individuals every single day of the year, including 
weekends and holidays—a process that Dr. Segarra claims requires between 60 and 90 minutes 
per individual, In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 594, 623 (S.D. Tex. 
2005) (footnote omitted); and (5) the fact that Dr. Segarra has retreaded hundreds of the X-rays he 
graded as 1/0 and “consistent with asbestosis” by re-reading these same X-rays a few years later 
as indicating silicosis. See Certain Defendants’ Combined Motion and Brief to Exclude Expert 
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percentages of positive X-ray readings are in the 10-30% range or 
below, but the available evidence casts considerable doubt on the 
credibility of these assertions.36  In addition, it would appear that these 
same B Readers and other doctors are diagnosing 80% or more of those 
whose X-rays have been read as indicating radiographic changes graded 
1/0 or higher with asbestosis “within a reasonable degree of medical 
certainty.”37  Based upon the data I have assembled, I conclude that 
 
Testimony by Dr. Jay T. Segarra and to Dismiss the Claims of Plaintiffs Relying on Same at 38-
46, In re Asbestos Prods. Liab. Litig. (No. IV), MDL Docket No. MDL 875  (E.D. Pa. Sept. 7, 
2007).  Such dual diseases diagnosis are virtually “smoking gun” evidence of fraud.  See text at 
infra notes 218-221.  
 36 The comparative handful of B Readers most frequently used by plaintiffs’ lawyers 
generally claim that their percentages of positive X-ray readings are at most 30%.  Dr. Alvin J. 
Schonfeld is one of the most prolific B Readers and diagnosing doctors in asbestos and silica 
screenings.  According to the Manville Trust, which has kept records only since 2002, Dr. 
Schonfeld has authored 41,573 reports submitted to the Trust, is considered the “primary 
diagnosing doctor” on 31,211 reports, and his diagnoses make him the second most prolific 
“primary diagnosing doctor” in the Trust’s history.  CRMC Response, supra note 19, at ques. 
14(a) and 14(c).  Dr. Schonfeld has testified that he never sees a “huge percentage of abnormal 
films” and that seventy five to ninety percent of the films he reads are normal and do not show 
signs of asbestos-related illnesses.”  Deposition Testimony of Alvin J. Schonfeld at 19-21, 
Blackburn v. Ill. Cent. R.R., Civ. Action No. 04-L-25 (Cir. Ct. Ill. July 10, 2006).  Dr. 
Schonfeld’s credibility is subject to question, however, in light of his steadfast refusal to produce 
his records, which would enable calculation of his percentage of positive X-ray readings and his 
policy of destroying his records in screenings.  See infra notes 254, 259. 
Dr. Jay Segarra variously testified that his positive rate was 10-20% and 10-40% but recently 
acknowledged a 47% positive rate.  Even that is open to question.  See supra note 35. 
Other B Readers who have testified on their percentage of positive X-ray readings include Dr. 
Dominic Gaziano (5%-30%), Deposition of Dominic Gaziano at 89-90, 92-94, Master 
Consolidated Case Silica (and Mixed Dust), Asbestos Docket No. CV46912 (Ohio Ct. Com. Pl. 
Feb. 24, 2005); Dr. Philip Lucas (20%-30%), Deposition of Dr. Phillip Lucas at 42, In re 
Manville Pers. Injury Settlement Trust Med. Audit Procedure Litigation, No. 98 Civ. 5693 
(E.D.N.Y. & S.D.N.Y. March 31, 1999); and Dr. Walter Oaks (30%), Deposition of Walter Oaks 
at 26-27, 86, 89-90, Koontz v. AC & S No. 49D029601-MI-0001-688 (Ind. Sup. Ct. Nov. 25, 
2002).  None of these B Readers have provided access to their records which would allow 
calculation of their percentages of positive X-ray readings. 
 37 Dr. Ray Harron is the most prolific of the B Readers and diagnosing doctors; he has 
accounted for over 80,000 medical reports filed with the Manville Trust in support of asbestos 
claims generated by litigation screenings.  See CRMC Response, supra note 19, at exh. F.  Dr. 
Harron has testified that if he finds radiographic evidence of bilateral interstitial fibrosis and is 
provided a statement that the screened litigant had exposure to asbestos in the workplace (usually 
provided by the plaintiffs’ lawyer or in the screening intake process), then he finds that that 
litigant has asbestosis within a reasonable degree of medical certainty.  See, e.g., Deposition of 
Ray Anthony Harron, M.D. at 60-62, Jurecek v. Quigley Co., No. 03-CV-0594 (Tex. Dist. Ct. 
Sept. 28, 2004); Deposition of Ray Harron, M.D. at 240-41, Owens Corning v. Glenn E. Pitts, 
No. 96-2095 “S” (3) (E.D. La. Jan. 17 1997)  Thus, Dr. Harron diagnoses 100% of the litigants 
whose X-rays he or others have reviewed and graded as 1/0 or higher, as having asbestosis.  Since 
Dr. Harron’s positive rate for X-ray readings is in the 80-95% range, see supra note 35, then for 
every 1000 potential litigants screened by Dr. Harron, he would diagnose 800-950 with 
asbestosis.  Based in part on Dr. Harron’s testimony in MDL 1553, the Texas Medical Board 
instituted a disciplinary action against him.  On April 13, 2007, the Board and Dr. Harron entered 
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there is a significant likelihood that each of these B Readers and 
diagnosing doctors, as well as the screening companies that hire them, 
have predetermined “signature” percentages of positive X-ray readings 
and diagnoses that fall within the 50-90% range.  Indeed the “product” 
that these doctors appear to be selling to lawyers and screening 
companies are high fixed percentages of “positive” X-ray readings and 
diagnoses of silicosis and asbestosis. 
 
A.     “Shopping Around” of X-Rays and Diagnoses 
 
A screening-generated X-ray read as negative for fibrosis 
represents tens of thousands of dollars of lost revenue.  Between 1990 
 
into an Agreed Order whereby Dr. Harron agreed to cease practicing medicine in the period 
before his medical license expires and not to seek or grant renewal of that license.  See 
Investigated Physician Surrenders Medical License, HOUSTON CHRON., Apr. 22, 2007, at B3.  
For additional commentary on Dr. Harron, see infra notes 216, 226. 
As indicated, RTS screened at least 40,507 individuals.  See supra note 35.  Analysis of the 
diagnoses provided to the first 32,119 persons in this group reveals that 17,877 (56%) were 
provided with a diagnosis of asbestosis.  See Motion to Exclude RTS claims, supra note 35, at 8.  
Assuming that RTS’s rate of positive X-ray readings was 55.5%, as indicated by an analysis of 
RTS records, see supra note 35, then 17,826 of the 32,119 had their X-rays read as 1/0 or higher.  
Since 17,877 of the 32,119 were diagnosed with asbestosis, it is clear that RTS’s rate of positive 
X-ray readings is higher than 56%.  Assuming it was 60%, then RTS’s rate of diagnoses of 
asbestosis of those with positive X-ray readings is 92.8%.  Dr. Todd Coulter saw approximately 
600 litigants and diagnosed approximately one half with silicosis, during an eleven day silicosis 
screening. MDL 1553, 398 F. Supp. 2d at 616.  Assuming that he read 60-70% of the X-rays as 
positive for fibrosis, then his diagnosis rate would have been 80%. 
Dr. Gregory Nayden, working for American Medical Testing, a screening company, diagnosed 
100% of the 14,000 persons he examined as having asbestosis based on positive B reads by other 
physicians such as Drs. Lucas and Ballard.  Deposition of Dr. Gregory A. Nayden at 164-65, 
Bentley v. Crane Co., Civ. No.92-7655 (Miss. Cir. Ct. Mar. 28, 2002). 
Empirical data on the percent of those with X-rays graded as 1/0 or higher who are then 
diagnosed as having asbestosis is nonetheless sparse and is limited to the evidence cited above, 
though additional evidence is being produced in proceedings underway in MDL 875.  My 
estimate of a diagnosis rate of 80% or higher is based, in part, on reading scores of transcripts of 
depositions of litigation doctors and screening company principals as well as the discovery done 
in the silica MDL.  For a selection of data from the transcripts, see Brickman, Asbestos Litigation, 
supra note 1, at n.164.  Based on these depositions and materials, I would expect that Dr. 
Segarra’s claimed diagnosis percentage, 80%, is at the low end of the range.  Moreover, my 
estimate is conservative in that it does not fully reflect the full impact of Dr. Harron’s and Dr. 
Nayden’s 100% diagnosis rate. 
Another factor that supports my estimate is the economic context.  A litigant who was screened 
as 1/0 or higher could have generated $60,000-$100,000 in settlement payments in the 1990-2000 
period and a lesser sum thereafter, of which the lawyer would take about one half for fees and 
expenses.  See Korosec, Enough To Make You Sick, supra note 30; see also Brickman, Ethical 
Issues, supra note 13, at 841-42.  Having incurred the expense of screening the litigant, 
approximately $1,000-$1,500, there is a substantial economic incentive to monetize the claim by 
obtaining a diagnosis of asbestosis. 
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and 2000, an unimpaired nonmalignant asbestos claim was worth 
$60,000-$100,000, of which the lawyer would claim half for fees and 
expenses.38  To avert the substantial revenue loss that a negative X-ray 
reading would yield, lawyers or screening companies often send the X-
ray to another one of the cadre of litigation B Readers to re-read, 
without disclosing that the X-ray had previously been read as 
negative.39  This “shopping around” can include as many as four to six 
re-readings by other litigation B Readers until a positive reading is 
obtained.40  Accordingly, a 50-90% positive rate on initial X-ray 
readings may, in fact, be a 70-90% positive rate or higher when taking 
into account the subsequent re-readings.  To be conservative, however, I 
will continue to use the 50%-90% estimate. 
This same “shopping around” process is followed for diagnoses.  If 
one doctor concludes that the evidence is “insufficient to diagnose 
pneumoconiosis,” the plaintiffs’ lawyers often send the medical record 
for re-evaluation; once the “correct” diagnosis is obtained, the lawyer 
submits the diagnosis of “bilateral asbestosis” without any mention of 
the initial doctor’s report that he did not find disease.41  Accordingly, a 
pre-shopped diagnosis rate of 80% could well become a post-shopped 
90% plus diagnosis rate.  Again, however, in this Article, I will continue 
to use the 80% diagnosis rate estimate. 
 
II.     CLINICAL STUDIES OF THE PREVALENCE OF FIBROSIS 
 
One method of evaluating the reliability of the X-ray readings and 
diagnoses of the litigation doctors is to compare those results with 
 
 38 See Korosec, Enough To Make You Sick, supra note 30, at 3.  For discussion of fees and 
expenses charged in asbestos litigation, see Brickman, Ethical Issues, supra note 13, at 840-43.  
After a wave of bankruptcies that began in 2000, the value declined. 
 39  See Status Report on Non-Party Discovery, Brief of Debtors and Debtors in Possession, In 
re W.R. Grace & Co., No. 01-01139 (JKF) (Bankr. D. Del. Dec. 1, 2006) for examples of specific 
X-rays and diagnoses that were shopped around by plaintiffs’ lawyers.  See also, David Egilman, 
MD, MPH, Letter to the Editor, Asbestos Screenings, 42 AM. J. INDUS. MED. 163 (2002) (“I was 
amazed to discover, that in some of the screenings, the worker’s X-ray had been ‘shopped 
around’ to as many as six radiologists until a slightly positive reading was reported by the last one 
of them.”). 
 40 Egilman, supra note 39; see also MDL 1553, 398 F. Supp. 2d at 601 (“Sometimes, law 
firms . . . would ask N&M to have another doctor do re-reads of the x-rays which had been read 
as positive for silicosis.  And if the subsequent B-reader . . . did not make a positive silicosis 
finding, then N&M would send the x-ray to a third B-reader for yet another read . . . . [I]t was 
even possible that if the third reader also did not make a positive silicosis finding, then the x-ray 
would be sent to a fourth reader.”) (footnotes and references to transcripts omitted). 
 41  Egilman, supra note 39. 
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clinical studies of workers who were occupationally exposed to 
asbestos.  There have been over eighty studies of both exposed and 
unexposed populations to determine the prevalence of radiographic 
evidence of fibrosis.42  It is not possible to state with certainty that the 
subjects in the clinical studies were workers with similar exposures to 
those that were screened for litigation purposes.  Nonetheless, the 
number of clinical studies and the number of workers included in the 
studies, as well as the range of occupational groups included, appear to 
cover a sufficiently broad sample as to constitute a valid basis for 
comparison.  Moreover, the analyses that I have undertaken in this 
Article, and others referenced herein, as well as the findings of U.S. 
District Court Judge Janis Jack in MDL 1553, strongly suggest that 
many litigation screenings were of workers with modest occupational 
exposures to asbestos (and silica).  Most clinical studies, however, 
would likely be of occupationally exposed groups that were thought to 
be intensely exposed to asbestos.  Thus, it is not unlikely that the 
exposure levels of those workers in the clinical studies exceeds the 
exposure levels of those recruited for asbestos screenings. 
To introduce the results of a review43 of these studies, I first 
discuss the uniquely high disease level of insulators44 and the effect that 
 
 42 Of the eighty-five studies reviewed, seventy-two were of populations exposed to asbestos.  
Fourteen of these studies were excluded because they did not meet certain criteria described 
below. Thus, the review includes fifty-eight studies of populations exposed to asbestos. There 
were thirteen studies of unexposed populations, of which eleven are included and two excluded. 
 43 The review I have undertaken is of studies determining the prevalence of radiographic 
evidence of fibrosis in populations exposed to asbestos.  The definition of “prevalence” is the 
proportion of a population which has the condition of interest.  It is a useful measure of chronic 
and irreversible conditions such as asbestosis.  The prevalence can be expressed in any unit, 
depending on how rare or common the condition is.  Common conditions are often expressed as 
percentages, while extremely rare conditions may be expressed as occurences per million 
population members.  Prevalence is a static measure and should be not considered a rate.  I have 
not undertaken to do a meta-analysis of these studies because any increase in the statistical 
validity of the results would not appreciably add to the utility of the review for purposes of 
comparison to the results of litigation screenings.  In a meta-analysis, the prevalence of lung 
opacities (P) is a random variable with a prevalence of P(1-P)/n.  The pooled prevalence 
calculated would be a weighted average where weights assigned are the inverse of the variances.  
For a description of the procedures to be used in a meta-analysis, see H. Frumkin & J. Berlin, 
Asbestos Exposure and Gastrointestinal Malignancy: Review and Meta Analysis, 14 AM. J. 
INDUS. MED. 79 (1988); V. Velanovich, Meta-Analysis for Combining Bayesian Probabilities, 35 
MED. HYPOTHESES 192 (1991). 
 44 Insulators apply insulation materials to pipes and ductworks, or other mechanical systems 
to help control and maintain temperature.  They are primarily employed in the building trades 
doing construction insulation work but are also employed as insulation workers in shipyards and 
powerhouse construction and repair.  I.J. Selikoff et al., The Occurrence of Asbestosis Among 
Insulation Workers in the United States, 132 ANNALS N.Y. ACAD. SCIS. 139, 141 (1965) 
[hereinafter Selikoff et al., 1965].  Some of the insulation materials used contained no asbestos.  
One of the asbestos-containing products used was magnesia block insulation which usually 
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five insulators’ studies have on the results of such a review. 
 
A.     Insulator Studies 
 
Insulators have sustained the highest levels of asbestosis of any 
occupational group exposed to asbestos during the course of 
employment.  This unfortunate distinction is a function of the dose-
related nature of asbestosis: the development and severity of asbestos-
induced lung disease is a function of the intensity of exposure (dose) 
and latency—the time between first exposure and disease 
manifestation.45  The latency period for asbestosis is at least 10 years 
but is mostly in the 20-30 year range, though it can be as long as 40 
years.46  Most occupational exposures to asbestos-containing products 
of the duration and intensity to cause disease took place in the shipyards 
during World War II and in construction and certain industrial trades 
thereafter, peaking in the late 1960s to early 1970s and substantially 
lessening by the end of the 1970s.47  Of the more than 40 occupational 
groups exposed to asbestos dusts,48 insulators were typically exposed to 
 
contained approximately 15% asbestos.  Asbestos cement, another important product, generally 
had 15-20% asbestos content.  Id. 
 45 See Brickman, Asbestos Litigation, supra note 1, at 49 n.42 for a detailed explanation; see 
also Jill Ohar at el., Changing Patterns in Asbestos-Induced Lung Disease, 125 CHEST 744, 745 
(2004) [hereinafter Ohar et al., 2004]; infra note 64.  In clinical studies, latency is also used to 
mean the time between first exposure and when the study is done or the X-rays taken. 
 46 See Jeffrey M. Shea & Catherine M. Martinez, Pulmonary-Critical Care Associates of E. 
Tex., Asbestosis, http://www.pcca.net/Asbestosis.html (“There is a well-defined latency period of 
approximately 20 years or more between the initial exposure to asbestos and the development of 
asbestos related calcification and scarring.”); Kun-Il Kim et al., Imaging of Occupational 
Disease, 21 RADIOGRAPHICS 1371, 1379 (2001) (“Most workers in whom pulmonary fibrosis 
(asbestosis) develops have been exposed to high dust concentrations for a prolonged period. 
There is a definite dose-effect relationship. Disease usually occurs approximately 20 years 
following initial exposure.”). 
 47 The first governmental restrictions on levels of exposure to asbestos were promulgated by 
OSHA in 1971.  See BARRY I. CASTLEMAN, ASBESTOS: MEDICAL AND LEGAL ASPECTS 331 
(1996).  Industrial consumption of asbestos peaked in the late 1960s and early 1970s. Nat’l 
Toxicology Program, Public Health Serv., U.S. Dep’t. of Health & Human Servs., Eleventh 
Report on Carcinogens (2005), available at 
http://ntp.niehs.nih.gov/ntp/roc/eleventh/profiles/5016asbe.pdf. 
 48 There were 41 occupations listed in the Manville Trust data base: (1) Air Conditioning & 
heating installer, maintenance; (2) Asbestos miner, plant worker; (3) Asbestos removal, 
abatement; (4) Auto mechanic/bodywork; (5) Boilerworker, cleaner, inspector, engineer, repair; 
(6) Brake manufacturing, installer, repair; (7) Brick mason, layer, hod carrier; (8) Building 
maintenance, building engineer; (9) Building occupant, officeworker, clerical, professional; (10) 
Carpenter/woodworker/cabinet maker; (11) Chipper, grinder; (12) Custodian, janitor; (13) 
Electrician, electrical worker; (14) Engineer (chemical, mechanical etc.); (15) Factory worker 
(assembly line) non asbestos; (16) Family member, bystander; (17) Firefighter; (18) Furnace 
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the highest levels of asbestos in the workplace and for the longest 
periods of time.  While they constituted a very small percentage 
(0.67%) of the population at risk to an asbestos-associated disease, 
because of occupational exposure,49 insulators’ risk of contracting a 
respiratory malignancy was 4-25 times that of other occupationally 
exposed groups.50 
A number of the clinical studies reviewed include insulators among 
the subjects of the study, generally without separately identifying the 
results attributable solely to the insulators.51  Eight studies, however, 
 
worker, repair installer; (19) Glass Worker; (20) Heavy equipment operator (includes 
truck/forklift/crane); (21) Insulator, asbestos; (22) Laborer (construction, demolition, shipyard); 
(23) Longshoreman, dock-worker; (24) Machinist; (25) Millwright; (26) Painter; (27) 
Pipecoverer—asbestos; (28) Pipefitter, steamfitter; (29) Plasterer, sheet-rock, drywall, joiner; (30) 
Plumber; (31) Railroad engineer, brakeman, carman, conductor, fireman; (32) Rigger; (33) 
Sandblaster; (34) Seaman—other than engine room; (35) Seaman—engine room only; (36) Sheet-
metal worker; (37) Shipfitter; (38) Shipwright; (39) Steelworker, foundry, aluminum; (40) 
Warehouse Worker; (41) Welder, blacksmith. Claims Resolution Management Corp., 1995 
Industry/Occupation Chart, http://www.claimsres.com/DocumentsMT.html (last visited Nov. 30, 
2006). 
 49 Of an estimated total of 27,527,000 workers occupationally exposed to asbestos in the 
1940-1979 period, 184,000 (0.67%) did insulation work.  William J. Nicholson et al., 
Occupational Exposure to Asbestos: Population at Risk and Projected Mortality—1980-2030, 3 
AM. J. INDUS. MED. 259, 283 tbl. XII (1982) [hereinafter Nicholson et al., 1982]. 
 50 Insulators’ relative risk of contracting cancer after 25 years employment is substantially 
higher than that of other occupational groups because of their longer average employments in the 
trade and their exposure to higher concentrations of asbestos fibers.  From 1942-1979, insulators’ 
average employment time ranged from 12.5 to 15.9 years, whereas other occupational groups’ 
employment durations were typically one quarter to one half that of insulators.  Id. at 284 tbl. 
XIII.  Insulators also were exposed to substantially higher concentrations of asbestos fibers than 
other occupational groups.  Id. at 286 tbl. XV.  Those in the construction trades (not including 
insulators) have 15-25% of the risk of insulators of contracting cancer, utility services—30%, 
chemical plant and refinery maintenance workers—15%, and automobile maintenance workers—
4%.  Id. at 287 tbl. XVII.  Taking into account both exposure levels and average duration of 
employment, the following relative population risks of contracting cancer were calculated: 
Insulators   46 
Manufacturing 4.6 
Utility Services 4.9 
Shipyard employee 3.3 
Construction 1.8 
Id. at 288. 
 51 See, e.g., S. Barnhart et al., The CARET Asbestos-Exposed Cohort: Baseline 
Characteristics and Comparison to Other Asbestos-Exposed Cohorts, 32 AM. J. INDUS. MED. 573 
(1997); R.T. Myint & S. Myint, Small Airway Impairment Findings at the Screening of 639 
Asbestos Workers with Exposure History of 20 Years, in NAT’L INST.FOR OCCUPATIONAL 
SAFETY & HEALTH, U.S. DEP’T OF HEALTH & HUMAN SERVS., PROCEEDINGS OF THE VIITH 
INTERNATIONAL PNEUMOCONIOSES CONFERENCE, DHHS (NIOSH) Pub. No. 90-108, at 375 
(1990), available at http://www.cdc.gov/niosh/pdfs/90-108.html [hereinafter PROCEEDINGS OF 
THE VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE]; John M. Dement et al., 
Surveillance of Respiratory Diseases Among Construction and Trade Workers at Department of 
Energy Nuclear Sites, 43 AM. J. INDUS. MED. 559 (2003). 
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were solely of insulators. The first and most prominent of these studies 
was published in 1965 by Dr. Irving Selikoff.52  This study evaluated 
members of the Insulation Workers Union and reported that of 1,117 
insulators studied, 542 (48.5%) had asbestosis based on radiological 
changes only.53  A later re-reading of the films using ILO scoring 
reported that 422 (37.7%) exhibited radiographic changes graded 1/0 or 
greater.54  The Selikoff study was instrumental in informing both 
industry and workers that asbestos-related diseases were not only 
caused by asbestos exposures during the manufacture of asbestos-
containing products but also when those products were used in the 
workplace. 
Four other insulators’ studies also characterized by greater latency 
periods and higher concentrations of fiber exposures than that of most 
of those who participated in clinical studies of occupationally exposed 
workers, also showed high levels of radiographic evidence of fibrosis.55  
 
 52 Selikoff et al., 1965, supra note 44. 
 53 Id.  In fact, the Selikoff study did not diagnose insulators but only measured the prevalence 
of radiographic findings of fibrosis.  For the protocol for performing a diagnosis, see infra note 
141. 
 54 In his published study, Selikoff stated that 542 (48.5%) of the 1,117 had asbestosis based 
on the sole criteria of radiological changes.  Selikoff et al., 1965, supra note 44, at 144-45.  The 
study did not use the ILO system because it had not yet been uniformly adopted. Twenty years 
later, these same X-rays were re-examined and graded on the ILO system and the results were 
that 422 (37.7%) of the 1,117 X-rays were graded 1/0 or higher.  No diagnoses were undertaken. 
R. Lilis et al., Asbestosis: Interstitial Pulmonary Fibrosis and Pleural Fibrosis in a Cohort of 
Asbestos Insulation Workers: Influence of Cigarette Smoking, 10 AM. J. INDUS. MED. 459 (1986). 
 55 See Miller et al., Relationship of Pulmonary Function to Radiographic Interstitial Fibrosis 
in 2,611 Long-term Asbestos Insulators, 145 AM. REV. RESPIRATORY DISEASE 263 (1992) 
[hereinafter Miller et al., 1992]. The Miller study examined 2,611 X-rays, of which 1,557 
(59.6%) had small and irregular opacities graded 1/0 or higher, thus showing asbestos-induced 
parenchymal abnormalities. Id. at 283-84. The elapsed time from first exposure averaged 35.5 
years. 
R. Lilis et al., Radiographic Abnormalities in a Large Group of Insulators with Long Term 
Asbestos Exposure: Effects of Duration From Onset of Exposure and Smoking, 20 AM. J. INDUS. 
MED. 1 (1991). This study examined 2,790 insulators, finding that 1,683 (60.3%) had opacities 
graded 1/0 or higher.  Id.  Of the 2,790 insulators examined, 86.8% had a latency of more than 30 
years.  The latency periods for this population were broken down as follows: 368 (13.2%) were 
first exposed less than 29 years before examination; 1,712 (61.36%) were first exposed 30-39 
years before examination, and 710 (25.44%) were first exposed over 40 years before examination. 
R.L. Murphy, Jr. et al., Effects of Low Concentrations of Asbestos: Clinical, Environmental, 
Radiographic and Epidemiologic Observations in Shipyard Pipe Coverers and Controls, 285 
NEW ENG. J. MED. 1271 (1971). The Murphy Study found that, of 101 pipecoverers examined, 44 
(43.56%) had opacities graded 1/0 or higher.  In addition to the 101 pipecoverers, 94 pipefitters 
who were a control group also exposed to asbestos were examined. The results of the part of the 
examination dealing with pipefitters is included in the review of the other exposed workers. All 
195 workers were employed at a New England shipyard in November 1965.  The pipecoverers 
were employed at the yard for an average of 17.4 years. Of the 101 pipecoverers examined, 45 
(44.55%) had been exposed more than 30 years, dating back as far as the 1920s. 
M.J. Campbell & J.H.M. Langlands, Analysis of a Follow-up Study: An Example from 
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A review of these five insulators’ studies indicates that of 6,790 
insulators studied, 3,790 (55.8%) were found to have radiographic 
evidence of fibrosis graded as 1/0 or higher on the ILO scale.56 
In addition to the five insulator studies discussed above, there have 
been three other insulator-only studies (including pipecoverers57); these 
found much lower levels of prevalence of radiographic evidence of 
fibrosis than did the five studies listed above.58  Of a total of 617 X-rays 
examined in these three studies, 100 (16.2%) were found to have 
opacities of 1/0 or greater.  A review of all eight insulators’ studies 
indicates that of a total of 7,407 X-rays, 3,890 (52.5%) exhibited 
opacities of 1/0 or higher. 
The purpose of the review of clinical studies undertaken for this 
 
Asbestos-Exposed Insulation Workers, 8 SCANDINAVIAN J. WORK ENV’T & HEALTH 43 (Supp. 
1982).  This study examined one hundred and seventy-one insulators.  The original study was 
conducted in 1965 to 1966, had 252 subjects, but had not used the ILO system to classify X-ray 
abnormalities.  See J.H.M. Langlands et al., Insulation Workers in Belfast; Morbidity in Men Still 
at Work, 28 BRIT. J. INDUS. MED. 217 (1971).  The eleven-year follow-up of 171 men from the 
original study did use the ILO grading.  Of the 171 examined, 84 (49.12%) had opacities graded 
1/0 or greater.  Although in the follow-up, no attention is given to exposure years and duration, 
the information was provided in the original.  Of the 252 studied in 1965-1966, 37% were 
insulators for more than 20 years (thus exposures began in 1945-46 or earlier).  By the time of the 
follow-up, these men had been insulators for more than thirty years, and a larger percentage was 
already working for more than twenty years. 
 56 Langlands et al, supra note 55. 
 57 I am including “pipecoverers,” a separate occupational group listed in the statistics 
compiled by the Manville Trust, with insulators because they appear to do the same work as 
insulators.  The number of pipecoverers that filed claims with the Manville Trust through 
September 30, 2006 is 614.  See infra note 60. 
 58 J. Bourbeau et al., The Relationship Between Respiratory Impairment and Asbestos-related 
Pleural Abnormality in an Active Workforce, 142 AM. REV. RESPIRATORY DISEASE 837 (1990) 
[hereinafter Bourbeau et al., 1990] (examining 110 X-rays, of which 11 (10%) showed 
parenchymal fibrosis—these opacities were always of a small irregular type, such as would be 
consistent with asbestosis); S.M Kennedy et al., Lung Function and Chest Radiograph 
Abnormalities Among Construction Insulators, 20 AM. J. INDUS. MED. 673 (1991); [hereinafter 
Kennedy 1991] (examining 88 X-rays, of which 16 (18.2%) showed parenchymal abnormalities); 
K.H. Kilburn et al., Interaction of Asbestos, Age, and Cigarette Smoking in Producing 
Radiographic Evidence of Diffuse Pulmonary Fibrosis, 80 AM. J. MED. 377 (1986) [hereinafter 
Kilburn et al., 1986] (examining 419 X-rays, of which 73 (17.4%) showed diffuse pulmonary 
fibrosis). 
I am excluding a study done in 1946 of shipyard workers who had been heavily exposed to 
asbestos, which found that virtually none of those examined had lung profusions indicating the 
existence of disease, because it was done prematurely.  W.E. Fleischer et al., A Healthy Survey of 
Pipe Covering Operations in Constructing Naval Vessels, 28 J. INDUS. HYGEINE & TOXICOLOGY 
9 (1946) [hereinafter Fleisher et al., 1946].  The latency period for asbestosis is at least ten years. 
Agency for Toxic Substances & Disease Registry, Dep’t of Health & Human Servs., Center for 
Disease Control, Asbestos-Health Effects, (2006), available at 
http://www.atsdr.cdc.gov/asbestos/asbestos/health_effects.  Of the 1,074 workers examined, only 
approximately 4.7% had been in the industry for more than ten years.  Because the study was 
done prematurely, using the Fleischer results would skew the percentage of fibrosis among 
insulators downward and detract from the validity of the review. 
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Article is to determine the prevalence of fibrosis based on radiographic 
evidence found among a wide range of workers occupationally exposed 
to asbestos, and to compare those results with the prevalence found by 
the litigation doctors.  Because of the substantial impact of the 
insulators’ studies on the results of the review of clinical studies,59 it is 
important to determine whether that impact is disproportionate to the 
point of diminishing the validity of the comparison. 
In the clinical studies reviewed, insulators account for almost 9% 
of all occupationally exposed workers who were subjects of the studies.  
This is more than three and a half times the percentage that insulators 
represent of all those with known occupations who filed claims for 
compensation with the Manville Trust between 1992 and 2006.  In that 
time period, insulators constituted 2.5% of the claimants with known 
occupations who filed claims with the Manville Trust.60 
Substantially all of the nonmalignant claims filed with the 
Manville Trust were generated by litigation screenings.61  Moreover, 
very few screened litigants with diagnoses of asbestosis failed to file 
claims with the Manville Trust.62  Accordingly, claim filings with the 
Manville Trust are a surrogate for the population of screened litigants. 
Because insulators are substantially overrepresented in the clinical 
studies when compared to their percentage of filings with the Manville 
Trust and thus the population screened, it is necessary to adjust the 
results of the review to maintain comparability.  Since insulators 
account for almost 9% of all occupationally exposed workers who were 
the subjects of the clinical studies63 but only 2.5% of the screened 
 
 59 The five insulators’ studies with the greatest latency periods and length of exposure to and 
concentration of fibers exposures, see supra notes 54-55, alone account for 31.98% of the total 
number of findings of radiographic evidence of fibrosis (ILO 1/0 or greater) identified in the fifty-
seven studies of exposed populations (3,790 of 11,851), and thus these studies would have a 
substantial impact on the outcome of a review of clinical studies of exposed workers’ levels of 
fibrosis based on X-ray readings. 
 60 Though insulators constituted only 0.67% of the total occupationally exposed population in 
the United States, see supra note 49, they account for 4.4% of those with identified occupations 
who filed claims for compensation with the Manville Trust between 1988 and 2006.  See Claims 
Resolution Management Corp., Alleged Occupation by Summary Injury Chart, through 
September 30, 2006 (Nov. 21, 2006) (on file with author) [hereinafter Occupation Chart]. The 
Manville Trust has received 687,352 claims for compensation through September 30, 2006.  Of 
these, 458,556 have identified occupations, of which 20,215 are insulators and pipecoverers 
(4.4%); 19,601 (4.27%) are listed as insulators and 614 (0.13%) are listed as pipecoverers.  Id. 
 61 See supra note 13. 
 62 It is commonly understood by those with experience in asbestos litigation that at least until 
the Manville Trust changed its Trust Distribution Procedures, effective in mid-2004, the vast 
majority—at least 90%—of those seeking compensation for asbestos-related injuries filed claims 
with the Manville Trust. 
 63 As noted, in addition to the eight insulator studies, there were a number of other studies 
which included insulators but did not separate out the results for just the insulators.  See supra 
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population, then to maintain the desired comparability, the results of the 
seven insulator studies should be discounted by 72.22%.64 
 
B.     Clinical Studies of Exposed Workers 
 
I conducted a literature search to identify all published studies65 
that: (1) sampled populations occupationally exposed to asbestos;66 (2) 
 
note 51. 
 64 There is additional support for a downward adjustment based upon insulators’ falling levels 
of claim filings.  Between 1988 and 1991, they accounted for 52% of the personal injury claims 
filed with the Manville Trust, but that percentage declined precipitously to 2.5% between 1992 
and 2006.  See Occupation Chart, supra note 60.  Including these insulators’ studies in the review 
without any correction would result in overstating the prevalence of radiographic prevalence of 
fibrosis in occupationally exposed workers. 
The very high percentages of parenchymal abnormalities found by the five studies, see supra 
note 59, even as compared to the three other insulator studies, is likely attributable to the longer 
periods of exposure of the insulators in those four studies where initial exposures extended back 
as far as 1929.  In the Selikoff et al., 1965 study, 315 of the 1,117 insulators had over 30 years 
pass since the onset of exposure.  Approximately 18% of the sample had already been working as 
insulators by or prior to 1929.  Selikoff et al., 1965, supra note 44, at 145.  The Miller et al., 1992 
study established as the cohort, those insulators enrolled in the union as of January 1, 1967 and 
who had reached at least 30 years from the onset of exposure by the time of the testing in 1981 to 
1983.  This population totaled 2,611. Eighty-seven percent (2,270) of the participants had first 
exposures that dated back to no later than 1953.  The mean years since first exposure was 35.5.  
Miller et al., 1992, supra note 55, at 283-84.  In the Murphy et al., 1971 study, the participants 
were established in November 1965.  Of the 101 pipecoverers examined, 13 (12.87%) were in the 
20-35 years of exposure category, meaning their exposures took place between 1930 and 1945. 
Murphy et al., 1971, supra note 55, at 1276. In the Lilis et al., 1991 study, 86.8% of the 
participants had latency periods of more than 30 years, dating back to the late 1930s.  Lilis et al., 
1991, supra note 55.  In the Campbell 1982 study, approximately 37% had been insulators for 
over thirty years, with initial exposures in the mid 1940s. 
These five insulators’ studies and other studies of construction workers found that radiographic 
abnormalities varied in direct relation to years since starting employment in the trade.  Kennedy 
et al., 1991, supra note 58, at 681.  A peak prevalence of about 20% for parenchymal fibrosis is 
reached given a working career of about thirty years.  Id.  The reason advanced for why two of 
the insulator studies, Selikoff et al., 1965 and Miller et al., 1992, found higher levels of fibrosis is 
that many of the insulators in those studies had over thirty years of work experience and were 
working in the trade in the 1920s and 1930s when exposures may well have been considerably 
more intense than those experienced by workers in other trades.  Id.  The Selikoff et al., 1965 
study shows that for 121 workers who had 40 years or more pass since the onset of exposure, 
there were abnormal findings 94.2% of the time; of the 194 workers who had 30-39 years since 
onset of exposure, there were abnormal findings in 87.1%; of the 77 workers who had 20-29 
years since onset, there were abnormal findings in 72.8%; of the 392 workers who had 10-19 
years pass since onset, there were abnormal findings in 44%; and for those with less than 10 years 
of latency, there were abnormal findings in 10.4%. 
 65 One study that is included was not published.  See J. Miller, Benign Exposure to Asbestos 
Among Power Plant Workers (1990) (unpublished study on file with author). 
 66 I have excluded studies of miners from the review because the number of workers 
identified as asbestos miners asserting claims against the Manville Trust between 1988 and 2006 
was approximately 0.015% of the total claims filed with the Trust in that period.  See Occupation 
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administered pulmonary X-rays; (3) had doctors, whether or not 
certified by NIOSH as B Readers, grade the X-rays using the ILO 
classification system; and (4) identified the number of the X-rays 
graded as 1/0 or higher.67  Where a study re-evaluated the X-rays read 
for a previous study, I included only the re-readings.68  In addition to the 
eight insulators’ studies, I identified fifty other studies of occupationally 
exposed workers,69 which examined over twenty different occupational 
groups.70  The criteria listed led me to exclude of fourteen of the 
 
Chart, supra note 58.  I have included all the other studies notwithstanding the type of exposure 
the workers experienced, whether it was a consequence of the use of asbestos containing 
products, the proximity to those using asbestos containing products, or involvement in the 
manufacturing or production of asbestos containing material where exposure levels were often 
more intense. 
 67 As noted, eight of the studies reviewed list the number of X-rays graded as 1/1 or higher 
but do not list the number of 1/0s, or list the 1/0s only if there are other indicia of asbestos 
exposure.  I am nonetheless including these studies because doing so provides a more complete 
representation of the clinical studies while not compromising the validity of the review.  
Including these eight studies decreases the prevalence percentage found by the clinical studies 
from 11.75% to 11.56%. The eight studies are O. Metadilogkul & P. Supanachart, Occupational 
Asbestosis and Asbestos Related Diseases Among Workers Exposed To Asbestos, 1987, Thailand, 
in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE, supra note 51, 
at 331; Myint & Myint, supra note 51; P. Oksa et al., Parenchymal and Pleural Fibrosis in 
Construction Workers, 21 AM. J. INDUS. MED. 561 (1992) [hereinafter Oksa et al., 1992]; C.E. 
Rossiter & P.G. Harries, U.K. Naval Dockyards Asbestosis Study: Survey of the Sample 
Population Aged 50-59 Years, 36 BRIT. J. INDUS. MED. 281 (1979); C.E. Rossiter et al., Royal 
Naval Dockyards Asbestosis Research Project: Nine-Year Follow-Up Study of Men Exposed to 
Asbestos in Devonport Dockyard, 73 J. ROYAL. SOC’Y. MED. 337 (1980); G. Sheers et al., UK 
Naval Dockyards Asbestosis Study: Radiological Methods in the Surveillance of Workers 
Exposed to Asbestos, 35 BRIT. J. INDUS. MED. 195 (1978) [hereinafter Sheers et al., 1978]; M. 
Silberschmid et al., Chest Radiographs in Railroad Employees with Asbestos Exposure—A 5 year 
Follow-Up Using ILO 1980 Classification, in PROCEEDINGS OF THE VIITH INTERNATIONAL 
PNEUMOCONIOSES CONFERENCE, supra note 51, at 381 [hereinafter “Silberschmid et. al.,].  See 
infra note 72 for more information on these studies. 
 68 This has the effect of increasing the number of fibroses found, presumably because of the 
longer latency period. In the Kagamimori 1997 study, the original number X-rayed was 4,919, of 
which 67 (1.4%) were found to have opacities of 1/0 or higher.  S. Kagamimori et al., Studies on 
Changes in Categories for Pneumoconiosis X-ray Classification in Japanese Workers with 
Occupational Exposure to Mineral Dusts, in PROCEEDINGS OF NINTH
 
INTERNATIONAL 
CONFERENCE ON OCCUPATIONAL RESPIRATORY DISEASES, Kyoto, Japan, 166-69 (1997).  Nine 
years later, 3,024 of the original population were re-examined and the new X-rays showed 81 
(2.7%) as having opacities of 1/0 or higher.  For purposes of this computation, only the second 
study is included.  
 69 This is in addition to the eight insulators’ studies. 
 70 These studies examined boilermakers, tire workers, merchant marine seamen, construction 
workers, sheet metal workers, ironworkers, pipefitters, electricians, plumbers, cleaners, elevator 
construction workers, cement plant workers, laborers, welders, drywall construction workers, 
millwrights, insulators, ship repairmen, painters, building custodians, naval dockyard workers, 
mineral dust workers, textile workers, and factory workers, among other occupational groups. 
Also, in one study of an exposed population, the study group consisted of wives of shipyard 
workers. Kilburn et al., 1986, supra note 58. 
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seventy-two studies that were identified in the literature search.71 
The result of a review of the fifty-eight studies (including the 
adjusted results of the review of eight insulators’ studies) is that of a 
total of 78,219 exposed workers’ X-rays, 9,042 (11.56%) were found to 
 
 71 H.E. Amandus et al., Significance of Irregular Small Opacities in Radiographs of 
Coalminers in the USA, 33 BRIT. J. INDUS. MED. 13 (1976).  This study was excluded because in 
order to be eligible for the study, a person must have already been read as 1/0 or higher. 
H. Anton-Culver et al., An Epidemiologic Study of Asbestos-Related Chest X-ray Changes to 
Identify Work Areas of High Risk in a Shipyard Population, 4 APPLIED INDUS. HYGIENE 110 
(1989) (presenting results in narrative form regarding the possibility of asbestos-related 
abnormalities, without discussion of the ILO classifications). 
A.C. Friedman et al., Asbestos-Related Pleural Disease and Asbestosis: A Comparison of CT 
and Chest Radiography, 150 AM. J. ROENTGENOLOGY 269 (1988) [hereinafter, Friedman 1988].  
This study of 60 men is excluded because the subjects were selected based on previous chest X-
rays interpreted as indicating asbestos-related pleural and parenchymal disease or a malignancy. 
P.G. Harries et al., Radiological Survey of Men Exposed to Asbestos in Naval Dockyards, 29 
BRIT. J. INDUS. MED. 274 (1972).  This study is excluded because it does not provide ILO scores 
though it does list the number found with “confirmed pulmonary fibrosis.”  However, this 
determination is based on X-ray readings, lung function testing, and clinical examinations.  Based 
on this criteria, of 3,856 tested, 12 (0.3%) were found to have the condition listed which appears 
to be the equivalent of a diagnosis of asbestosis. 
Kagamimori et al., supra note 68, at 166-69 (1997) (reporting two studies, one originally done 
in 1986, and then a second which was a re-evaluation of part of the same population in 1995.) 
Only the results of the reevaluation study are included in the compilation of the exposed workers 
examined. 
J.H.M. Langlands et al., supra note 55.  This study did not use the ILO classification system, 
and further, some of the subjects of this study were re-evaluated in another study, the results of 
which are presented in the insulator section. 
F.D.K. Liddell et al., Radiological Changes and Fibre Exposure in Chrysotile Workers Aged 
60-69 Years at Thetford Mines, 26 ANNALS OCCUPATIONAL HYGIENE 889 (1982).  This study is 
excluded because it was of asbestos miners. 
G.H.G. McMillan et al., Effect of Smoking on Attack Rates of Pulmonary and Pleural Lesions 
Related to Exposure to Asbestos Dust, 37 BRIT. J. INDUS. MED. 268 (1980) (not using the ILO 
classification system). 
E.R.A. MEREWETHER ET AL., REPORT ON EFFECTS OF ASBESTOS DUST ON THE LUNGS AND 
DUST SUPPRESSION IN THE ASBESTOS INDUSTRY (1930) (examining textile workers engaged in 
manufacturing insulation materials containing asbestos). 
L.C. Oliver et al., Asbestos-Related Radiographic Abnormalities In Public School Custodians, 
6 TOXICOLOGY & INDUS. HEALTH 629 (1990) (examining the X-rays only for pleural plaques). 
J.L. Pearle, Smoking and Duration of Asbestos Exposure in the Production of Functional and 
Roentgenographic Abnormalities in Shipyard Workers, 24 J. OCCUPATIONAL MED. 37 (1982) 
(not using the ILO classification system). 
H. Robin et al., Clinical, Radiological and Functional Abnormalities Among Workers of an 
Asbestos-Cement Factory, in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES 
CONFERENCE, supra note 51, at 405.  This study is excluded because it did not present results of 
the X-ray readings, but instead only provided the results of PFTs and then made conclusionary 
statements about how many people had each type of disorder. 
G.F. Rubino et al., Radiologic Changes After Cessation of Exposure Among Chrysotile 
Asbestos Miners in Italy, 330 ANNALS N.Y. ACAD. SCIS. 157 (1979).  This study is excluded 
because it was of asbestos miners. 
William Weiss, Cigarette Smoking, Asbestos, and Pulmonary Fibrosis, 104 AM. REV. 
RESPIRATORY DISEASE 223 (1971). 
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have fibroses graded as 1/0 or higher on the ILO scale.72  If the 
 
 72 Eight of the studies that have been included listed findings of radiographic evidence of 
fibrosis graded as 1/1 or higher but did not include those X-rays graded as 1/0.  See supra note 
67.  In addition to the eight insulator studies, the fifty other studies reviewed are: 
M. Albin et. al., Chest X-ray Films From Construction Workers: International Labour Office 
(ILO 1980) Classification Compared With Routine Readings, 49 BRIT. J. INDUS. MED. 862 (1992) 
[hereinafter M. Albin et al., 1992] (identifying the number of 1/0s but not considering a reading 
of under 1/1 as indicating fibrosis).  The study found that 20% (41 of 210) of the subjects within 
ILO profusion category 1/1 had a pneumoconiosis, but did not indicate whether any of the 41 
pneumoconioses were caused by asbestos exposure.  Id. at 864. 
S. Barnhart et al., supra note 51. 
G. Berry et al., Asbestosis: A Study of Dose-Response Relationships in an Asbestos Textile 
Factory, 36 BRIT. J. INDUS. MED. 98 (1979) (studying asbestos textile factory workers working 
for at least ten years).  An earlier 1968 study was of male workers with ten or more years of 
exposure  after January 1, 1933, who were still working on June 30, 1966; the present study 
includes 89 men who by 1972 completed ten or more years. The results were that of 379 
evaluated, 88 (23.2%) were found to have opacities graded 1/0 or higher. 
E.A. Bresnitz et al., Asbestos-Related Radiographic Abnormalities in Elevator Construction 
Workers, 147 AM. REV. RESPIRATORY. DISEASE 1341 (1993). 
C-R Chen et al., Occupational Exposure and Respiratory Morbidity Among Asbestos Workers 
in Taiwan, 91 J. FORMOSAN MED. ASSOC. 1138 (1992). 
S. Cordier et al., Epidemiologic Investigation of Respiratory Effects Related to Environmental 
Exposure to Asbestos Inside Insulated Buildings, 42 ARCHIVES. ENVTL. HEALTH 303 (1987). 
G.L. Delclos et al., Interobserver Variability Using the ILO (1980) Classification in Subjects 
Referred for Compensation Evaluation, in PROCEEDINGS OF THE VIITH INTERNATIONAL 
PNEUMOCONIOSES CONFERENCE supra note 51, at 960-64. 
J.M. Dement et al., Surveillance of Respiratory Diseases Among Construction and Trade 
Workers at Department of Energy Nuclear Sites, 43 AM. J. INDUS. MED. 559 (2003). 
R.Y. Demers et al., Asbestos-Related Pulmonary Disease in Boilermakers, 17 AM. J. INDUS. 
MED. 327 (1990). 
A. Fischbein et al., Drywall Construction and Asbestos Exposure, 40 AM. INDUS. HYGIENE 
ASSOC. J. 402 (1979). 
A. Fischbein et al., Respiratory Findings Among Ironworkers; Results From a Clinical Survey 
in the New York Metropolitan Area and Identification of Health Hazards From Asbestos in Place 
at Work, 48 BRIT. J. INDUS. MED. 404 (1991). 
E.A. Gaensler & A.M. Goff, Asbestos-Related Disease in Crocidolite and Chrysotile Filter 
Paper Plants, in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE, 
supra note 51, at 397 (examining workers who were engaged in manufacturing of specialty and 
filter papers containing asbestos). 
E.A. Gaensler et al., Radiographic Progression of Asbestosis With or Without Continued 
Exposure, in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE, 
supra note 51, at 386 [hereinfter Gaensler et al., Radiographic Progression] (examining the 
workers at six locations—two shipyards, three paper manufacturing plants, and one plant 
specializing in manufacturing insulation board containing asbestos). 
M. Garcia-Closas & D.C. Christiani, Asbestos-Related Diseases in Construction Carpenters, 
27 AM. J. INDUS. MED. 115 (1995). 
J. Gitlin et al., Comparison of ‘B’ Readers’ Interpretations of Chest Radiographs for Asbestos 
Related Changes, 11 ACAD. RADIOLOGY. 843 (2004). 
B. Hilt et al., Chest Radiographs in Subjects with Asbestos-Related Abnormalities: 
Comparison Between ILO Categorizations and Clinical Reading, 21 AM. J. INDUS. MED. 855 
(1992). 
N. Hisanaga et al. Pleural Plaques and Irregular Opacities on Chest Radiographs Among 
Construction Workers, in PROCEEDINGS OF NINTH INTERNATIONAL CONFERENCE ON 
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OCCUPATIONAL RESPIRATORY DISEASES, Kyoto, Japan, 286-289 (1997). 
J.M. Hughes & H. Weill, Pulmonary Fibrosis as a Determinant of Asbestos-Induced Lung 
Cancer in a Population of Asbestos Cement Workers, in PROCEEDINGS OF THE VIITH 
INTERNATIONAL PNEUMOCONIOSES CONFERENCE, supra note 51, at 370. 
K. Jakobsson et al., Radiological Changes in Asbestos Cement Workers, 52 OCCUPATIONAL & 
ENVTL. MED. 20 (1995). 
J. Jankovic & R. Reger, Health Hazard Evaluation Report- United Rubber Workers’ 
International Union, NIOSH Investigation, MHETA 87-017-1949, at 1088 (1989). 
Kagamimori et al., supra note 68, at 166-169 (1997). 
Kilburn et al., 1986, supra note 58 (including several study groups—some exposed and some 
not—separately, and is being treated as separate studies for this analysis). 
K.H. Kilburn & R. Warshaw, Airway Obstruction in Asbestosis Studied in Shipyard Workers, 
in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE, supra note 51, 
at 408. 
K. Koskinen et al., Radiographic Abnormalities Among Finnish Construction, Shipyard and 
Asbestos Industry Workers, 24 SCANDINAVIAN  J. WORK ENV’T & HEALTH 109 (1998). 
J. Lefante et al., An Analysis of X-Ray Reader Agreement: Do Five Readers Significantly 
Increase Reader Classification Reliability Over That of Three Readers?, in PROCEEDINGS OF THE 
VIITH INTERNATIONAL PNEUMOCONIOSES CONFERENCE, supra note 51, at 482. 
S.M. Levin & I.J. Selikoff, Radiological Abnormalities and Asbestos Exposure Among 
Custodians of the New York City Board of Education, 643 ANNALS. NY. ACAD. SCIS. 530 (1991); 
Metadilogkul & Supanachart, supra note 66, at 331 (studying workers involved in the 
manufacturing of products containing asbestos). 
Miller, supra note 64.  
Murphy et al., supra note 53. 
Myint & Myint, supra note 67, at 375 (presenting the results of the X-rays as positive only 
when the interpretation was 1/1 or higher). 
J. Ohar et al., Changing Patterns in Asbestos-Induced Lung Disease, 125 CHEST 744 (2004) 
[hereinafter Ohar et. al., 2004].  This study did not distinguish between 0/1 and 1/0.  Thus, this 
review includes only the X-rays that were read 1/1 or higher. Of the 437 X-rays examined, 16% 
(70) had 1/1 or higher and 40% (175) were either 0/1 or 1/0. 
Oksa et al., 1992, supra note 67 (presenting the number of X-rays graded as 1/1 or higher but 
did not list the number graded as 1/0). 
Reger et al., 1990, supra note 35.  This study is included although it was a re-reading of 439 X-
rays that had been found positive for asbestos-related disease which had been the basis for filing 
legal claims for asbestos-related injury, and although the re-readings included all profusions of 
0/1 and above. 
A.Z. Rocskay et al., Respiratory Health in Asbestos-Exposed Ironworkers, 29 AM. J. INDUS. 
MED. 459 (1996). 
L. Rosenstock et al., The Relation Among Pulmonary Function, Chest Roentgenographic 
Abnormalities, and Smoking Status in an Asbestos-Exposed Cohort, 138 AM. REV. RESPIRITORY 
DISEASE 272 (1988). 
Rossiter & Harries, supra note 66.  This study included what the authors called “high exposure 
trades,” (referring to sprayers and laggers) and the results are presented separately for the high 
exposure trades (30.8% were found to have 1/1 or higher graded opacities) and everyone else 
(2.9% were found to have 1/1 or higher graded opacities.)  For the review, the results are 
combined. 
Rossiter et al.,  supra note 66.  
C. Rubin & L. Ringenbach, The Use of Court Experts in Asbestos Litigation, 137 F.R.D. 35 
(1991).  As noted, this was not a clinical study but is included because it is a functional 
equivalent.  See supra note 90 and accompanying text; see also infra note 153. 
R. Saito et al., A Study On Asbestos-Associated Lung Diseases Among Former U.S. Naval 
Shipyard Workers, in PROCEEDINGS OF THE VIITH INTERNATIONAL PNEUMOCONIOSES 
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insulators’ studies are included without adjustment, then of the total 
83,568 X-rays reviewed, 11,851 (14.18%) were found to have fibroses 
graded as 1/0 or higher. 
 
 
 
 
 
 
 
 
 
 
 
 
CONFERENCE, supra note 51, at 362 [hereinafter R. Saito et al., 1990] Saito et al. studied 248 
former U.S. Naval shipyard workers and found that 232 (93.5%) had parenchymal fibrosis.  The 
study found “[n]ot only small irregular opacities characteristic of asbestos exposure but also small 
nodular opacities . . . [which are probably caused by] welding, sandblasting and other dusty work 
in ship repair and/or building work.  Therefore the development of parenchymal fibrosis was 
interpreted as combined profusion.”  Id. at 362. A part of this study had an unexposed control 
group and the results of this group are separately included in the review of studies of unexposed 
populations. 
D.A. Schwartz et. al., Asbestos-Induced Pleural Fibrosis and Impaired Lung Function, 141 
AM. REV. RESPIRATORY DISEASE 321 (1990). 
I.J. Selikoff et al., Asbestotic Radiological Abnormalities Among United States Merchant 
Marine Seamen, 47 BRIT. J. INDUS. MED. 292 (1990). 
I.J. Selikoff & R. Lilis, Radiological Abnormalities Among Sheet-Metal Workers in the 
Construction Industry in the United States and Canada: Relationship to Asbestos Exposure, 46 
ARCHIVES ENVTL. HEALTH 30 (1991). 
Sheers et al., 1978, supra note 66.  The focus of this study was to compare the methods of 
finding asbestos related abnormalities.  It did not provide detail about the study group, exposure 
levels, or prevalence.  It used various subgroups within itself to test positives read by one method 
against another.  Finally, it identified small opacities as “positive” when graded as 1/1 or higher.  
Silberschmid et al., supra note 66.  This study presented the results of the X-ray readings by 
placing them into three categories: 0/0-1/0, 1/1-2/1, and 2/2-3/+. Thus, included in the review are 
those X-rays that were read 1/1 or higher. 
N.L. Sprince et al., Asbestos Related Disease in Plumbers and Pipefitters Employed in 
Building Construction, 27 J. OCCUPATIONAL MED. 771 (1985); 
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Radiologic Findings. National Sheet Metal Examination Group, 25 AM. J. INDUS. MED. 635 
(1994). 
William Weiss & P.A. Theodos, Pleuropulmonary Disease Among Asbestos Workers in 
Relation to Smoking and Type of Exposure, 20 J. OCCUPATIONAL. MED. 341 (1978). 
A.J. Zitting et al., Radiographic Small Lung Opacities and Pleural Abnormalities as a 
Consequence of Asbestos Exposure in an Adult Population, 21 SCANDINAVIAN J. WORK ENV’T &  
HEALTH 470 (1995). 
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A Review of Clinical Studies of the Prevalence of 
Fibrosis Among Exposed Workers 
 
 
 
N 
 
 
≥ 1/0 
 
% 
58 studies (including eight 
adjusted insulator studies) 
 
78,219 
 
9,042 
 
11.56% 
58 studies (including eight 
insulator studies without 
adjustment) 
 
83,568 
 
11,851 
 
14.18% 
 
III.     DISPARITIES BETWEEN THE FINDINGS OF CLINICAL STUDIES AND 
LITIGATION SCREENINGS 
A.     Understatement of the Degree of Disparity 
 
The litigation B Readers’ 50-90% positive X-ray reading range for 
radiographic evidence of fibrosis graded as 1/0 or higher on the ILO 
scale is many multiples of the 11.56% percentage generated by a review 
of the clinical studies.  This alone provides compelling evidence of 
systematically erroneous, if not fraudulent, medical reports by the 
comparative handful of B Readers and doctors employed by screening 
companies and plaintiffs’ lawyers.  Moreover, this simple comparison 
understates the degree of disparity between the two sets of results. 
 
1.     The Effect of Differing Shapes and Locations of Opacities on X-
Ray Readings 
 
The clinical studies included in the review, grade the X-rays on the 
ILO scale and identify those X-rays with radiographic evidence of 
fibrosis, i.e., opacities or visible scarring of the lung of grade 1/0 or 
higher.  The shape, size, and location of opacities, however, are 
important factors in the determination of the cause of the radiographic 
evidence of fibrosis.73  For example, if the opacities graded 1/0 or 
 
 73 “The ILO system standardizes the interpretation of chest x-rays using descriptions of the 
size, shape, and profusion (i.e., degree or severity) of radiographic abnormalities (i.e., visible lung 
markings or scarring).”  In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 591 
(S.D. Tex. 2005).  The ILO classification system describes both small and large opacities as 
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higher were small and rounded, and located in the mid and upper zones 
of the lung, and the individual’s work history indicated substantial 
occupational exposures to sand dusts such as that experienced by 
sandblasters, and a medical examination of the individual yielded 
consistent results, the individual’s diagnosis would likely be silicosis.74  
Opacities caused by asbestos exposure are primarily irregular and linear 
and appear mostly on both sides at the base and periphery of the lungs.75  
Because some of the 58 clinical studies only grade the opacities and do 
not identify the shapes and locations of the opacities, and few of the 
studies actually state that the opacities were determined on the basis of 
 
parenchymal abnormalities.  INT’L LABOUR ORG., GUIDELINES FOR THE USE OF ILO 
INTERNATIONAL CLASSIFICATION OF RADIOGRAPHS OF PNEUMOCONIOSIS (rev. ed. 2000).  Small 
opacities are those up to 10mm in width.  Id.  Large opacities are those exceeding 10mm in width.  
Large opacities are also then categorized into three subcategories (A, B and C) by their specific 
size, profusion, and location in the lungs.  Neither asbestosis nor silicosis, however, present as 
large opacities.  Small opacities are classified by profusion, location in the lungs, shape, and size.  
Id.  Profusion refers to the “concentration of small opacities in affected zones of the lung.”  Id.  
“Affected zones” refers to the “zones in which the opacities are seen . . . . Each lung is divided 
into three zones (upper, middle, lower) by horizontal lines drawn at approximately one-third and 
two-thirds of the vertical distance between the lung apices and the domes of the diaphragm.”  Id. 
Small opacities can have an irregular or a rounded shape and each shape is subcategorized by 
the size of the opacities.  Id.  Small rounded opacities are classified in three categories by size and 
recorded with the letters p, q, and r; they are “defined by the appearances of the small opacities on 
the corresponding standard radiographs”:  p-opacities are small rounded opacities with diameters 
up to about 1.5mm; q-opacities are small rounded opacities with diameters between 1.5mm up to 
about 3mm; r-opacities are small rounded opacities with diameters between 3mm up to about 
10mm.  Id.  Small irregular opacities are recorded with the letters s, t, and u, and are also “defined 
by the appearances of the small opacities on the corresponding standard radiographs”:  s-opacities 
are small irregular opacities with widths up to about 1.5mm; t-opacities are small irregular 
opacities with widths between about 1.5mm up to 3mm; u-opacities are small irregular opacities 
with widths between 3mm up to about 10mm.  Id. 
“[O]n a chest x-ray, silicosis presents with small, rounded opacities, in the upper ormid zones 
of the lungs. . . . By contrast, on a chest x-ray, asbestosis presents with irregular linear opacities, 
primarily at the bases and periphery of the lungs.”  MDL 1553, 398 F. Supp. 2d at 594.  
“Asbestosis specifically refers to interstitial fibrosis caused by the deposition of asbestos fibers in 
the lung . . . .  In its classic form, there is diffuse, bilateral, pale, firm fibrosis most severe in the 
peripheral zones of the lower lobes.”  Am Thoracic Soc’y, supra note 17.  Eventually, the 
opacities may spread to the middle and upper lung zones. Also, even though irregular opacities 
are primarily presented from exposure to asbestos, mixed irregular and rounded opacities can also 
often be seen.  Id. 
 74 See supra note 73.  If the individual was a coal miner, however, the diagnosis would likely 
be coal workers’ pneumoconiosis (“black lung” disease) instead of, or in addition to, silicosis.  A. 
Oikonomou & N.L. Müller, Imaging of Pneumoconiosis, 15 IMAGING 11 (2003).  Both present 
similarly on radiographic manifestations as small, round opacities in the mid and upper zones of 
the lungs.  Id.  In a study of 6,166 coalminers, 801 (13%) X-rays were graded as 1/0.  Of these, 
only 222 were irregular opacities, 455 were rounded opacities and 124 were mixed.  See H.E. 
Amandus et al., Significance of Irregular Small Opacities in Radiographs of Coalminers in the 
USA, 33 BRIT. J. INDUS. MED. 13 (1976) 
 75 See supra note 73. 
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clinical or radiographic evidence to be consistent with asbestosis,76 at 
least some of the X-rays graded 1/0 or higher in these studies were 
based on opacities that may not have been consistent with asbestosis.  
By contrast, the litigation B Readers assert that they are identifying and 
grading only those opacities “consistent with asbestosis.”  If the medical 
studies were to have limited identifying opacities to only those 
“consistent with asbestosis,” they would have found a lower prevalence 
of fibrosis due to asbestos exposure than their published results. 
 
2.      The Possibility of Over-Reading of Fibrosis in the Clinical Studies 
 
According to medical literature, there are some conditions that 
manifest themselves on pulmonary X-rays that are not properly read as 
radiographic evidence of fibrosis but are similar enough to fibrosis to be 
easily misinterpreted as such.77  Some medical conditions may cause 
lung changes that can “mimic roentgenographically the specific 
fibrogenic dust entity or forms of immunologic occupational disease.”78  
In addition, parenchymal abnormalities produced by aging and smoking 
have been postulated to be “indistinguishable from occupationally 
related pulmonary fibrosis.”79  Thus, it is possible that the medical 
studies may have overstated the number of X-rays with radiographic 
evidence of fibrosis graded as 1/0 or higher. 
 
 76 Of the 58 studies, 16 do not say anything about the size, shapes, or location of the 
opacities; 10 state only that they identified small opacities; 26 state that the opacities observed 
were of irregular shape; and only 6 of the studies state that the opacities are of irregular shape and 
located in the lower lung zones.  Of the 16 studies that did not describe the opacities, 5 indicated 
that a radiologist had interpreted the X-rays as consistent with asbestosis (even though the bases 
for these interpretations are not set out in the studies).  In addition, for 5 studies, the authors 
referred to those identified with radiographic evidence of fibrosis graded 1/0 or higher, as having 
asbestosis.  No diagnoses, however, were undertaken in these studies and the use of the term 
“asbestosis” does not appear to be used in a medically rigorous manner. 
 77 Chest radiographic interpretations have been read as positive for fibrosis when, in fact, they 
were negative; the misinterpretation results from “increased basilar linear markings caused by 
emphysema or pleural changes that overlay the parenchyma.”  A.C. Friedman et al., Computed 
Tomography of Benign Pleural and Pulmonary Parenchymal Abnormalities Related to Asbestos 
Exposure, 11 SEMINARS ULTRASOUND CT & MR 393, 399-400 (1990) [hereinafter Friedman, 
Computed Tomography].  Prominent vessels, chronic obstructive pulmonary disease, 
bronchiectasis, scarring from surgery, old tuberculosis, obscuration of the lung by plaques en 
face, and walls of bullae (emphysema) have also been misread as parenchymal asbestosis.  See 
Friedman 1988, supra note 71, at 270-71. 
 78 H.S. Van Ordstrand, M.D., Pneumoconioses and Their Masqueraders, 19 J. 
OCCUPATIONAL MED. 747, 753 (1977). 
 79 John D. Meyer et al., Prevalence of Small Lung Opacities in Populations Unexposed to 
Dusts: A Literature Analysis, 111 CHEST 404, 404 (1997) [hereinafter Meyer, 
Prevalence/Unexposed]; see also infra notes 84 and 163. 
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Additionally, a study comparing techniques in diagnosing 
asbestos-related pleural disease and asbestosis concluded that on the 
basis of the study that “a positive diagnosis of pleural or parenchymal 
disease would be correct in only approximately 50% of patients.”80 
 
3.     “Background” Prevalence of Fibrosis 
 
A second reason why the clinical studies may overstate the number 
of X-rays with radiographic evidence of fibrosis graded 1/0 or higher 
due to asbestos exposure is that there is a “background” prevalence of 
small opacities in populations occupationally unexposed to asbestos or 
other mineral dusts.  Of the thirteen studies published on the prevalence 
of small lung opacities in such populations, eleven are included and two 
are excluded from the review.81  These studies indicated a prevalence of 
 
 80 Friedman 1988, supra note 71, at 272.  (evaluating the utility of the HRCT compared to 
chest X-rays in the diagnosis of asbestos-related disease);  see infra note 154. 
 81 The eleven included studies are: 
R.M. Castellan et al., Prevalence of Radiographic Appearance of Pneumoconiosis in an 
Unexposed Blue Collar Population, 131 AM. REV. RESPIRATORY DISEASE 684 (1985) 
(examining 1,422 X-rays and finding opacities graded as 1/0 or higher in 3 (.21%)). 
D.M. Epstein et al., Application of ILO Classification to a Population without Industrial 
Exposure: Findings to be Differentiated from Pneumoconiosis, 142 AM. J. ROENTGENOLOGY 53 
(1984) (examining 200 X-rays and finding opacities graded as 1/0 or higher in 36 (18%)). 
J.R. Glover et. al., Effects of Exposure to Slate Dust in North Wales, 37 BRIT. J. INDUS. MED. 
152 (1980) (examining 402 X-rays and determining that there were opacities graded as 1/0 or 
higher in 39 (9.7%)). 
K. Jakobsson et al., supra note 72 (examining 29 X-rays and finding that there were opacities 
graded as 1/0 or higher in 2 (6.8%)).  This study was separated for the purposes of the review 
because some of the population was exposed.  The results of the study as it pertains to the 
exposed is included in the review of exposed populations. 
S.M. Kennedy et al., Lung Function and Chest Radiograph Abnormalities among Construction 
Insulators, 20 AM J. INDUS. MED.. 673 (1991) (examining 149 unexposed in addition to its study 
of insulators, and finding 7 (4.7%) to have opacities graded 1/0 or higher). 
K.H. Kilburn et al., Interaction of Asbestos, Age, and Cigarette Smoking in Producing 
Radiographic Evidence of Diffuse Pulmonary Fibrosis, 80 AM. J. MED. 377 (1986) (examined 
2,514 X-rays and finding opacities graded as 1/0 in 32 (1.27%)).  This study had five categories 
of populations. Two of them were unexposed and are included here with the unexposed studies, 
one was an insulator population and was included with the insulators’ studies, and two were of 
exposed populations and are included in the review of exposed populations. 
A.J. Zitting et al., Radiographic Small Lung Opacities and Pleural Abnormalities as a 
Consequence of Asbestos Exposure in an Adult Population, 21 SCANDINAVIAN J. WORK ENV’T. 
& HEALTH 470 (1995) (examining 3,494 X-rays and finding opacities graded as 1/0 or higher in 
408 (11.7%)).  The population that was examined was classified as probably exposed, possibly 
exposed, and unlikely exposed; for the purposes of this review, the results were separated out.  In 
the review of unexposed populations, only the results of the unlikely exposed are included.  The 
other two categories are presented in the exposed populations above. 
S. Cordier et al., Epidemiologic Investigation of Respiratory Effects Related to Environmental 
Exposure to Asbestos Inside Insulated Buildings, 42 ARCHIVES OF ENVTL. HEALTH 303 (1987) 
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radiographic evidence of fibrosis graded as 1/0 or higher ranging from 
0.21% to 57%.  The approximate median prevalence was 6.8%.  A 
review of the results of the eleven studies indicates a prevalence of 
radiographic evidence of fibrosis among these unexposed populations of 
3.19% (3,547 of 111,127).82  Additionally, Swedish studies of white 
collar workers who were not occupationally exposed to asbestos 
indicated that 11% had a medium reading of 1/0 or greater and 5%  had 
a reading of 1/1 or greater.83 
 
[hereinafter Cordier et al., 1987].  This study was of three groups: occupationally exposed; 
environmentally exposed (working in asbestos-insulated buildings for at least 15 years with no 
known occupational exposure); and nonexposed.  For purposes of this cumulation, I am excluding 
only the occupationally exposed because the prevalence of fibrosis caused by working in 
buildings with asbestos insulation is extremely low.  For this study, N=1108 and averaging the 
results of two B Readers, the number of X-rays graded 1/0 or higher was 174. 
Alan M. Ducatman et al., “B-Readers” and Asbestos Medical Surveillance, 30 J. 
OCCUPATIONAL MED. 644 (1988) [hereinafter Ducatman et al., 1988].  For the Ducatman et al., 
1988 study, N=105,029 and the number with X-rays of 1/0 or higher was 3778 (3.51%).  I am 
excluding an outlier B Reader who was 5-100 times more likely to find 1/0 or higher than the 
other readers.  Therefore, N=100,381 and the 1/0 and higher total is 2,799 (2.79%). 
Bjorn Hilt et al., Asbestos-Related Radiographic Changes by ILO Classification of 10 x 10 cm 
Chest X-Rays in a Screening of the General Population, 37 J. OCCUPATIONAL & ENVTL. MED. 
189 (1995) [hereinafter Hilt et al., 1995]. The Hilt et al., 1995 study describes a previous 
screening of 21,453 males aged 40 years or more in the county of Telemark, Norway.  It was 
found that 18.1% had been occupationally exposed to asbestos and the prevalence rate was 0.4% 
(86).  A sample of 1,388 of these X-rays was randomly selected for reevaluation.  The results of 
the reevaluation were that 25 (1.8%) were found to have small opacities of 1/0 or higher.  In this 
sample, 18% were found to have had occupational exposure.  Neither study provides a means for 
excluding those occupationally exposed from the results.  Somewhat arbitrarily, and in view of 
the relatively low number of opacities graded 1/0 or higher, I am including the results of the 
reevaluation in the review. 
R. Saito et al., 1990, supra note 72 (finding that of the 40 person without occupational asbestos 
exposure, 22 (57%) had X-rays graded 1/0 or higher). 
The two studies of unexposed populations that were excluded were: William Weiss, Cigarette 
Smoking and Diffuse Pulmonary Fibrosis, 99 AM. REV RESPIRATORY DISEASE 67 (1969) 
[hereinafter Weiss, 1969] and William Weiss, Cigarette Smoking and Diffuse Pulmonary 
Fibrosis, 14 ARCHIVES ENVTL. HEALTH 564 (1967) [hereinafter Weiss, 1967].  Both of these 
studies are excluded because they did not provide the results using the ILO classification system.  
The results of both of these studies showed a prevalence of diffuse pulmonary fibrosis in the same 
range as other studies of unexposed populations.  The Weiss 1967 study examined 999 people 
and found fibrosis in 3.10%.  The Weiss 1969 study examined 2,825 people and found fibrosis in 
1.4%. 
82A meta-analysis of the first seven studies listed above found a prevalence of 5.3%.  Meyer, 
Prevalence/Unexposed, supra note 79.  The prevalence found in these seven studies ranged from 
0.21% to 11.7%.  Id.  The prevalence was 11.3% in Europe and 1.6 % in North America.  A 
review of the results of the seven studies indicates a prevalence of 6.4% (527 of 8,210).  The 
meta-analysis required that each study had at least two B Readers or their equivalent read the X-
rays and grade then on the ILO scale.  Because of this requirement, the meta-analysis omitted the 
Ducatman et al., 1988 study—the largest of all the studies—because the 23 B Readers did not 
read the same films. See id. 
 83 M. Albin et al., 1992, supra note 72, at 866. 
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A variety of reasons for the background prevalence are examined 
in the literature.  One explanation is that increasing age and smoking 
each result in opacities that are indistinguishable from occupationally 
related pulmonary fibrosis.84 
This background prevalence of fibrosis in the general population is 
likely to have resulted in elevated findings of radiographic evidence of 
fibrosis in the clinical studies of populations occupationally exposed to 
asbestos.  No study has been done to attempt to identify the amount of 
misattribution of fibrosis to asbestos exposure in clinical studies. 
One 1985 study suggests that the degree of misattribution may be 
significant.  This study, looked at the routine admission chest X-rays of 
patients hospitalized in an urban university medical center who were not 
known to have any industrial exposure to asbestos.85  Out of 200 X-rays 
examined, 36 (18%) had profusion levels of 1/0 or greater, and 35 
(17.5%) had profusions of 0/1.86  If the chest X-rays of the patients with 
profusions of 0/1 were read by the comparative handful of B Readers 
with all the financial incentives attendant in the litigation context to 
grade the X-rays as 1/0 or higher,87 it is likely that these B Readers 
would have read the 0/1s as 1/0s.  On that basis,88 it would be plausible 
to conclude that a third or more of the adult population without 
occupational exposure to asbestos could be found to have lung opacities 
 
 84 “Age and smoking habits have been postulated to produce radiographic parenchymal 
abnormalities in unexposed populations indistinguishable from occupationally related pulmonary 
fibrosis.” Meyer, Prevalence/Unexposed, supra note 79, at 405.  One study showed a threefold 
increase in lung abnormalities in smokers when compared to nonsmokers.  Id. at 408.  Older 
workers have an increased prevalence of opacities which may be due to cumulative 
environmental exposures and, perhaps, age itself.  Id.; see also, Weiss, 1969, supra note 81; 
Weiss, 1967, supra note 81 (studying 999 men and women who came to the survey unit of the 
Philadelphia Tuberculosis and Health Association for free chest X-rays and finding that the 
prevalence of “diffuse pulmonary fibrosis” showed a strong dose-response relationship to 
cigarette smoking).  Of 527 current smokers, 23 (4.4%) were found to have “diffuse pulmonary 
fibrosis.” For men who smoked more than one pack a day for 20 years or more, the prevalence 
exceeded 20%.  Id.; Anders J. Zitting, Prevalence of Radiographic Lung Opacities and Pleural 
Abnormalities in a Representative Adult Population Sample, 107 CHEST 126, 127 (1995) 
[hereinafter Zitting, Prevalence] (finding that a correlation exists between aging and the presence 
of fibrosis); see infra notes 161-170. 
 85 David M. Epstein et al., Applications of ILO Classification to a Population Without 
Industrial Exposure: Findings to be Differentiated from Pneumoconiosis, 142 AM. J. 
ROENTGENOLOGY 53 (1984). 
 86 Id. at 54. 
 87 For discussion of the financial incentives of “entrepreneurial” B Readers to read X-rays as 
1/0 or higher, see Brickman, Asbestos Litigation, supra note 1, at 90. 
 88 Conclusions based on the results of this study are subject to serious caveats.  The sample 
was certainly not a representative one and the fact that all of the X-rays were of hospitalized 
patients injects another level of caution.  Nonetheless, the study provides a useful, if anecdotal, 
insight into the prevalence of fibrosis among those not known to have been occupationally 
exposed to asbestos. 
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of 1/0 or higher on the basis of the standards used by the B Readers 
most selected to read X-rays obtained in the course of attorney-
sponsored asbestos screenings.  Even if the X-rays are read in a clinical 
rather than a litigation setting, another study concludes that one-quarter 
of men between 55 and 64 in the general population have lung 
abnormalities that register at least 1/0 on the ILO scale, and the 
prevalence of such X-ray readings continues to increase with age.89 
 
B.     Clinical Re-readings of Litigation B Readers’ Results 
 
Beyond the review of the clinical studies, there is additional 
support for the conclusion that the B Readers most frequently selected 
by plaintiffs’ lawyers for litigation screenings are manufacturing B 
reads for money.  In five clinical studies, a judicial proceeding, and an 
investigation undertaken by the American Bar Association, X-rays read 
as 1/0 or higher and found to be “consistent with asbestosis” were re-
read by a panel of independent B Readers or otherwise analyzed.  These 
studies and proceedings, summarized below, indicate error rates ranging 
from 60-97%. 
1.  In an aggregated asbestos litigation, U.S. District Court Judge 
Carl B. Rubin substituted impartial medical experts for the parties’ 
experts.  The impartial experts found that only 10 (15%) of the 65 
plaintiffs claiming to have asbestosis in the 1987-1990 proceeding, did 
in fact have asbestosis.90 
2.  In 1986, the United Rubber Workers’ International Union 
(URW) requested that NIOSH conduct an evaluation of the occurrence 
of pneumoconiosis among tire workers to determine if the 
union/industry-operated medical surveillance program, which failed to 
detect any excess asbestosis or other pneumoconiotic conditions among 
tire workers, had missed cases of asbestos-related disease.91  The basis 
for this concern was a very high rate of pneumoconiosis generated by 
asbestos screenings.  Information distributed to tire workers by 
plaintiffs’ lawyers stated that at one screening location, 64% of those 
screened, tested positive for asbestosis, and at a second screening 
 
 89 Zitting, Prevalence, supra note 84, at 127. 
 90 Carl B. Rubin & Laura Ringerbach, The Use of Court Experts in Asbestos Litigation, 137 
F.R.D. 35 (1991).  It can be presumed that since the plaintiffs were claiming to have asbestosis, 
all had had their X-rays read as 1/0 or higher. 
 91 See JOHN JANKOVIC & ROBERT REGER, HEALTH HAZARD EVALUATION REPORT, NIOSH 
Rep. No. HETA 87-017-1949 (Dep’t Health & Human Servs. Feb. 1989) [hereinafter JANKOVIT 
& REGER, 1989]. 
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location, 94% tested positive for asbestosis.92  Focusing on workers with 
the greatest potential for disease, NIOSH had an independent panel 
evaluate 987 X-rays from the surveillance program of workers over 
forty years of age.  The NIOSH panel found that only two, or 0.2%, 
showed physical changes consistent with the mildest form of 
asbestosis.93 
3.  In a 1990 study of 439 tire workers who filed suit after litigation 
screenings, four medical professors and radiologists re-examined the 
plaintiffs’ X-rays and found that realistically, only eleven of the 
claimants (2.5%) had lung conditions consistent with asbestos 
exposure—a 97.5% error rate.94 
4. Doctors interviewed for a report for the American Bar 
Association Commission on Asbestos Litigation reported having “seen 
hundreds or even thousands of examples of over-reading of x-rays for 
litigation purposes.”95  One doctor reviewed the medical records of 
15,000 people who had been diagnosed with asbestosis based solely on 
X-ray readings, and determined that “only 10% of the persons could 
validly be diagnosed with asbestosis.”96  “Another doctor reported a 
62% error rate on review of X-ray screening results previously read as 
‘consistent with asbestosis,’” and a third doctor reviewed 22,000 
asbestos-related claims and “found a presumptive x-ray review error 
rate of up to 86% among five readers, none of whose results matched 
the general patterns in epidemiological studies.”97 
5.  Between 1994 and 1995, the Manville Trust experienced huge 
increases in the number of claims by unimpaired people with non-
malignant lung disease.  In 1995, this spike spurred the Trust to institute 
a medical audit program, in which neutral academics analyzed and 
evaluated 5% of the claims submitted by each law firm during each 
payment cycle.  The review process was intentionally designed “in 
favor of confirming the disease documented by the claimant and to give 
 
 92 See Raymark Indus., Inc. v. Stemple, No. 88-1014K, 1990 WL 72588, at *10 (D. Kan. May 
30, 1990). 
 93 JANCOVIC & REGER, 1989, supra note 91, at 12-14. 
 94 Reger et al., 1990, supra note 35.  The Reger study did not indicate how many of the 439 
active and retired tireworkers had been diagnosed with asbestosis—only that they had been 
diagnosed with a condition consistent with asbestos exposure which would include pleural 
abnormalities.  Of the eleven subjects that he found actually had lung conditions consistent with 
asbestos exposure, approximately half may have been found in the study to have pleural 
abnormalities only.  See id. at 1089  In that case, only about half of the 11 subjects were 
diagnosed with asbestosis. 
 95 ABA REPORT, supra note 11, at 13 (2003). 
 96 Id. 
 97 Id. 
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the benefit of any doubt to the claimant.”98  The results of the audit 
revealed that even by the extremely conservative audit criteria, there 
was a high medical audit failure rate, especially for the 1/0 asbestosis 
claims.99  For example, analysis of asbestosis claims filed in 1996 
revealed that over 66% of the claimants had either no disease at all, or 
had a less severe condition than alleged in the submission,100 and that 
the ten physicians used most often by plaintiffs’ law firms had an 
average failure rate of 63%.101  The audit was discontinued after 
plaintiffs’ lawyers strongly objected to its use.102 
6.  In 2004, a study (Gitlin Study) compared 492 B reads of X-rays 
that were used to support asbestos lawsuits with a panel of six 
consultant B Readers’ interpretations of the same X-rays.103  The 
consultant B Readers104 were completely blinded to the source of 
payments, source of X-rays, the attorneys involved, the status of films 
in litigation, the identity of the B Readers, the individuals’ names, and 
the results of their cumulative findings.  All of the films originally came 
from plaintiffs’ counsel and had been filed in support of plaintiffs’ 
asbestos lawsuits. 
While plaintiffs’ B Readers had found 95.9% of the 492 X-rays to 
 
 98 Affidavit of Patricia G. Houser ¶ 14, In re Manville Pers. Injury Settlement Trust Med. 
Audit Procedures Litig. (E.D.N.Y. & S.D.N.Y. Mar. 31, 1999) (No. 98 Civ. 5693) [hereinafter 
Houser Affidavit]. 
 99 A.R. LOCALIO ET AL., DEP’T OF HEALTH EVALUATION SCIS., PA. STATE UNIV. COLLEGE 
OF MED, THE MANVILLE PERSONAL INJURY SETTLEMENT TRUST X-RAY AUDIT: AN 
ASSESSMENT OF THE IDENTIFICATION OF THE UNDERLYING DISEASE PROCESS FOR MEDICAL 
REVIEW BY CERTIFIED B-READERS 14 (1998) [hereinafter LOCALIO REPORT]. 
100 See Letter from Mark E. Lederer, Manville Trust, to Elihu Inselbuch 2 (April 24, 1998) (on 
file with author). 
101 Nine of these doctors had failure rates ranging from 50% to 70% while the tenth failed 
36% of the time.  Roger Parloff, Mass Tort Medicine Men, AM. LAW, Jan. 3, 2003, at 98.  It 
should be borne in mind that the X-ray review process was “intentionally designed . . . to operate 
in favor of confirming the disease documented by the claimant and to give the benefit of any 
doubt to the claimant.”  Houser Affidavit, supra note 98, ¶ 14. 
102 See Brickman, Asbestos Litigation, supra note 1, at 128-37. 
103 The study was designed and conducted by two researchers: Dr. Joseph N. Gitlin, an 
associate professor at Johns Hopkins University, who designed and directed the National X-ray 
Exposure Studies in the United States for the U.S. Public Health Service; and Mr. Otha Linton, a 
senior executive of the American College of Radiology, where he managed the Task Force on 
Pneumoconiosis for NIOSH, and was involved in the development of the B Reader program.  See 
Joseph N. Gitlin et al., Comparison of “B” Readers’ Interpretations of Chest Radiographs for 
Asbestos Related Changes, 11 ACAD. RADIOLOGY 843 (2004) [hereinafter Gitlin Study]. 
104 Id. at 1402. The B Readers on the panel included one who had consulted primarily for 
plaintiffs, two who consulted for plaintiffs and defendants, two who consulted primarily for 
defendants, and two who had no previous participation in reading films for litigation.  The total is 
seven because one of the consultant B Readers died during the course of the study and was 
replaced.  Affidavit of Joseph N. Gitlin DPH, In re Congoleum Corp., No. 03-51524 (Bankr. 
D.N.J. March 23, 2005). 
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have a profusion of 1/0 or higher on the ILO scale, and that these 
findings were “consistent with asbestosis,” the six consultant readers 
found that only 4.5% of the same X-rays had a profusion of 1/0 or 
higher.  Even these readings did not mean that 4.5% of the 492 had 
asbestosis.  Rather, the re-readings only indicated that 4.5% of the X-
rays had small opacities of 1/0 or greater, which could have been the 
result of old age, obesity, smoking and more than one hundred other 
causes, including exposure to asbestos. 
Based on a statistical analysis, the Gitlin Study determined that 
there was “a probability of less than 1 in 10,000 that the differences 
noted between initial and consultant readers are due to chance alone.”105 
Of the seven B Readers106 who accounted for a substantial majority 
of the initial 492 B reads that the Gitlin Study found to have a more than 
90% error rate—two have refused to testify about their diagnoses and 
invoked their Fifth Amendment right against self-incrimination,107 and 
one recanted all of his asbestosis and silicosis diagnoses.108  These 
seven B Readers appear in a compilation by the Manville Trust of the 
top twenty-five doctors who authored medical reports in support of 
claims submitted to the Trust through December 31, 2005.  In total, they 
account for a staggering 222,410 medical reports. 109 
7. The Gitlin Study has been critized by various plaintiffs’ lawyers 
and others.110  The gist of the criticism is that (1) the X-rays used in the 
 
105 Gitlin Study, supra note 103, at 850. 
106 The seven B Readers who account for a substantial majority of the initial 492 B-reads are 
Dr. Dominic G. Gaziano, Dr. Ella A. Kazerooni, Dr. Jay T. Segarra, Dr. James W. Ballard, Dr. 
Phillip H. Lucas, Dr. Ray A. Harron, and Dr. Richard B. Levine.   
107 Letter from the Law Firm of Leitman, Siegal & Payne, P.C., to Daniel J. Mulholland (Nov. 
11, 2005) (on file with author) (indicating that Dr. James Ballard “will not be producing . . . 
[subpoenaed] documents in accordance with his rights under the Fifth Amendment to the United 
States Constitution”); Defendants’ Brief In Support of Motion For An Evidentiary Hearing And 
Motion to Dismiss at 3, In re All Asbestos Cases, Special Docket 073958 (Ohio C.P. Feb. 3, 
2006) (indicating that in addition to Dr. Ballard, Dr. Ray Harron was refusing to answer questions 
about the medical evidence he had provided on Fifth Amendment grounds); see also infra note 
256. 
108 Dr. Richard B. Levine filed an affidavit in MDL 875, in which he stated that he never 
diagnosed asbestosis or silicosis, Affidavit of Richard Levine ¶¶ 3, 6, 9, In re Asbestos Prods. 
Liab. Litig. (No. VI), Civ. Action No. MDL 875 (E.D. Pa. May 1, 2006), despite the fact that he 
provided over 22,000 medical reports in support of claims filed with the Manville Trust.  See 
CRMC Response, supra note 19, at ques. 14(a) and 14(c). 
109 CRMC Response, supra note 19. 
110  See, e.g., Objection and Response of The Official Committee of Asbestos Claimants to the 
Motion of the Official Committee of Asbestos Property Damage Claimants at 15, In re Federal-
Mogul Global, Inc., Case No. 01-10578 (RTL) (Bankr. D. Del. Sept. 21, 2004); Letters to the 
Editor (Dr. Kenneth D. Rosenman), 11 ACAD. RADIOLOGY 1396 (2004); Letters to the Editor 
(Dr. L. Christine Oliver), 11 ACAD. RADIOLOGY 1397 (2004); Letters to the Editor (Drs. Alfred 
Franzblau and Brenda Gillespie, 11 ACAD. RADIOLOGY 1400 (2004).  
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Gitlin Study were not a representative random sample; (2) there was no 
control group; and (3) the film selection may have been biased.  Dr. 
Gitlin has rebutted these criticisms.111  Moreover, the results of his 
study have been corroborated by a new re-reading study which used a 
random sample and a control group and which was undertaken in the 
course of a bankruptcy proceeding. 
 Despite the fact that in most asbestos-related bankruptcies, there 
are usually tens of thousands of pending nonmalignant claims, thus 
making a randomized sample for re-reading easily available, attempts 
by the debtor or commercial creditors to have such a re-reading have 
been vigorously opposed by plaintiffs’ lawyers and have mostly been 
turned down by bankruptcy courts.112  In a handful of bankruptcies, 
however, bankruptcy judges have allowed the debtor to conduct 
discovery of the pending claims including examining a sample of these 
claims.113  In the W.R. Grace bankruptcy, the court allowed the debtor 
to conduct discovery of pending claims including distributing Personal 
Injury Questionnaires to these claimants.114  According to the responses, 
“there were 5,438 claimants who alleged a non-mesothelioma 
malignancy caused by a Grace exposure and who were relying on X-ray 
evidence to support the attribution of their cancer to asbestos 
exposure.”115  Two proportionate random samples of 500 X-rays each 
which met the criteria of the study designed by Dr. Daniel A. Henry 
 
111  See Letters to the Editor (Joseph Gitlin), 11 ACAD. RADIOLOGY 1402 (2004); Affidavit of 
Joseph Gitlin, DPH, In re Congoleum Corp., No. 03-51524 (Bankr. D.N.J., Mar. 25, 2005); 
Supplemental Report of Dr. Joseph N. Gitlin, In re Owens Corning et al., No. 00-3837 to 3854 
(Bankr. D. Del., Nov. 10, 2004).  In addition, I have responded to a number of these criticisms 
which were repeated during a symposium on civil justice issues.  See Written Response of Lester 
Brickman to remarks of Bryan Blevins of Provost & Umphrey at 3-4 & app. D, Toxic Torts & 
Mass Actions:  Medical Screening, Panel of the AEI-Brookings Judicial Symposium on Civil 
Justice Issues, (Wash. D.C., Dec. 7, 2006), available at 
http://www.cardozo.yu.edu/uploadedFiles/FACULTY/Lester_Brickman/Response%20to%20Bry
an%20Blevins%20including%20Appendices%20A%20to%20F.pdf. 
112  See, e.g., Owens-Corning v. Credit Suisse First Boston, 322 B.R. 719 (D. Del. 2005) 
113  Order Re: Personal Injury Claim Estimation, In re USG Corp., No. 01-2094 (JFK) (D.Del. 
Oct. 21, 2005); Order Concerning Schedule for Motions to Compel Regarding the W.R. Grace 
Asbestos Personal Injury Questionnaire and Schedule for Supplementation of Questionnaire 
Responses, In re W.R. Grace & Co., No. 01-1139 (JFK) (Bankr. D. Del. Nov. 14, 2006) 
[hereinafter Order Concerning Schedule for Motions to Compel]; In re G-I Industries, Inc. at 46, 
54, Case No. 01-3035 (Bankr. D.N.J. Aug. 11, 2006) (rejecting the motion for appointment of a 
medical panel to review the medical evidence in the pending claims but allowing the debtor a 
limited period of time to conduct a proposed sampling of pending claims to include use of a 
“questionnaire”); see also Order Implementing G-I’s Claimant Questionnaire and Sampling 
Protocol, In re G-I Holdings, Inc., Case No. 01-3035 (Mar. 1, 2007) (containing the detailed 
Questionnaire to be filled out for the 2500 claims in the sample). 
114  Order Concerning Schedule for Motions to Compel, supra note 113.  
115  Report of X-ray Study by Dr. Daniel Henry at 1, In re W.R. Grace & Co., No. 01-1139 
(JFK) (Bankr. D. Del. June 11, 2007). 
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(Henry Study), were drawn from a total of 2,857 of these claims.116  
Because of overlapping claims in the two samples, the total number of 
study films was 807.  These X-rays were read by three B Readers who 
were blinded as to the source of the X-rays, the purpose of the Study 
and the entity on whose behalf they were reading the X-rays.117  Of the 
807 claimants, 471 had an X-ray and accompanying ILO reading that 
met the inclusion criteria and were selected for the comparison study.118 
 The B Readers selected by plaintiffs’ lawyers had found that 383 
of the 471 claimants (81.31%) had a profusion of 1/0 or greater on the 
ILO scale; this was eleven times more frequent than the majority 
readings of the study B Readers who reported profusions in 33 (about 
7%) of these same claimants.119  The Henry Study, which used both a 
proportionate random sample and a control group,120 noted that its 
results are consistent with those of the Gitlin Study.121   
 A number of the B Readers who had initially read the X-rays had 
also read X-rays that were reread in the Gitlin Study.  The error rates (% 
over-read) for these B Readers are indicated in the chart below.122 
 
 
 
 
 
 
 
 
 
 
116  Id.  Dr. Henry is Director, Thoracic and Cardiac Radiology, Department of Radiology, 
Medical College of Virginia Hospitals.   
117  Id. at 5. 
118  Id. at 4. 
119  Id. at 5-6. 
120  A total of 47 control films, including 25 negative and 22 positive films, were selected.  See 
id. at 7 & app. E. The Kappa statistic (which compares agreement against that which might be 
expected by chance), sensitivity (likelihood that a positive film will be correctly classified as 
positive), and specificity (likelihood that a negative film will be correctly classified as negative) 
were computed for the majority reading and for each of the 3 independent B Readers.  Id. at 7.  
The Kappa statistic for the majority reading was 0.74 which was in the “substantial agreement” 
range.  Id. at 8.  The majority readings had similar high sensitivity and specificity, correctly 
classifying positive films as positive and negative films as negative more than 85% of the time.  
Id. 
121 Id. at 8.  The Gitlin Study found a virtually identical error rate (91%).  Gitlin Study, supra 
note 103. 
122 Dr. Henry’s Supplement to the Henry X-ray Study, In re W.R. Grace & Co., No. 01-1139 
(JFK) (Bankr. D. Del. June 26, 2007). 
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PrProfusion ≥ 1/0  
Claimant B-Reader 
 
Number of 
Readings % of 
Readings  
% Overread123 
Gaziano, Dominic 41 87.8 80.48 
Ballard, James  40 97.5 95 
Harron, Ray 24 91.67 83.33 
Lucas Phillip 20 100 100 
Segarra, Jay 17 94.12 94.12 
 
 As noted in the chart above, Drs. James Ballard, Dominic 
Gaziano, Ray Harron, Philip Lucas and Jay Segarra had found between 
87.8% and 97.5% of the X-rays they read as positive for asbestosis and 
had error rates that ranged from 80.48% to 100%.124  
 The Henry Study also analyzed the error rates of the law firms 
which had submitted the most films in the samples and their percentage 
of over-reads.125  For eight of the top nine law firms ranked by number 
of claims included in the sample, the percentage of over-reads ranged 
from 71.3% to 93.33%.126  
Finally, though it is not a re-reading, one additional unpublished 
study produced results that are fully consistent with the very high error 
rates found by the re-readings discussed above. 127 
 
123  %Overread = [((# Claimant prof≥1/0)) - ( # Consensus prof≥1/0)) / # Read] x 100.  Id. 
124  Id. 
125  Id.  The claimants in the samples that met inclusion criteria were represented by 40 law 
firms. 
126  Id.  One law firm had only 35.82% of over-reads. 
127 An unpublished study of workers in power plants provides an additional basis for 
validating the very high error rates that clinical studies and medical experts report.  Electricity 
generating power plants (powerhouses) have extensive amounts of thermal insulation.  In older 
plants, the insulation is likely to include large amounts of asbestos-containing products.  R.C. 
Browne, Health in Power Stations, 64 PROCEEDINGS ROYAL. SOC’Y. MED. 1075 (1971); Jack H. 
Fontaine & David M. Trayer, Asbestos Control in Steam Generating Plants, 36 AM. INDUS. 
HYGIENE. ASSOC. J. 126 (1975); R. Lazarus, Lung-Function Reference Values From Victorian 
Power-Industry Workmen,  2 MED. J. AUSTL. 121 (1982).  The most intense asbestos exposures 
associated with powerhouses are realized by construction workers during construction, 
maintenance and the dismantling of powerhouses.  See, e.g., In re Joint E. & S. Dists. Asbestos 
Litig: All Powerhouse Cases, No. NYAL-PH-8888, 1991 U.S. Dist. LEXIS 8401 (E.D.N.Y & 
S.D.N.Y. 1991) (describing 700 cases that were consolidated for trial, in which mostly 
construction workers were claiming injurious exposure to asbestos during the construction or 
repair of powerhouses).  Workers employed in powerhouses, however, may spend large portions 
of their workday in close proximity to asbestos insulation and may be called upon to make 
occasional repairs.  At least some of these powerhouse workers have brought suit, but there is no 
clear indication of how many of these claims were generated by litigation screenings.  See In re 
N.Y. City Asbestos Litig., 142 F.R.D. 60 (E.D.N.Y. & S.D.N.Y. 1992) (attaching the report of a 
special master regarding the resolution of asbestos personal injury and wrongful death claims 
brought in federal and state courts, including approximately 1,000 state court claims that were 
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In the table below, I summarize the error rates found by the five 
clinical studies, the one judicial proceeding where the court-appointed 
experts re-read the X-rays, and the ABA investigation. 
 
Clinical Study Error Rates 
Judge Rubin 85% 
NIOSH128 78% 
Reger (tire workers) 97.5% 
ABA 62-90% 
Manville Trust 63% 
Gitlin Study 91-92% 
Henry Study 91.4% 
 
part of the Powerhouse and Brooklyn Naval Yard consolidation).  Several studies have been done 
of powerhouse workers. See, e.g., Fontaine & Trayer, supra; A. Hirsch et al., Asbestos Risk 
Among Full-Time Workers in an Electricity-Generating Power Station, 330 ANNALS N.Y. ACAD. 
SCIS. 137 (1979); G. Cammarano et. al., Cancer Mortality Among Workers in a Thermoelectric 
Power Plant, 10 SCANDINAVIAN J. WORK ENV’T. & HEALTH 259 (1984); G. Cammarano et al., 
Additional Follow-Up of Cancer Mortality among Workers in a Thermo-Electric Power Plant, 12 
SCANDINAVIAN J. WORK ENV’T. & HEALTH 631 (1986); F. Forastiere et al., Respiratory Cancer 
Mortality Among Workers Employed in Thermoelectric Power Plants, 15 SCANDINAVIAN J. 
WORK ENV’T. &. HEALTH 383 (1989); Y. Lerman et al., Asbestos Related Health Hazards among 
Power Plant Workers, 47 BRIT. J. INDUS. MED. 281 (1990); G. Petrelli et al., A Retrospective 
Cohort Mortality Study on Workers of Two Thermoelectric Power Plants: Fourteen-Year Follow-
Up Results, 5 EUR. J. EPIDEMIOLOGY 87 (1989).  However, these studies have either been limited 
to, or have also included, insulators whose asbestos exposure involved work prior to power plant 
employment.  See Joseph M. Miller, M.D., Benign Exposure To Asbestos Among Power Plant 
Workers, at tbl. 4 (1990) (unpublished manuscript on file with author) [hereinafter Miller 1990].  
For discussion of insulators’ high exposures and resulting disease prevalence, see supra notes 44-
64 and accompanying text.  To provide a valid comparison, a study of powerhouse workers 
whose lifespan of employment was confined to power plant operations was undertaken.  This 
unpublished study identified 114 workers who had extensive work histories with an average of 23 
years of exposure and a mean latency of 32 years.  Id. at tbls. 2 & 4.  The study found that none 
of the 114 workers had asbestosis and 95% had no impaired lung function.  Id. at 3, 5-6.  One of 
the two readers found 2 of the 114 with 1/0 readings and none with higher; the other found none 
with 1/0 or higher.  Id. at tbl. 3.  The study concluded that no cases of “definite asbestosis” were 
found.  Id. at 5.  Extensive exposure to asbestos was confirmed by the findings of circumscribed 
pleural plaques in 40-46% of those studied.  Id. at 5.  While this unpublished study did not re-read 
X-rays generated for litigation, it can be seen functionally as a re-reading on the assumption that 
whatever litigation screenings of the powerhouse workers that did take place produced the same 
rate of positive X-ray readings, 60-80%, that most litigation screenings, including re-reads, 
generate, and, the same rate of diagnoses of asbestosis of those screened positive, 80-90%.   
128 The NIOSH study did not indicate whether the X-rays had previously been read by 
litigation B Readers.  I am using the reported results of 64% and 94% positive for two screenings 
simply averaging them (79%), and comparing that to the 0.2 prevalence rate found by the NIOSH 
Study.  See supra note 91. 
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C.     The Disparity Between the Prevalence of Pleural Plaques in 
Litigation Screenings and Clinical Settings 
 
Pleural plaques (pleural fibrosis), sometimes referred to in asbestos 
litigation as “pleural disease,” are deposits of collagen fibers on the 
linings (pleura) of the lung, usually detectable only by X-rays, 15-20 
years after initial and substantial exposure to asbestos.  As described in 
the medical literature, the vast majority of individuals found to have 
pleural plaques have no symptomatology or lung impairment. 129 
Medical studies consistently show that, among those exposed to 
asbestos in a variety of settings, pleural plaques are two to three times 
more likely to be prevalent than pulmonary asbestosis.130  Consistent 
with the medical science literature, pleural plaque claims accounted for 
the majority of nonmalignant asbestos claims in the 1980s.131 
By the mid-1990s, however, the volume of 1/0 asbestosis claims 
exceeded pleural plaque claims by a substantial margin.132  This abrupt 
 
129 See, e.g., Victor L. Roggli, Fiber Analysis, in OCCUPATIONAL & ENVTL. MED. 255 (2d ed. 
1992); VICTOR ROGGLI, DONALD GREENBERG & PHILLIP PRATT, PATHOLOGY OF ASBESTOS 
ASSOCIATED DISEASES 30 (1992).  A severe form of pleural fibrosis can, however, be impairing.  
See Brickman, Asbestos Litigation, supra note 1, at 51-54, 60 for further description of pleural 
plaques and their role in asbestos litigation. 
130 See Gunnar Hillerdale et al., Asbestos, Asbestosis, Pleural Plaque and Lung Cancer, 23 
SCANDINAVIAN J. WORK ENV’T. &. HEALTH 93, 96 (1997) (“[I]n most investigations pleural 
plaques are the most common radiologists’ finding in persons exposed to asbestos.”); Irving 
Selikoff, Asbestosis: Interstitial Pulmonary Fibrosis and Pleural Fibrosis in a Cohort of Asbestos 
Insulation Workers: Influence of Cigarette Smoking, 10 AM. J. INDUS. MED. 459, 469 (1986) 
(concluding, based on a study of 1,117 insulation workers, that pleural changes (pleural plaques) 
were more common that pulmonary fibrosis (asbestosis) regardless of smoking history); see also 
Albert Miller et al., Spirometric Impairment in Long Term Insulators, 105 CHEST 175 (1994); 
Albert Miller et al., Relation of Spirometric Function To Radiographic Interstitial Fibrosis in 
Two Large Work Forces Exposed To Asbestos And Evaluation Of The ILO Profusion Score, 53 
OCCUPATIONAL & ENVTL. MED. 808 (1996); Laura S. Welch et al., The National Sheet Metal 
Worker Asbestosis Disease Screening Program Radiographic Findings, 25 AM. J. INDUS. MED. 
6345 (1994).  In a study of men occupationally exposed to asbestos in naval dockyards, pleural 
abnormalities were found ten times more frequently than interstitial fibrosis.  See Harries et al., 
supra note 71. 
131 See In re Joint E. & S. Dists. Asbestos Litig., 129 B.R. 710, 934 (E.D.N.Y. & S.D.N.Y 
1991), rev’d 982 F.2d 721 (2d Cir. 1992) (indicating that of the 136,250 claims pending against 
the Manville Trust, as of April 10, 1991, 54.4% were for pleural plaques and 30.7% were for 
asbestosis, for a ratio of 1.77 to 1); see also, Brickman, Administrative Alternative?, supra note 
12, at 1861 (reviewing disease mix data, indicating that pleural plaques accounted for 45-60% of 
outstanding claims in the 1988-1991 period whereas asbestosis accounted for 25-37% of the 
claims). 
132 In a study by Dr. Gary Friedman of 1,691 X-ray and pulmonary function reports involving 
claims against Owens Corning, see supra note 19, Dr. Friedman determined that none of the five 
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shift in X-ray readings by litigation doctors is accounted for by the 
global Georgine settlement in January 1993,133 which was later 
invalidated by both the Third Circuit and the U.S. Supreme Court.134  
As part of that settlement, most of the leading plaintiffs’ lawyers, who 
exchanged upwards of $300 million in fees for settling their current 
inventories of asbestos claimants including pleural plaque claims, 
agreed that future pleural plaque claims would have no value (unless 
and until the claimants later manifested with an actual asbestos related 
disease).135 
Thereafter, B Readers regularly selected by these lawyers 
significantly diminished their findings of pleural plaques and instead 
found radiographic evidence of fibrosis graded as 1/0 or higher, which 
was “consistent with asbestosis.”  Thus, between 1994 and 2002, in 
filings with the Manville Trust, claimaints alleged “pleural disease” 
alone approximately 55,000 times, but more than five times that number 
of asbestosis claims (278,000).136  Moreover, the ratio of asbestosis to 
pleural plaque claims steadily increased in this period.137  These B 
Readers, and other doctors, then went on to diagnose the vast majority 
of these claimants as having asbestosis—a compensable disease.  These 
new claimants, who were diagnosed with asbestosis, had worked 
alongside other claimants at identical work sites whose screening-
generated X-rays these same B Readers had often previously read as 
showing “pleural disease” only and not asbestosis. 
The substantial disparity between the ratio of pleural plaques to 
pulmonary asbestosis found in clinical settings (2:1 to 3:1) and the ratio 
generated by litigation screenings after the Georgine settlement (0.2:1) 
is further evidence of the speciousness of the medical reports generated 
by litigation screenings.  In addition, the apparent fungibility between 
X-ray readings of pleural plaques and fibrosis consistent with asbestosis 
of the litigation doctors is itself at least circumstantial evidence that the 
X-ray readings of the litigation doctors are “manufactured for money.” 
 
B Readers who accounted for 80% of the X-ray readings in the sample examined, had identified 
more “pleural only” cases than pulmonary asbestosis.  In fact, of the 1,691 cases reviewed, only 
124 “pleural only” cases were identified.  Moreover, the ratio of pulmonary asbestosis to “pleural 
only” disease for the four B Readers in the sample accounting for 76.8% of the claims, was 47 to 
1, whereas in the remaining reports submitted by over 40 other B Readers and physicians, the 
ratio of pulmonary asbestosis to “pleural only” disease was 2 to 1. 
133 See Georgine v. Amchem Prods., Inc., 878 F. Supp. 716 (E.D. Pa. 1994). 
134 Amchem Prods., Inc. v. Windsor, 521 U.S. 591 (1997), aff’g 83 F. 3d 610 (3d Cir. 1996). 
135 Id. at 601-04. 
136 See Chart: Detailed Injury through 2005, provided to author by the Claims Resoilution 
Management Corp. (CRMC) (Sept. 22, 2006) (on file with author). 
137 Id. 
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D.     The Disparity Between Rates of Clinical Diagnoses of Asbestosis 
and Those Generated by Litigation Screenings 
 
Just as the process of reading screening-generated X-rays is 
fundamentally flawed from the perspective of applicable medical 
protocols, so too is the process of diagnosing those whose X-rays have 
been read as indicating radiographic evidence of fibrosis.  In a clinical 
setting, the diagnosis of asbestosis or other type of pneumonocosis 
follows a specific process.  Because there are many possible causes of 
pulmonary fibrosis,138 the American Medical Association, the American 
Thoracic Society,139 NIOSH, the Association of Occupational and 
Environmental Clinics, and others have developed diagnostic protocols 
for occupational disease.  The most critical task in the process of 
diagnosing the cause of pulmonary fibrosis is to “exclu[de] alternative 
causes for the findings.”140  Based upon the testimony of prominent 
occupational medicine physicians, the American Bar Association 
Commission on Asbestos Litigation described the established protocol 
for diagnosing nonmalignant asbestos-related diseases: 
Each of the doctors interviewed by the Commission independently 
stated that the diagnosis of asbestos-related pleural disease, and 
particularly asbestosis, requires assessment of a number of factors 
including the review of chest x-rays, pulmonary function tests, 
latency, and the taking of a complete occupational, exposure, 
medical and smoking history.  Because many symptoms and findings 
are not specific to asbestos-related disease, this approach is 
necessary to enable a physician to exclude other more probable 
causes for various findings.  This then enables the physician to 
support a conclusion that the patient’s medical condition is the result 
of asbestos exposure.  These types of requirements are typical for 
assessment of disability or impairment under various legislative and 
regulatory systems, including Social Security, the Federal Employees 
Compensation Act (FECA), and state worker compensation 
programs.141 
The diagnostic process followed by litigation doctors falls well 
short of the requisite standards set by the medical profession.  Judge 
Jack found that a critical part of the diagnostic process is the taking of a 
detailed occupational history by a trained professional—a task that 
 
138 See infra notes 161-170 
139 See supra note 17. 
140 Am. Thoracic Soc’y, supra note 17. 
141 ABA REPORT, supra note 11, at 12. 
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requires thirty minutes or more.142  In litigation screenings, the 
occupational histories are taken by people with no medical training who 
have significant financial incentives to create a history that would 
support a diagnosis of asbestosis (or silicosis).143  Judge Jack concluded 
that “virtually all of these diagnoses fail to satisfy the minimum, 
medically acceptable criteria.”144  Judge Jack further found that the 
litigation doctors “simply ignored” the requirement that they consider 
and rule out other, more probable, causes of fibrosis.145  Indeed, she 
noted that to the extent that differential diagnoses were made at all in 
the course of litigation screenings, they were done by the medical 
stenographers who typed the medical reports by interpreting the boxes 
checked on the ILO forms by the litigation doctors.146 
It should come as no surprise then to learn that the disparity 
between diagnoses of asbestosis done in clinical studies and those done 
in the course of litigation screenings are even more pronounced than the 
disparities in the X-ray readings.  I estimate that at least 80% of litigants 
whose screening-generated X-rays are graded as 1/0 or higher are then 
diagnosed with asbestosis “within a reasonable degree of medical 
certainty.”147  Only two of the clinical studies included in the review 
undertook to diagnose the causes of the radiographic evidence of 
fibrosis.  Two other studies also provide relevant information. 
The Koskinen Study of 18,943 Finnish workers occupationally 
exposed to asbestos in the construction, shipyard, and “asbestos 
industry” found that 2.8% (534) were found to have opacities of 1/0 or 
greater.148  Of these 534, 23.2% (124) were diagnosed with 
 
142 In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 623 (S.D. Tex. 2005). 
143 Id. at 622; see also sources cited in Brickman, Asbestos Litigation, supra n. 1, at 67 n.101. 
144 MDL 1553, 398 F. Supp. 2d at 625. 
145 Id. at 629. 
146 Id. at 630. 
147 See supra note 37; see also Brickman, Asbestos Litigation, supra note 1, at 86 n.164. 
Diagnoses were not always required.  For example, the Manville Trust initially did not require a 
diagnosis to be eligible for compensation; a B read was sufficient. 
148 See Koskinen et al., supra note 72. The study was limited to those who fit the following 
criteria: individuals with at least ten years in construction, who had commenced work before 
1980; individuals with one year in a shipyard, who had commenced work before 1980; or 
individuals with one year in the asbestos industry, who had commenced work before 1976.  The 
mean year of onset of exposure for the entire group was 1960.  The mean duration of employment 
was 26 years, and the average duration of asbestos exposure was 9 years.  The number studied 
totaled 18,943.  Of the total 4,133 individuals who screened positive, three-quarters were 
diagnosed with an occupational disease, of which 4% (124) were diagnosed with asbestosis.  The 
criteria for testing positive were: (i) small irregular lung opacities clearly consistent with 
interstitial fibrosis (1/1); (ii) small irregular lung opacities indicating mild interstitial fibrosis (1/0) 
and findings consistent with unilateral or bilateral pleural plaques; (iii) findings indicating marked 
abnormalities of the visceral pleura not known to be caused by infection; and (iv) findings 
consistent with bilateral pleural plaques. 
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asbestosis.149 
The Murphy Study150 found that of 195 workers exposed to 
asbestos in shipyards, a total of 65 (33.3%) had radiographic evidence 
of fibrosis graded as 1/0 or higher and of these, 18.5% (12 of 65) were 
diagnosed with asbestosis.151  Thus, of the number of workers studied, 
6.15% were diagnosed with asbestosis.  It is noteworthy that 101 of the 
195 workers studied were pipecoverers who “prepared and applied 
insulating materials to machinery and pipes.”152  As previously 
indicated, the disease rates of pipecoverers and insulators have been far 
higher than that of other occupational groups with asbestos exposure.  
Of the 101 pipe coverers, 44 had X-ray readings of 1/0 or higher, and of 
these, 11 were diagnosed with asbestosis.  Only one of the 94 pipefitters 
who were included as a control group was diagnosed with asbestosis. 
In addition to these two clinical studies, in a consolidated asbestos 
trial, U.S. District Court Judge Carl. B. Rubin substituted impartial 
medical experts for the parties’ medical experts.153  Sixty-five plaintiffs 
were claiming that they had asbestosis and presumably had X-rays 
graded at 1/0 or higher.  The court appointed experts diagnosed ten of 
the 65 plaintiffs with asbestosis—a diagnosis rate of 15%.  
One additional study sheds light on the diagnosis rate.  This study 
was of English naval dockyard workers who had occupational exposure 
to asbestos and indicated that of the 3,856 workers studied, only 0.3% 
were diagnosed with asbestosis.  However, because the study used more 
exacting diagnostic criteria—the effect of which could not be measured 
or estimated—I am not including it in my review of rates of clinical 
diagnoses of asbestosis.154 
 
149 Because of the way the data is presented, it is possible that the percentage that might have 
been diagnosed with asbestosis could have been somewhat higher or lower.  The study only 
submitted for diagnosis those with “positive” X-ray readings.  As defined in the study, that 
excluded the 0.5% (95) with 1/0 readings who did not have any pleural plaques.  Id. at 11.  Had 
these 95 workers been included in the group of 4,133 who were identified in the study as 
“positive,” it is possible that some of them would have been diagnosed with asbestosis, and thus 
the percentage could have been higher.  In addition, the study counted as positive those with 
bilateral plural plaques and pleural thickening even if they had no opacities graded as 1/0 or 
higher.  While it is unclear form the study, it may be that some of these 3,694 (of the 4,133) were 
among the 124 diagnoses with asbestosis.  In that event, the percentage with X-ray readings of 
1/0 and higher diagnosed with asbestosis would have been lower. 
150 Murphy et al., 1971, supra note 55. 
151 The criteria for the “epidemiologic diagnosis” that was done included the presence of at 
least three of five standardized clinical abnormalities commonly reported in persons with known 
asbestosis.  Id. at 1274-75. 
152 Id. at 1271. 
153 See supra note 90. 
154 See P.G. Harris et al., supra note 70. This study of workers exposed to asbestos at four 
naval ports found that of 3,856 studied, 12 (0.3%) had “confirmed pulmonary fibrosis.”  The 
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A simple comparison of the diagnoses rates of 15%, 18.5%, and 
23.2%, with the estimated 80% or higher rate generated by asbestos 
litigation screenings understates the degree of difference.  As noted, the 
litigation screenings have generated a 50-90% positive rate for 
radiographic evidence of fibrosis and findings that these are “consistent 
with asbestosis,” as compared to the 11.76% rate found in the review of 
clinical studies, and the 2.8% prevalence rate found in the Koskinen 
Study.  A more informative comparison is the percentages of those 
screened that were diagnosed with asbestosis.  In the Koskinen Study, 
0.65% (124 of 18,943) were diagnosed with asbestosis.155  Had the 
18,943 occupationally exposed workers been recruited to attend 
asbestos litigation screenings, perhaps 9,500 (50%) to 13,200 (70%) or 
more would have been found to have radiographic evidence of fibrosis 
and, of these, 7,500 to 10,500 would have been diagnosed with 
asbestosis, compared to the 124 actually diagnosed in the clinical 
setting.156 
Other informative comparisons are those between the Koskinen 
Study and the results of the litigation screenings conducted by RTS, and 
 
criteria for “confirmed pulmonary fibrosis” consisted of an X-ray reading indicating fibrosis, a 
clinical examination of the chest (for basal rales), and measurement of pulmonary function.  Thus, 
the study is using the term “confirmed pulmonary fibrosis” as the equivalent of a diagnosis of 
asbestosis.  However, the study included a requirement of diminished lung function and the 
presence of basal rales but did not break down the results so that the effect of these additional 
criteria could be measured. 
In a Swedish study of 210 construction workers exposed to fibrogenic dust such as asbestos 
and crystalline silica, and found to have a profusion of 1/1, only 41 (20%) were reported as 
showing a pneumonconiosis.  M. Albin et al., 1992, supra note 72, at 864.  The study did not 
provide diagnoses but, given the exposures to crystalline silica and presumably other 
occupational dusts, it is undoubtedly true that the number with asbestosis was less than the 20% 
determined to have a pneumoconiosis. 
The Friedman 1988 study, supra note 71, is also relevant.  It focused on the role of high 
resolution CT in the diagnosis of asbestosis.  Sixty men, average age 58 years, with at least one 
year of occupational asbestos exposure, were studied.  These sixty men were chosen because they 
already had X-rays read as indicating an asbestos-related abnormality.  Of the 60, 55 had 
asbestos-related pleural disease with or without parenchymal asbestosis.  The remaining 5 had: 
pleural disease and mesothelioma (2); interstitial lung disease (2); and interstitial lung disease 
with lung cancer (1). New X-rays were taken, which resulted in thirteen patients (22%) being 
diagnosed with pleural disease without parenchymal involvement, two patients (3%) diagnosed 
with parenchymal asbestosis without pleural disease, and nineteen patients (32%) being 
diagnosed with both asbestos-related pleural disease and parenchymal asbestosis.  The diagnosis 
of asbestosis was reached, with the use of the HRCT, in 21 patients (35%).  This diagnosis rate is 
elevated due to the limitation of the study to those who already had X-rays read as indicating 
asbestos-related abnormalities. 
 155 See supra note 148. 
 156 In the unpublished powerhouse study, see supra note 65, of 114 powerhouse workers who 
averaged 23 years of exposure, had a mean latency of 32 years, and of whom 40-46% had 
radiographic evidence of asbestos exposure, none were found to have asbestosis. 
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of the results of the review of clinical studies with RTS’s results.  As 
noted, RTS doctors diagnosed 17,877 of the 32,119 persons (55.7%) 
screened by RTS—whose records had been analyzed in the course of 
MDL 875—as having asbestosis.157  If we superimpose the results of the 
Koskinen Study of 18,943 occupationally exposed workers, then instead 
of 17,877 having been diagnosed with asbestosis by RTS doctors, the 
number would have been 209. 
Additionally, if we superimpose the results of the review of clinical 
studies on the 32,119 persons screened by RTS whose records have 
been analyzed in the course of MDL 875, then approximately 3800 
would have had their X-rays read as indicating evidence of fibrosis 
graded 1/0 or higher, and of these, approximately 950 or less would 
have been diagnosed with asbestosis.  RTS doctors, however, diagnosed 
17,877 of those RTS screened with asbestosis.158 
The results of the Murphy and Koskinen Studies, as well as those 
of the review of clinical studies, are consistent with the medical 
literature that states that new manifestations of asbestosis largely ceased 
by 1990.  Indeed, more than fifteen years ago, medical experts called 
asbestosis a “disappearing disease,”159 and a condition that is 
“exceedingly rare.”160 
 
1.     Other Causes of Fibrosis in Addition to Asbestos Exposure 
 
The Koskinen Study indicates a falloff of approximately 75% from 
X-ray readings of radiographic evidence of fibrosis to diagnoses of 
asbestosis.  A principal reason is that there are well over one hundred 
possible causes of radiographic evidence of fibrosis besides asbestos 
 
 157 See supra note 37. 
 158 Id. 
 159 Kevin Browne, Asbestos-Related Disorders, in OCCUPATIONAL LUNG DISORDERS 410 (3d 
ed. 1994). 
 160 “We have not seen a single case of significant asbestosis with first exposure during the past 
30 years.” E.A. Gaensler, P.J. Jederlinic & A. Churg, Idiopathic Pulmonary Fibrosis in Asbestos-
Exposed Workers, 144 AM. REV. RESPIRATORY DISEASE 695, 695-96 (1991); E.A. Gaensler, 
Asbestos Exposure in Buildings, 13 CLINICAL CHEST MED. 231 (1992).  In a study published in 
1990 of workers engaged in manufacturing of specialty and filler papers containing asbestos, the 
authors concluded that “[t]his study confirmed our impression that asbestosis is a disappearing 
disease. Among persons first exposed before 1950, 47.6% had developed fibrosis … decreased to 
18.0% for 1950-1959, and among those first exposed after 1959 only 2.0% had developed 
asbestosis.”  Gaensler et al., Radiographic Progression, supra note 72, at 387; see D.M. 
Rosenberg, Asbestos Related Disorders A Realistic Perspective, 111 CHEST 1424 (1997); see also 
Letter from Dr. James Crapo, S. COMM. ON THE JUDICIARY, THE FAIRNESS IN ASBESTOS INJURY 
RESOLUTION ACT OF 2003, S. REP. NO. 108-118, at attach. A (2003). 
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exposure,161 including aging,162 smoking,163 obesity, and the use of 
certain medications.164  Some of the conditions that must be excluded as 
possible causes of radiographic evidence of fibrosis before a diagnosis 
of asbestosis can be made are collagen-vascular disease and sarcoid,165 
cholesterol pneumonitis,166 parenchymal Hodgkin’s disease, rheumatoid 
lung167 as well as others.168  A condition called “idiopathic pulmonary 
fibrosis,”169 that is, fibrosis with no known cause, is indistinguishable 
on radiographs from the fibrosis produced by asbestos exposure and has 
been misread as asbestosis.170 
Accordingly, it is probable that the substantial disparity between 
the X-ray readings of the litigation doctors and the results of the clinical 
 
 161  See Marvin I. Schwartz, Approach to the Understanding, Diagnosis and Management of 
Interstitial Lung Disease, in INTERSTITIAL LUNG DISEASE 1, 4-5, tbl. 1-1 (Marvin I. Schwartz & 
Talmadge E. King, eds. 1998); PULMONARY PATHOLOGY 647, 648-49 (D. Dail & S. Hammar, 
eds. 2d ed. 1994) (“More than 100 known causes of interstitial lung disease are recognized. . . . 
[M]ost patients with advanced pulmonary fibrosis, whose tissue samples d[o] not meet the 
histological criteria for asbestosis . . . d[o] not have asbestos-induced fibrosis, even though there 
may have been a history of exposure to asbestos.”). 
162 See supra notes 84 and 89. 
163 Id.  In the Weiss & Theodos study of workers in asbestos products manufacturing plants, 
Weiss concludes that “there is no doubt that cigarette smoking alone produces pulmonary 
interstitial fibrosis.”  Weiss & Theodos, supra note 72, at 344.  The authors go on to suggest that, 
especially in case of mild pulmonary disease, more research needs to be done in order to ascertain 
if the two causes (smoking and asbestos) are entirely separate or work synergistically to cause 
fibrosis.  Id. 
164 In addition to aging, commonly found “conditions/diseases not related to asbestosis which 
appear as interstitial lung disease on X-rays include. . . smoking history, obesity, lupus, silicosis, 
or numerous other medical conditions.”  Affidavit of Dr. Robert Steiner re: Medical Standards of 
Care for Diagnosing Asbestos-Related Diseases, Motion For Case Mgmt Order Concerning Litig. 
Screenings at 3, In re Asbestos Prods. Liability Litig. (No.VI), No. MDL 875 (E.D. Pa. July 30, 
2001); see also Tatsuji Enomoto et al., Diabetes Mellitus May Increase Risk for Idiopathic 
Pulmonary Fibrosis, 123 CHEST 2007 (2003) (discussing the correlation between prevalence of 
idiopathic pulmonary fibrosis and age, smoking history, and lifestyle-related diseases, such as 
obesity and diabetes mellitus).  Pulmonary fibrosis is also known to be caused by certain 
medications, radiation, connective tissue or collagen diseases, sarcoidosis—a disease 
characterized by the formation of granulomas (areas of inflammatory cells), which frequently 
affects the lungs—Farmer’s  Lung, an allergic reaction to some organic substances, such as 
moldy hay, various environmental exposures, and sometimes genetic / familial history. Am. Lung 
Assoc., Interstitial Lung Disease and Pulmonary Fibrosis. Known Causes of Pulmonary Fibrosis, 
available at www.http://www.lungusa.org/site/pp.aspx?c=dvLUK9O0E&b=35436&printmode=1 
(last visited Nov 21, 2006). 
165 Friedman, Computed Tomography, supra note 77, at 399-400, 401. 
166 See supra note 78. 
167 Id. 
168 Id. 
169 Idiopathic pulmonary fibrosis, also known as cryptogenic fibrosing alveolitis, is a “chronic 
lung condition of uncertain etiology . . . characterized histologically by the presence of usual 
interstitial pneumonia, and often has typical radiological appearances.” O.J. Dempsey et al., 
Idiopathic Pulmonary Fibrosis: An Update, 99 Q.J. MED. 643 (2006). 
170 Friedman, Computed Tomography, supra note 77, at 399-400. 
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studies would be exceeded by the disparity between the diagnoses of 
asbestosis by the litigation doctors and the results that clinical studies 
would have produced had they, as did Koskinen, Murphy, and Judge 
Rubin, also undertaken to provide diagnoses. 
 
E.     The Disparity Between the Pandemic Outbreak of Asbestosis 
Filings in the Courts and the Number of Annual Hospitalizations 
Primarily Due to Asbestosis 
 
Between 1990 and 2004, approximately 80% of the more than 
470,000 claims of nonmalignant asbestos-related disease claims filed 
with the Manville Trust, which were mostly generated by litigation 
screenings, claimed asbestosis.171  The volume of these claims of 
asbestosis is inconsistent with the following: the medical literature 
which concludes that by 1990, new cases of asbestosis had largely 
disappeared;172 clinical re-readings of X-rays generated by litigation 
screenings, which indicate an error rate ranging from 60-97%;173 and 
the clinical studies reviewed in this Article, which indicate that, of those 
occupationally exposed to asbestos, approximately 3% would likely be 
diagnosed with asbestosis.174 
The validity of the screening diagnoses is further undermined by 
survey data from the National Center for Health Statistics (NCHS), 
which annually conducts the National Hospital Discharge Survey 
(NHDS).  This survey provides data on inpatient utilization of non-
Federal, short-stay hospitals in the United States.175 To generate the 
data, the NCHS annually identifies approximately 500 hospitals which 
it surveys to collect a sampling of hospital discharge diagnoses.176  
 
171 Data for the specific 1990-2004 period on the number and types of nonmalignant claims 
are not available.  The available data is that for the period 1988 through September 30, 2006, of 
the approximately 585,440 nonmalignant claims filed, approximately 465,200 claimants alleged 
asbestosis. 
172 See supra note 160. 
173 See supra notes 127-128. 
174 See supra notes 148-156. 
175 NAT’L CTR. FOR HEALTH STATISTICS, DIV. OF HEALTH CARE STATISTICS, HOSP. CARE 
STATISTICS BRANCH, U.S. DEP’T OF HEALTH AND HUMAN SERVS., NATIONAL HOSPITAL 
DISCHARGE SURVEY, 1979-2003 MULTI-YEAR PUBLIC USE DATA FILE DOCUMENTATION, 
(2005) [hereinafter NHDS MULTI-YEAR DOCUMENTATION 2005]. 
176 The design of the survey includes a three stage sampling.  Since 1988, the sampling frame 
consists of approximately 6,000 hospitals listed in the SMG Hospital Market database.  VITAL & 
HEALTH STATISTICS, ESTIMATES FROM TWO SURVEY DESIGNS: NATIONAL HOSPITAL 
DISCHARGE SURVEY, SERIES 13: DATA FROM THE NATIONAL HEALTH SURVEY, NO. 111, DHHS 
PUB. NO. (PHS) 92-1772 (1992) [hereinafter VITAL AND HEALTH NO. 111, 1992].  The first step 
is to assign each of the approximately 6,000 hospitals to a PSU (geographic sampling unit), and to 
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Accessing this data base, I have been able to determine the number of 
hospitalizations primarily due to asbestosis that took place in the same 
time period as the claim filings with the Manville Trust.  In the 15-year 
period (1990-2004), surveys of the medical records of a random sample 
comprising approximately 4,500,000 patients discharged from non-
federal hospitals, indicated that the total number of patients who were 
hospitalized primarily because of asbestosis was 57.177 
 
separate the hospitals into five classes based on specialty and size.  Id. The NHDS sample 
includes, with certainty, all hospitals with 1000 or more beds or 40,000 or more discharges 
annually.  Id.  Non-certainty hospitals are arrayed based on their PSU, then whether they have 
previously responded to the survey, then by class, then by type of service, and then by annual 
numbers of discharges.  Id.  Once so arranged, hospitals are systematically randomly sampled 
with probability proportional to size, where size is defined as the annual number of discharges.  
Id.  Of the 500-558 hospitals the NCHS so identifies and contacts, approximately 400-500 
respond. NHDS MULTI-YEAR DOCUMENTATION 2005, supra note 175. 
There are two methods of data collection: manual and automated.  DESIGN AND OPERATION OF 
THE NATIONAL HOSPITAL DISCHARGE SURVEY: 1988 REDESIGN, SERIES 1: PROGRAMS AND 
COLLECTION PROCEDURES, NO.39, DHHS PUB. NO. (PHS) 2001-1315 (2000) [hereinafter 1988 
REDESIGN 2000].  In both cases, the data originates in the patient’s hospital record and an abstract 
is created from the record either manually or in the automated way.  Id.  Under the manual 
system, the sample selection and the transcription of information from the hospital records to 
abstract forms are done at the hospitals and then forwarded to NCHS for medical coding, editing 
and weighting.  Id.  In 1988, of the hospitals using the manual system, about two thirds had this 
work done by their own medical records staff and the remaining ones using the manual system 
had the U.S. Bureau of the Census do this work for NCHS.  Id.  For automated hospitals, NCHS 
purchases tapes of machine readable data from abstracting service organizations, mostly state-
based systems such as state departments of health, and then NCHS selects the sample discharges. 
Id.   When the method of collection is manual, the discharges are selected at the hospital or its 
abstract service agent from daily listing sheets, computer files, or other lists in which discharges 
are listed in some chronological order.  Iris M. Shimizu, The New Statistical Design of the 
National Hospital Discharge Survey, in PROCEEDINGS OF THE SURVEY RESEARCH METHODS 
SECTION, AM. STATISTICAL ASSOC. 702 (1990).  For most of these hospitals, the sample 
discharges are selected on the basis of the terminal digit(s) of the patient’s medical record 
number.  Id.  In some cases, an admission number, billing number, or other number is used and if 
none of the available patient numbers are useful for sampling purposes, the sample is selected by 
starting with a randomly selected discharge and taking every kth discharge thereafter.  Id.  If the 
data is collected manually, the medical information recorded on the sample patient abstracts is 
coded centrally by NCHS staff using the ICD-9-CM. 1988 REDESIGN 2000, supra. For hospitals 
whose data is collected by the automated system, the discharges are selected by NCHS from 
discharge medical abstract files after sorting the records in those files.  Id.  The records are first 
sorted on the first two digits of the ICD-9-CM code of the first-listed diagnosis and then within 
the diagnostic codes, the records are sorted by patient age group at time of admission (under 1 
year, 1-14 years, 15-44 years, 45-64 years, 65-74 years, 75-84 years, 85 years and over, and age 
unknown) and then by sex and within sex by date of discharge. Id. These samples are selected by 
starting with a randomly selected discharge and taking every kth discharge thereafter.  Id.  One 
percent and five percent of discharges in the certainty hospitals are selected under the manual and 
automated systems, respectively.  Id.  Except for certainty hospitals, the target sample size is 250 
discharges each from all manual system hospitals and from the automated system hospitals which 
have fewer then 4,000 discharges annually.  Id.  Samples of 2,000 are targeted for each of the 
remaining non-certainty automated system hospitals.  Id. 
177 See E-mails from Karen A. Lees, MPH, Center for Disease Control & Prevention, National 
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Each surveyed medical record of a person discharged from a 
hospital can be assigned up to seven diagnostic codes using the ICD-9 
codes.178  The first listed diagnosis is the principal diagnosis—the 
condition primarily responsible for causing the admission of the patient 
to the hospital.179 
The NHDS data is used to project the diagnoses of all discharged 
patients annually.180  Since 1988, approximately 300,000 records are 
pulled annually for sampling. 181  This is approximately 1% of the about 
30 million annual hospital discharges.182  The projections based on the 
300,000 records are then published in an annual report.  If a projection 
is based on less than 30 records, or has a relative standard error of more 
then 30 percent, it is not published because of the unreliability of the 
estimate.183  If the projection is based on 30-59 records, it is presented 
but is preceded by an asterisk (*) to indicate that it has a low 
reliability.184 
In each of the years 1990-2004, during which there were 
approximately 4,500,000 hospital discharge records included in the 
survey, asbestosis was never listed as the principal diagnosis more than 
 
Center for Health Statistics (NCHS) to author, (Aug. 15, 2006 & Nov. 3, 2006) (on file with the 
author) [hereinafter, Emails from Karen A. Lees, MPH] (providing the raw and projected data for 
the number of diagnoses of asbestosis by position). 
178 See 1988 REDESIGN 2000, supra note 176. 
179 The NHDS usually presents the data on diagnoses in the order that it is listed on the 
abstract form or obtained from abstract services.  VITAL AND HEALTH NO. 111, 1992, supra note 
176.  The NCHS defines certain key terms describing the process: a Diagnosis is a disease or 
injury (or factor that influences health status and contact with health services that is not itself 
necessarily a current illness or injury) listed on the medical record of the patient.  Id.  A Principal 
Diagnosis is the condition established after study to be primarily responsible for causing the 
admission of the patient to the hospital for care.  Id.  A First Listed Diagnosis is the diagnosis 
identified as the Principal Diagnosis or listed first on the face sheet or discharge summary of the 
medical record if the principal diagnosis cannot be identified.  Id.  The total number of first-listed 
diagnoses is equivalent to the total number of discharges.  Id.  Finally, All-listed Diagnoses means 
the number of diagnoses on the face sheet of the medical record.  Id.  As stated, there can be up to 
seven diagnostic codes on the record, and may include any factor that influences health status, 
even if it is not the reason for the hospitalization listed by the attending physician on the medical 
record of the patient.  See 1988 REDESIGN 2000, supra note 176. 
180 For its projections, the NCHS uses a “multi-stage estimation procedure that produces 
essentially unbiased national estimates and has three basic components: inflation by reciprocals of 
the probabilities of sample selection, adjustment for nonresponse, and population weighting ratio 
adjustments.”  See 1988 REDESIGN 2000, supra note 176, at 9. 
181 Before 1988, about 200,000 records were sampled from the approximately 500 hospitals 
surveyed.  NHDS MULTI-YEAR DOCUMENTATION 2005, supra note 175.  
182  Id. 
183 See, e.g., L.J. Kozak et al., Nat’l Center for Health Statistics, National Hospital Discharge 
Survey: 2000 Annual Summary With Detailed Diagnosis and Procedure Data, VITAL HEALTH 
STAT Nov. 2002, at 5.   
184 Id. 
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eight times; in some of the years, it was listed zero times.185  Because 
the number of patients discharged with a principal diagnosis of 
asbestosis was below 30 for each of the 15 years, the annual NHDS 
publication did not list any projections for asbestosis as a First Listed 
Diagnosis.186  Indeed, the ICD Code for asbestosis was simply omitted 
in each of the years 1990-2004 from the tables listing First Listed 
Diagnosis.  By way of comparison, in the period 1990-2003, chronic 
obstructive pulmonary disease (COPD, ICD-9 Code 496) was projected 
to be the primary cause of almost 2,000,000 hospitalizations. 
The NHDS survey also provides the number of times asbestosis 
was listed in a second through seventh position.  Between 1990 and 
2004, the number of diagnoses of asbestosis for each of first through 
seventh positions per year ranged from 0 to 41.187  In the 105 diagnosis 
 
185 The ICD-9-CM code for asbestosis is 501. AM. MED. ASS’N, INTERNATIONAL 
CLASSIFICATION OF DISEASES, NINTH REVISION, CLINICAL MODIFICATION, PHYSICIAN ICD-9-
ICM 2005, at 565 (2004). In the period 1990-2004, the number of annual hospitalizations which 
were primarily due to asbestosis as generated by the sampling of about 500 hospitals, ranged from 
0 to 8.  See Emails from Karen A. Lees, MPH, supra note 177.  For the 15 year period, the total 
of First Listed asbestosis diagnoses was 57.  Id. 
 186 E.J. Graves, Nat’l Ctr. for Health Statistics, Detailed Diagnosis and Procedures, National 
Hospital Discharge Survey, 1990, VITAL HEALTH STAT., June 1992;  E.J. Graves, Nat’l Ctr. for 
Health Statistics, Detailed Diagnosis and Procedures, National Hospital Discharge Survey, 1991, 
VITAL HEALTH STAT., Feb. 1994;  E.J. Graves, Nat’l Ctr. for Health Statistics, Detailed 
Diagnosis and Procedures, National Hospital Discharge Survey, 1992, VITAL HEALTH STAT., 
Aug. 1994;  E.J. Graves, Nat’l Ctr. for Health Statistics, Detailed Diagnosis and Procedures, 
National Hospital Discharge Survey, 1993, VITAL HEALTH STAT., Oct. 1995;  E.J. Graves & B.S. 
Gillum, Nat’l Ctr. for Health Statistics, Detailed Diagnosis and Procedures, National Hospital 
Discharge Survey, 1994, VITAL HEALTH STAT., Mar. 1997;  E.J. Graves & B.S. Gillum, Nat’l 
Ctr. for Health Statistics, Detailed Diagnosis and Procedures, National Hospital Discharge 
Survey, 1995, VITAL HEALTH STAT., Nov. 1997;  E.J. Graves & L.J. Kozak, Nat’l Ctr. for Health 
Statistics, Detailed Diagnosis and Procedures, National Hospital Discharge Survey, 1996, VITAL 
HEALTH STAT., Sept. 1998;  M.F. Owings & L. Lawrence, Nat’l Ctr. for Health Statistics, 
Detailed Diagnosis and Procedures, National Hospital Discharges Survey, 1997, VITAL HEALTH 
STAT., Dec. 1999;  J.R. Popovic & L.J. Kozak, Nat’l Ctr. for Health Statistics, National Hospital 
Discharge Survey: Annual Summary, 1998,  VITAL HEALTH STAT., Sept. 2000;  J.R. Popovic, 
Nat’l Ctr. for Health Statistics, 1999 National Hospital Discharge Survey: Annual Summary With 
Detailed Diagnosis and Procedure Data, VITAL HEALTH STAT., Sept. 2001;  L.J. Kozak et al., 
Nat’l Ctr. for Health Statistics, National Hospital Discharge Survey: 2000 Annual Summary With 
Detailed Diagnosis and Procedure Data, VITAL HEALTH STAT., Mar. 2002;  L.J. Kozak et al., 
supra note 183; L.J. Kozak et al., Nat’l Ctr. for Health Statistics, National Hospital Discharge 
Survey: 2002 Annual Summary With Detailed Diagnosis and Procedure Data, VITAL HEALTH 
STAT., Mar. 2005;  L.J. Kozak et al., Nat’l Ctr. for Health Statistics, National Hospital Discharge 
Survey: 2003 Annual Summary With Detailed Diagnosis and Procedure Data, VITAL HEALTH 
STAT., May 2006;  L.J. Kozak et al., Nat’l Ctr. for Health Statistics, National Hospital Discharge 
Survey: 2004 Annual Summary With Detailed Diagnosis and Procedure Data, VITAL HEALTH 
STAT., Oct. 2006. 
187 For 1990, for example, there were 13 diagnoses of asbestosis listed in second position, 17 
in third position, 10 in fourth, 9 in fifth, 0 in sixth, and 1 in seventh, for a total of 50.  See Chart, 
Asbestosis by Year and By Position, in E-mails from Karen A. Lees, MPH, supra note 177 
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positions in that time frame (7 positions for each of the 15 years), 
asbestosis diagnoses were 30 or higher on six occasions, ranging from 
30 to 41.  Projections based on these numbers would have been 
asterisked to indicate that because they were based on 30-59 records, 
they had a low reliability.  Accordingly, though the NHDS publication 
does not separately list the number of projected hospital discharge 
diagnoses for each of positions two through seven, had it done so, it 
would have omitted asbestosis from those tables on 99 of the 105 
projections and asterisked the six projections that would have been 
published. 
In addition to tables listing the projected number of First Listed 
Diagnoses for all persons discharged from hospitals, the NHDS 
publication annually lists All-Listed Diagnoses.  In the 15 year period, 
the total of All-Listed Diagnoses of asbestosis derived from the survey 
ranged from 53 to 158.  Projections of the total number of All-Listed 
Diagnoses of asbestosis based on the survey data ranged from a low of 
4,865 in 1990 to a high of 22,441 in 2002.188  As noted, only six of the 
105 data cells had sufficient numbers of asbestosis discharges to 
generate publishable projections and these six projections would have 
had a “low validity.” 
In addition to the annual NHDS publication, NIOSH periodically 
publishes the Work-Related Lung Disease Surveillance Report.189  A 
table in the report presents the estimated number of hospital discharges 
with a diagnosis of asbestosis for 1970 to 2000, which ranges from 300 
to 20,000.190  These estimates are based on the NHDS All-Listed 
Diagnosis projections.  A note at the bottom of the table states “NCHS 
recommends that, in statistical comparisons, estimates of less than 5,000 
not be used and that estimates of 5,000 to 10,000 be used with 
caution.”191  For the year 2000, the NIOSH Report lists a projected 
nationwide estimate for discharges with an asbestosis diagnosis as 
20,000.192  This projection is based on raw survey data of 133 
discharges.  That is, asbestosis was listed on 133 records in the first 
 
(providing the raw and projected data for the number of diagnoses of asbestosis by position). The 
total for second through seventh positions ranged between 50-72 in the 1990-1995 period, 
increased to 89-116 in the 1996-1999 period, and increased again in the 2000-2004 period to 111-
153.  Id. 
188 Id. 
189 DIV. OF RESPIRATORY DISEASE STUDIES, NAT’L INST. FOR OCCUPATIONAL SAFETY & 
HEALTH, WORK-RELATED LUNG DISEASES SURVEILLANCE REPORT 2002, DHHS (NIOSH) NO. 
2003-111 (2003).  
190 Id. at 15. 
191 Id. 
192 Id.  The NHDS number is 20,223.  Id. 
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through seventh position of the about 300,000 hospital record sample 
reviewed by NCHS in the year 2000.193  The raw survey data indicates 
that asbestosis as a diagnosis appeared in the following positions: 
 
Discharge Diagnoses of Asbestosis in the year  
2000, in a Sample of Approximately 300,000  
Hospital Discharges 
 
 
Position 
Number of 
Diagnoses 
of Asbestosis 
1 6 
2 17 
3 18 
4 27 
5 23 
6 22 
7 20 
Total 133 
 
While none of the NHDS data regarding asbestosis as the primary 
cause of a hospitalization is sufficient to be the basis for projections of 
the number of national hospital discharges listing asbestosis as the 
primary cause, the All-Listed Diagnosis data, though averaging fewer 
than 100 diagnoses a year of asbestosis in each of the seven positions, 
has some statistical significance. 
The definition of the Principal Diagnosis as the condition primarily 
responsible for causing the admission of the patient to the hospital is 
specific and the results of the survey indicating a very low number of 
hospitalizations primarily because of asbestosis is consistent with 
medical literature on the prevalence of asbestosis.  The validity of the 
data and projections based on that data of the number of discharges in 
which asbestosis appears in second through seventh position, however, 
 
193 In the year 2000, the projected number of patients discharged from hospitals with a 
diagnosis of asbestosis in any of the first through seventh positions was 20,223.  The raw data on 
which this projection was based was 133 discharge diagnoses of asbestosis in the first through 
seventh positions.  Since there were approximately 300,000 hospital records reviewed and up to 
seven diagnostic positions per record, a total of approximately 2,100,000 diagnoses were in the 
sample.  A diagnosis of asbestosis in any one of the seven positions would exclude a diagnosis of 
asbestosis in any of the other six positions.  Accordingly while asbestosis could have been one of 
2,100,000 diagnoses 14.29% of the time, the raw data indicated that asbestosis was a listed 
diagnosis 0.006% of the time. 
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is open to question.194 
The evidence set forth in this Article assessing the reliability of X-
ray readings and diagnoses of asbestosis generated by litigation 
screenings may provide a plausible basis for questioning the validity of 
the results projected by the NHDS.  The issue posed is whether the 
published hospital discharge diagnosis projections of asbestosis in the 
second through seventh positions represent medical judgments or are 
more a function of litigation screenings.  Testing the hypothesis, 
 
194 The reliability of discharge diagnoses may be subject to a number of influences.  See Notes 
of Interview of the Data Quality Manager at a Major Hospital who is in Charge of Discharge 
Coding, Nov. 2, 2006 (on file with the author).  For example, the actual coding of diagnoses of 
discharged patients done by hospital personnel upon review of each patient’s medical chart may 
be affected by whether the diagnosis has associated procedures that are eligible for insurance 
coverage.  See Annlouise R. Assaf et al., Possible Influence of the Prospective Payment System 
on the Arrangement of Discharge Diagnoses for Coronary Heart Disease, 329 NEW ENG. J. MED. 
931 (1993) (finding that changes in the system used for hospital reimbursement may influence the 
assignment of discharge diagnostic codes, leading to the use of codes that result in higher 
reimbursement).  The study focused on two states, Rhode Island and Massachusetts, because each 
in 1983 and 1985 respectively, changed from a fee-for-service method of payment to a system 
under which diagnosis-related groups (DRGs) were used to reimburse hospitals for the care of 
Medicare patients.  The study compared the rates of hospital discharge diagnoses of various forms 
of coronary heart disease and determined that the frequency of assignment of codes for the acute 
forms of coronary heart disease (which provided higher reimbursement) rose from 35.2% to 
48.4% among discharged patients with cardiac disease after the institution of the DRGs.  The 
study found a trend away from discharge diagnoses with lower reimbursement towards those with 
higher levels of reimbursement for patients.  See also Ark. Dep’t. of Health & Human Servs., 
Div. of Aging & Adult Servs., Arkansas Senior Medicare/Medicaid Patrol Manual at app. 3, (in 
collaboration with University of Arkansas at Little Rock), available at 
http://www.arkansas.gov/dhhs/aging/asmp.html (last visited Apr. 26, 2007) (describing how 
providers of medical services have a financial incentive to “upcode” (use codes that result in 
higher payments), or otherwise misrepresent what medical conditions are present).  A review of 
the hospital records of 48 discharged patients in the period 1979-1982 who were diagnosed with 
extrinsic allergic alveolitis (EAA) indicates a basis for further caution.  Based on published 
criteria for the diagnosis of EAA, only three cases (6%) could be classified as probable EAA, 
while 10 (22%) were possible cases, and 34 (73%) were not EAA.  The study concluded that 
limitations were apparent in the accuracy of discharge coding and also in the accuracy of the 
physician’s diagnosis.  Howard M. Kipen et al., Limitations of Hospital Discharge Diagnoses for 
Surveillance of Extrinsic Allergic Alevolitis, 17 AM. J. INDUS. MED. 701 (1990).  The study noted, 
however, that because of the small number of hospital records obtained and reviewed, caution is 
warranted in generalizing the results.  Id. at 705-06. 
Another example of how unreliable diagnoses can show up on the abstracts collected by the 
NHDS is by repetition of an erroneous, never-substantiated diagnosis throughout the patient’s 
clinical record.  See, e.g., Lawrence Martin, Pitfalls in Diagnosising Occupational Lung Disease 
for Purposes of Compensation—One Physician’s Perspective, 
www.lakesidepress.com/pulmonary/papers/pitfalls/pitfalls1-7.html (1997).  Martin describes how 
one patient whose physician wrote “R/O [rule out] asbestosis” on a chest X-ray request form had 
an X-ray report generated which stated that the results were “not typical of asbestosis but cannot 
rule out that diagnosis.”  When the patient was hospitalized, the diagnosis of asbestosis was 
placed in the record.  A claim was made for asbestosis as the cause of death.  However, asbestosis 
was never established, and a review of the records showed it traceable to the single X-ray report. 
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however, that public health data that is published annually listing 
asbestosis as a discharge diagnosis has been corrupted by litigation 
screenings would require a substantial and costly study.195 
A scenario that may result in the generation of misleading data is 
as follows.  (1) The hospitalized patient who is discharged with a 
diagnosis of asbestosis appearing in the second through seventh position 
was one of over 700,000 who were recruited to participate in litigation 
screenings during the period 1988-2004.  (2) One of the litigation B 
Readers read the X-ray taken at a screening as indicating radiographic 
evidence of fibrosis graded 1/0 or higher on the ILO scale and 
concluded that this finding was “consistent with asbestosis.”  (3) That B 
Reader, or another litigation doctor, issued a diagnosis of asbestosis 
“within a reasonable degree of medical certainty.”  (4) On that basis, the 
lawyer that sponsored the screening brought suit against scores of 
defendants and also claimed against a number of asbestos bankruptcy 
trusts.  (5) Those claims generated a number of settlements grossing 
$60,000–$100,000 between 1990 and 2000, and a smaller amount 
thereafter, of which the litigant received about half.  (6) Years later, the 
litigant is hospitalized for heart disease, pneumonia, COPD, or 
numerous other diseases.196 (7)  As part of the admission procedure (or 
prior thereto, if hospitalized by his family doctor or a surgeon who is to 
operate), a medical history is taken.  (8) The patient states that he was 
diagnosed with asbestosis (and, as confirmation, received compensation 
his illness).  (9) This information is recorded in the patient’s medical 
chart.  (10) The chart is selected as one of those discharged patient’s 
charts to be sampled for the NHDS.  (11) Thereafter, hospital or survey 
personnel go through the chart and assign ICD-9 codes.  Finally, (12) 
the listing of asbestosis in the medical history part of the chart results in 
 
 195 Such a study could start by identifying a random sample of persons who participated in 
asbestos screenings in a given time period, e.g., 1990-2004, who were diagnosed with asbestosis 
by the litigation doctors.  These individuals would then have to be contacted to determine whether 
they were hospitalized at a later point in time.  For those that were hospitalized, their hospital 
records would have to be reviewed to see if an indication of asbestosis appears in their chart and, 
if so, what the basis was for that information.  For example, was the information elicited from the 
patient in the course of taking a medical history where the patient was requested to list all 
diseases?  And, if so, did the patient indicate how he learned that he had asbestosis?  Finally, it 
would have to be determined whether, on the basis of the information in the chart, asbestosis 
would be one of seven listed diagnoses if that chart were included in the annual National Hospital 
Discharge Survey.  In order for the study to have statistical significance, the size of the random 
sample at the front end would have to be quite substantial in order for back end cohorts to be of 
sufficient size. 
 196 Aside from an extensive study as set forth supra note 195, there is no way to determine the 
likelihood that those who were hospitalized and determined to have a discharge diagnosis of 
asbestosis had attended a screening and been diagnosed by one of the litigation doctors as having 
asbestosis. 
BRICKMAN.FINAL.VERSION.1 11/19/2007  4:17:47 PM 
574 CARDOZO LAW REVIEW  [Vol. 29:2 
 
 
ICD-9 code 501 being listed as one of the discharge diagnoses in second 
through seventh position. 
 
F.     The Disparity Between the Results of Pulmonary Function Tests 
Administered in Litigation Screenings and Clinical Settings 
 
A battery of pulmonary function tests (PFTs),197 if administered 
correctly, can provide a more objective assessment of the extent of 
pulmonary fibrosis than can radiographic readings grading opacities on 
the standardized, but nonetheless somewhat subjective, ILO scale.  My 
research indicates, however, that PFTs are being administered to 
generate false findings of impairment198 in order to materially increase 
the value of the claims.199  According to medical literature, on average, 
 
 197 Pulmonary function is determined by a series of tests comparing an individual’s 
measurements to a set of predicted values for that individual based on age and other physical 
characteristics.  The pulmonary measurements obtained through spirometry PFTs include: 
(a) forced vital capacity (FVC), which is the individual’s vital capacity, or the total expiratory 
volume of the lung, performed with maximum expiratory effort; (b) forced expiratory volume 
during the first second of expiration (FEV1) with maximum effort, which is the volume of air 
exhaled during the first second of the FVC; and (c) the FEV1/FVC ratio, which represents the 
percentage of the individual’s total forced vital capacity (FVC) which is exhaled during the 
patient’s initial one second of expiration (FEV1).  These measurements are used to determine 
whether the patient has any pulmonary function impairment by comparing the individual’s 
measurements to a set of predicted measurements for that individual based on age and other 
physical characteristics. 
In addition to forced spirometric PFTs, there are two other types of PFTs commonly 
performed to measure an individual’s pulmonary function.  One of these tests involves an 
individual’s performance of certain breathing maneuvers to determine an individual’s total lung 
capacity (TLC).  The other type of PFT involves the performance of certain breathing maneuvers 
to determine the individual’s diffusing capacity (DLCO), which indicates the ability of the 
individual’s lungs to properly transfer gases between the lungs and the blood.  See Brickman, 
Asbestos Litigation, supra note 1, at 111-14. 
In asbestos litigation, a person was usually considered impaired if his FVC, FEV1, TLC or 
DLCO fell below 80% of the predicted value.  The more appropriate medical impairment 
assessment, however, that is used, for example, by the American Medical Association, involves a 
statistical determination of the lower limits of normal (based on a 95% confidence interval). AM. 
MED. ASS’N, GUIDES TO THE EVALUATION OF PERMANENT IMPAIRMENT 87 (5th ed. 2001). 
 198 See Brickman, Asbestos Litigation, supra note 1, at 117-28 (describing a “scheme to 
generate false medical test results” that resulted in false PFT results);  id. at 117. 
 199 See Manville Trust, 2002 Trust Distribution Process, available at 
http://www.claimsres.com/documents/TDP02.pdf (last visited Nov. 24, 2006) (indicating that the 
scheduled value for an asbestosis claim with lung impairment (Level III) is about 2 1/2 times as 
great as an asbestosis claim without any lung impairment (Level II)).  The PI Settlement TDP of 
Armstrong World Industries provides that the scheduled value for a bilateral asbestos-related 
nonmalignant disease with impairment was more than 2 1/2 times the scheduled value for a 
bilateral asbestos-related nonmalignant disease without impairment. Exhibit 1.24 (Form of 
Armstrong World Industries, Inc. Asbestos Personal Injury Settlement Trust Distribution 
Procedures), In re Armstrong World Indus. Inc., 348 B.R. 136 (Bankr. D. Del. 2006) (Case No. 
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few of those screened for asbestosis, whose X-rays are legitimately 
graded 1/0 and 1/1 on the ILO scale, suffer from lung impairment as 
measured on the basis of an FVC, FEV1, TLC or DLCO falling below 
80% of the predicted value.200  This is so because, according to medical 
literature, lung impairment measured by the “below 80% standard” 
usually does not manifest until the interstitial fibrosis is severe enough 
 
00-4471 (RJN)).  A typical Settlement Agreement with Owens Corning and its subsidiary, the 
Fibreboard Corporation, indicates that a non-malignant claimant who was impaired was 
scheduled to receive compensation of $10,000.  No compensation, however, was provided for a 
non-malignant claimant without impairment.  See, e.g., Settlement Agreement of Owens Corning 
and Fibreboard Corporation with the Law Firm Climaco, Climaco, Lefkowitz & Garofoli Co., 
L.P.A. (Dec. 9, 1998) (on file with the author);  see also, David M. Setter & Jeanette S. Eirich, 
Medical Criteria Legislation: A Response to Screening Scandals, 21 MEALEY’S LITIG. REP.: 
ASBESTOS 43 (2006). 
 200 This is not to state that pulmonary function is not affected when there is evidence of 
radiographic asbestosis.  Studies have shown that as profusion scores increase, spirometry and 
diffusion capacity decrease.  See Albert Miller, Radiographic Readings for Asbestosis: Misuse of 
Science—Validation of the ILO Classification, 50 AM. J. INDUS. MED. 63 (2007).  However, by 
the “below 80% of predicted value” standard, the studies cited below conclude that the averages 
for those with ILO readings of 1/0 and 1/1 did not fall below 80% of predicted value. 
In a study of 2611 asbestos insulators—one of the largest reported populations 
occupationally exposed to asbestos in a single trade—none of the mean percentages of insulators 
with ILO scores of 1/0 (456, 17.5%) and 1/1 (627, 24 %), fell below 80% of predicted value on 
FVC and FEV1/FVC tests.  By the “below 80% of predicted value” measure, lung impairment 
was generally not found until ILO scores were 1/2 or higher.  A. Miller et al., Relationship of 
Pulmonary Function to Radiographic Interstitial Fibrosis in 2,611 Long-term Asbestos 
Insulators, 145 AM. REV. RESPIRATORY. DISEASE. 263 (1992).  Four studies co-authored by Dr. 
Jay T. Segarra relate ILO profusions with impairment as measured by pulmonary function tests: 
Longitudinal Pulmonary Function Changes in Asbestos-Exposed Workers, (San Francisco, 
Cal.. May 1997), published in abstract form in Am. Thoracic Soc’y; Comparison of Two Groups 
of Building Trades Workers Screened for Asbestos-Related Pneumoconiosis in 1988 and 1996, 
Am. Thoracic Soc’y World Congress, Chicago, Il., Apr. 1998, published in abstract form in AM. 
J. OF RESPIRATORY & CRITICAL CARE MED, (March 1998) (finding that 1,305 individuals had 
asbestos-related radiographic changes but not providing the profusion levels); R.H. Warshaw & 
J.T. Segarra, Relation of Single Breath Diffusing Capacity to Radiographic Interstitial Fibrosis in 
Workers Exposed Occupationally to Asbestos, Am. Thoracic Soc’y., The 98th International 
Conference, Atlanta, Ga. (May 2002), published in abstract form in AM. J. OF RESPIRATORY & 
CRITICAL CARE MED, (April 2002); A. Miller, R.H. Warshaw, J.T. Segarra, & J. Thornton, 
Forced Vital Capacity (FVC) and Diffusing Capacity (DL) in 5015 Exposed Workers: 
Relationships to Radiographic Interstitial Fibrosis and Pleural Thickening, Am. Thoracic Soc’y, 
The 100th International Conference, Orlando, Fla. (May 2004), published in abstract form in AM. 
J. OF RESPIRATORY & CRITICAL CARE MED  (April 2004). 
Assuming the profusion levels of the 1,305 individuals in the “Two Groups of Building 
Trades Workers” study found to have “asbestos-related radiographic changes” were 1/0 and 1/1, 
then the abstracts of these studies indicate that of a total of 11,408 individuals tested for asbestos-
related conditions, 48% (5517) were found to have ILO profusions of 1/0 or greater.  (This is 
consistent with the conclusion set forth, supra note 36, analyzing Dr. Segarra’s responses to the 
subpoenas in the Ragsdale case).  The average performance on each of the pulmonary function 
tests in each of the studies for those with ILO profusion of 1/0 and 1/1 was above 80% of 
predicted value.  Only those with ILOs of 1/2 or higher were, on average, found to have lung 
impairment by the “below 80%” standard. 
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to be graded as 1/2 level on the ILO scale.201  Nonetheless, screening 
companies that administer PFTs frequently find lung impairment for 
most of those with X-rays that have been read as 1/0 and 1/1 on the ILO 
scale.  A case in point.  N&M provided records in the silica MDL 
indicating that it administered PFTs to the large majority of the 
individuals it screened.202  An examination of “tens of thousands of PFT 
records from N&M” indicates that “N&M’s testing methods produced 
positive results (i.e., purportedly showed impairment) in over 75% of 
the tests.”203 making those claims eligible for substantially higher 
compensation.204  While N&M’s doctors graded 80-95% of the X-rays 
taken at screenings and put into the silica MDL repository that have 
been examined, as 1/0 or greater, 205 approximately 90% of N&M’s ILO 
readings were 1/0 and 1/1.206  According to the medical literature 
reviewed above, on average, few of the PFTs of those whose X-rays 
were graded 1/0 and 1/1 should have resulted in findings of lung 
 
 201 Id. 
 202 Certain Defendants’ First Amended Supplemental Brief in Response to Plaintiff’s 
Challenge to the Constitutionality of Florida’s Asbestos and Silica Compensation Fairness Act at 
9, Mixon v. Am. Optical Corp., No. 99-0869-AI (Fl. Cir. Ct. Oct. 4, 2006) (citing N&M records 
produced in MDL 1553, Sales by Item Summary).  The brief also cited to the Deposition of 
N&M, Inc., Designee Heath Mason, In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 
563 (S.D. Tex. June 8, 2005). 
 203 Certain Defendant’s First Amended Supplemental Brief in Response to Plaintiff’s 
Challenge to the Constitutionality of Florida’s Asbestos and Silica Compensation Fairness Act, 
supra note 202, at 27. 
 204 See supra note 199. 
 205 See supra note 35. 
 206 Litigation B Readers read the vast majority of the X-rays which they find positive for 
fibrosis as 1/0 and 1/1.  For example, in MDL 1553, Judge Jack discusses the rate of positive X-
ray readings of Dr. Ballard, MDL 1553, 398 F. Supp. 2d at 610-11, Dr. Oaks, id. at 619-20, and 
overall for 6,510 B readings, of which more than 92% were graded 1/0 or 1/1 and less than 2% 
were graded 2/1 or higher.  Id. at 629;  See Certain Defendants’ Combined Motion and Brief to 
Exclude Diagnostic Materials Created by Respiratory Testing Services, Inc., and to Dismiss 
Claims of Plaintiffs Relying on Same at 8, In re Asbestos Prods. Liab. Litig (No. VI), Case No. 
MDL 875 (E.D. Pa., April 3, 2007) (finding that over 93% of individuals screened by RTS and 
diagnosed for asbestosis had profusions of 1/0 or 1/1).  However, because of the progressiveness 
of some fibroses, in clinical practice the ILO range is much broader with significant percentages 
of 1/2s, 2/1s and higher, especially among aging populations.  See Transcript of Daubert 
Hearings at 80-86, MDL 1553, 398 F. Supp. 2d 563 (Feb. 18, 2005) (testimony of Dr. John E. 
Parker).  Dr. W. Allen Oaks, who read X-rays for N&M, testified that among a large group of 
people with silicosis, one would expect to find a greater profusion among older people.  However, 
for the 447 litigants’ X-rays that he read, which, according to Judge Jack, were of a fairly even 
distribution of people between 50 and 80 years of age, Dr. Oaks found 408 to be 1/0 and 39 to be 
1/1.  He did not find any with a profusion of greater than 1/1.  Dr. John E. Parker, the former 
administrator of NIOSH’s B Reader program, called this consistency of profusion “stunning,” 
“def[ying] all statistical logic and all medical and scientific evidence of what happens to the lung 
when it’s exposed to workday dust.”  MDL 1553, 398 F. Supp. 2d at 619-20.  Dr. Parker further 
stated that “this lack of variability suggests to me that readers are not being intellectually and 
scientifically honest in their classification.”  Id. 
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impairment by the “below 80% standard.”  Nonetheless, N&M-
administered PFTs generated a 75% rate of lung impairment. 
 
IV.     THE SILICA MDL 
 
 Additional evidence on the reliability of X-ray readings done as 
part of litigation screenings and diagnoses of asbestosis is set forth in 
Judge Jack’s opinion in the silica MDL.207  In that opinion, Judge Jack 
substantially corroborated my conclusions regarding the elements of the 
illegitimate “entrepreneurial” model of asbestos claim generation, 
including the production of hundreds of thousands of unreliable medical 
reports.  To be sure, Judge Jack’s findings were based on silicosis—an 
injury caused by exposure to silica.208  However, she was examining the 
identical “entrepreneurial” claim generation process, including some of 
the same screening enterprises and the same doctors who had engaged 
in the identical practices with regard to the generation of claims of 
asbestosis and the production of medical reports in support of those 
claims.209  In some cases, diagnoses of both asbestosis and silicosis 
were generated simultaneously by the same litigation doctor,210 on the 
 
 207  MDL 1553, 398 F. Supp. 2d at 563. 
 208 Silicosis is a disease of the lung caused by the inhalation of silica dusts.  Silica is the 
common name for minerals containing a combination of the elements silicon and oxygen and is 
one of the most common substances in the Earth.  Extensive exposure to silica dusts can cause 
severe damage to the lung, even death, depending on the dose and duration of exposure.  See 
Andrew P. Morriss & Susan E. Dudley, Defining What to Regulate: Silica and the Problem of 
Regulatory Categorization, 58 ADMIN. L. REV. 269, 272-73, 288-89 (2006).  Historically the 
highest exposures to silica dust occurs among sandblasters working in the construction, refinery, 
and shipyard trades; foundry workers; industrial painters; and miners.  G.R. Wagner, Asbestosis 
and Silicosis, 349 LANCET 1311 (1997).  Exposure during mining operations is a function of (1) 
the quartz content of overlying rock, which is made respirable by drilling, and (2) the use of dust-
control equipment.  Quartz is a crystalline form of silica.  Between 1996 and 1997, 1250 current 
and former coal miners at eight coal mining sites in Pennsylvania were screened for the 
prevalence of silicosis under the auspices of the Mine Safety and Health Administration in a joint 
effort with the Pennsylvania Department of Health, the Pennsylvania State University, College of 
Medicare, and NIOSH.  P.A. Tyson et al., Silicosis Screening in Surface Coal Miners—
Pennsylvania, 1996-1997, 49 MMWR WKLY. 612 (2000).  Radiographic (X-ray) evidence of 
silicosis of 1/0 or higher was found in 83 (6.7%) of 1236 screened miners.  Id.  Silicosis 
prevalence was found to increase with the number of reported years of drilling experience and 
with increasing age.  Id.  The study is subject to a number of limitations, including the fact that 
the sample was voluntary and may not therefore have been representative of all Pennsylvania coal 
miners.  Id.  If miners with confirmed or suspected silicosis did not participate, silicosis 
prevalence may be underestimated; if a higher percentage of affected workers participated, then 
the reported percentage may overestimate the prevalence. 
 209 For further discussion of the applicability of Judge Jack’s findings to asbestos litigation, 
see Brickman, Silica/Asbestos Litigation, supra note 22. 
 210 See infra notes 244-250. 
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basis of a single X-ray and a cursory review of the individual’s 
occupational history, largely produced by the law firm that hired the 
screening company. 
The MDL proceeding was the culmination of an “epidemic” of 
approximately 20,000 silicosis filings, mostly in state courts in 
Mississippi and Texas, beginning in 2002—an anomalous phenomenon, 
because as a result of government regulation and industry practice,211 
there had been a 70% decline in the death rate from silicosis over the 
previous thirty years.212  The reasons for this “phantom epidemic” are 
twofold.  First, the U.S. Senate began consideration of legislation to 
provide an administrative alternative to asbestos litigation, which 
would, inter alia, limit the recovery for non-malignant unimpaired 
asbestosis claims to medical monitoring expenses.213  Second, key 
states, most importantly, Mississippi and Texas, enacted substantial 
asbestos litigation reform.214  Worried about the future of claim 
generation and concerned that the end game had begun for asbestos 
litigation,215 some plaintiffs’ lawyers began directing some of the 
screening enterprises that they had hired, to screen hundreds of 
thousands of workers exposed to asbestos containing products, to 
instead screen for silicosis.  These screening companies then abruptly 
shifted gears from ginning up asbestosis claims to silicosis claims.216 
When evidence surfaced that the X-ray readings and diagnoses of 
 
 211 Morriss & Dudley, supra note 208, at 322-30. 
 212 Brickman, Silica/Asbestos Litigation, supra note 22, at 41. 
 213 See Lester Brickman, An Analysis of the Financial Impact of S.852: The Fairness in 
Asbestos Injury Resolution Act of 2005, 27 CARDOZO L. REV. 991, 994-95 (2005) 
 214 In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 620 (S.D. Tex. 2005); 
Hearings on Asbestos: Mixed Dust and FELA Issues Before the S. Comm. on the Judiciary, 109th 
Cong. 8-9 (Feb. 2, 2005) (written statement of Lester Brickman at 8-9 quoting Heath Mason, co-
owner of N&M, Inc., who testified that the reason his company changed from asbestos to silica 
screening is because of the “Hatch Bill”). 
 215 MDL 1553, 398 F. Supp. 2d at 620 (“One might also focus on the decline in measures in 
asbestos lawsuits, leaving a network of plaintiffs’ lawyers and screening companies scouting for a 
new means of support.”). 
 216 See id. at 597 (“[S]ometime around 2001, law firms began asking the companies to screen 
people for silicosis.” (citing Transcript of Daubert Hearing at 287, MDL 1553, 398 F. Supp.2d 
563 (Feb. 17, 2005)).  After N&M had begun screening for silica, Dr. Ray Harron diagnosed 
99.69% of 6,350 screenings with abnormalities consistent with silicosis; however, prior to 
silicosis screening, Dr. Harron diagnosed 1,087 of the same MDL plaintiffs with abnormalities 
consistent with asbestosis, not silicosis.  Id. at 607-08.   
In short, when Dr. Harron first examined 1,807 Plaintiffs’ x-rays for asbestos litigation 
(virtually all done prior to 2000, when mass silica litigation was just a gleam in a 
lawyer’s eye), he found them all to be consistent only with asbestosis and not with 
silicosis. But upon re-examining these 1,807 MDL Plaintiffs’ x-rays for silica 
litigation, Dr. Harron found evidence of silicosis in every case. 
Id. at 608 
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silicosis for the 10,000 claimants may have been fraudulently generated, 
Judge Jack presided over a Daubert hearing that she ordered to take 
place to test the reliability of the medical reports produced by a handful 
of litigation doctors.217  In addition, she permitted the defendants to 
undertake extensive discovery of the doctors and screening companies.  
Her actions were unprecedented in mass tort litigation.  Indeed, most 
judges, out of reluctance to, in effect, put the tort system on trial, would 
not have permitted the defendants to conduct the extensive discovery 
that Judge Jack allowed.218  But for the fortuity of Judge Jack’s 
selection to preside over the MDL, the pervasive fraud that she 
uncovered would likely never have come to public attention. 
Among the evidence of fraud that Judge Jack permitted to be 
introduced was the revelation that at least 60% of the silicosis claimants 
had previously filed asbestosis claims219—a phenomenon that become 
known as “retreading.”220  While it is medically possible for a claimant 
to have the dual diseases of asbestosis and silicosis, it is a “clinical 
rarity”221—a medical euphemism for “virtually never.”  Indeed, this 
dual disease phenomenon is so rare that most pulmonologists have 
 
 217 See id. 
 218 Cf. Brickman, Asbestos Litigation, supra note 1, at 164 n.503.  Consider, for example, 
Vicksburg, Mississippi Circuit Court Judge Isadore W. Patrick’s denial of a motion for sanctions 
against the former firm of O’Quinn, Laminack & Pirtle (now the O’Quinn Law Firm) for 
allegedly pursuing frivolous silicosis claims on behalf of clients and submitting allegedly 
unreliable diagnoses to support these claims that were the subject of Judge Jack’s report.  
Referring to the mass screening process, Judge Patrick held that: 
[O’Quinn, Laminack & Pirtle] relied upon a nationally accepted method used in prior 
mass tort cases, i.e. mass screenings of persons who potentially may have had a silica 
claim, due to injuries incurred as a result of exposure to silica. . . . [T]hese mass 
screenings were conducted by a physician, Dr. Harron, who had obtained a national 
certification to do such screenings. 
McDuff v. Aearo, No. 02-101, 2006 WL 1970163, at *1 (Miss. Cir. Ct. June 27, 2006); see also 
Mary Alice Robbins, Mississippi Judge Declines to Sanction O’Quinn, Laminack & Pirtle, TEX. 
LAW., July 10, 2006, at 7-8.  Notably, Judge Patrick did not take cognizance of the state of 
knowledge in the asbestos and silica litigation industry of Dr. Harron’s reputation for 
unreliability.  See Brickman, Silica/Asbestos Litigation, supra note 22, at 42.  Further the 
“nationally accepted method” of claim generation referred to by Judge Patrick had never been 
subjected to inquiry because no judge had ever permitted the wide ranging discovery that was 
required to uncover the fraudulent scheme.  Judge Patrick’s ruling is on appeal to the Mississippi 
Supreme Court.  See Silica Defendants Appeal Mississippi Sanctions,  COURTROOM NEWS, Sept. 
20, 2006, available at http://www.harrismartin.com//article_detail.cfm?articleid=7488.   
 219 MDL 1553, 398 F. Supp. 2d  at 628. 
 220 See Asbestos: Mixed Dust and FELA Issues: Hearing on the Proposed FAIR Act and the 
Effect of Mass filings of Silicosis Claims before the S. Comm. on the Judiciary, 109th Cong. (Feb. 
2, 2005) (statement of Lester Brickman). 
 221 MDL 1553, 398 F. Supp. 2d at 594-96 (collecting doctors’ testimony that, although it is 
theoretically possible, in their extensive pulmonary practice, none of them had ever seen such a 
case of dual disease). 
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never seen a single such case.  “Retreading” was done by having B 
Readers re-read X-rays previously read as indicating radiographic 
evidence of fibrosis “consistent with asbestosis,” to generate claims of 
silicosis.  In some cases, the same B Readers were contradicting their 
own prior readings.222 
Other evidence of fraud that was uncovered in the unprecedented 
discovery permitted by Judge Jack—though only after she repeatedly 
threatened contempt citations for failure to provide records—was the 
percentage of “positive” findings of silicosis.  As summarized by Judge 
Jack, over 92% of the 6,510 B reads produced as part of plaintiffs’ 
initial disclosures were positive.223  Dr. Ray Harron’s rates were simply 
off the chart with a 99.69% positive rate.224  Commenting on the 
“positives” rate achieved by N&M, Judge Jack observed: 
Overall, N&M—a small Mississippi [screening] company operated 
without medical oversight—managed to generate the diagnoses for 
approximately 6,757 MDL Plaintiffs. To place this accomplishment 
in perspective, in just over two years, N&M found 400 times more 
silicosis cases than the Mayo Clinic (which sees 250,000 patients a 
year) treated during the same period. 225 
The testimony by doctors and screening companies and the records 
produced in response to subpoenas enforced by threats of contempt led 
Judge Jack to conclude that “it is apparent that truth and justice had very 
little to do with these diagnoses . . . . [Indeed] it is clear that the lawyers, 
doctors and screening companies were all willing participants” in a 
scheme to “manufacture . . . [diagnoses] for money.”226  “[E]ach lawyer 
had to know that he or she was filing at least some claims that falsely 
alleged silicosis.”227  This is the equivalent of a finding of fraud. 
 
 222 Silica MDL Plaintiff Willie Jones was screened at least four times by Dr. Jay T. Segarra: 
(1) March 14, 2002; (2) September 9, 2002; (3) February 27, 2003; and (4) June 27, 2003.  The 
first and third screenings resulted in silicosis diagnoses by Dr. Segarra, with, in Dr. Segarra’s 
words, “no radiographic evidence for pulmonary asbestosis.”  The second and forth screenings 
resulted in wholly inconsistent diagnoses of “mixed dust pneumoconiosis (silicosis and 
asbestosis).”  Defendants’ Motion for Production of Pulmonary Diagnoses and Evaluations at 4, 
In re Tex. State Silica Prods. Liab. Litig., Cause No. 2004-70000 (Tex. Dist. Ct. Apr. 3, 2007). 
 223 MDL 1553, 398 F. Supp. 2d at 629. 
 224 Id. at 607-08; see also supra note 217 and infra note 226. 
 225 MDL 1553, 398 F. Supp. 2d at 603 (citation to record omitted). 
 226 Id. at 635.  Referring specifically to Dr. Ray Harron, who has done over 80,000 B-Reads 
for asbestos litigation, Judge Jack found that with regard to his silicosis diagnoses, “Dr. Harron 
[found] evidence of the disease he was currently being paid to find.”  Id. at 577. 
 227 Id. at 636. 
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A.     Dual Diagnoses and the Law Firm of O’Quinn, Laminack & Pirtle 
 
The Law Firm of O’Quinn, Laminack & Pirtle (O’Quinn) was 
Lead Plaintiffs’ Counsel in the silica MDL, and represented over 2,100 
plaintiffs in the proceeding.228 A defense counsel stated during the 
proceedings that 73% of one group of O’Quinn’s cases had previously 
filed asbestosis claims.229  In an August 22, 2005 exchange with Judge 
Jack, Richard Laminack attempted to respond to the overwhelming 
evidence presented in the MDL that most, if not all, of the dual disease 
claims were specious and defend the integrity of his firm’s silicosis 
claims, and to justify the bona fides of his clients’ silica claims by 
arguing that though many of his clients had previously filed asbestosis 
claims, “the explanation on a lot of the cases is the asbestosis diagnosis 
is wrong.”230 When pressed about the asbestosis claims, Mr. Laminack 
responded, “I doubt the numbers, and I doubt the diagnosis.”231  Thus, 
he was contending that his clients were not dual disease claimants 
because their prior filings of asbestosis claims were based on invalid 
diagnoses.232 
Consistent with this position, Laminack further stated that: “[the 
firm] never, never represented an asbestos claimant and then turned 
around and retread it as a silicosis claimant. We never, ever did that.”233  
This is belied by the statement of two of the firm’s clients.234  
Moreover, as set out below, at least some, if not most, of the asbestosis 
claims filings that were based upon diagnoses that Mr. Laminack opined 
were “wrong” were done by or for an affiliated law firm acting in 
 
 228 STAFF OF H. COMM. ON ENERGY & COMMERCE, MEMORANDUM TO THE SUBCOMM. ON 
OVERSIGHT AND INVESTIGATIONS: 109TH CONG., OVERSIGHT AND INVESTIGATIONS HEARINGS: 
“THE SILICOSIS STORY: MASS TORT SCREENING AND THE PUBLIC HEALTH” FOURTH DAY OF 
HEARINGS (Comm. Print July 25, 2006) (on file with author).  The Subcommittee on Oversight 
and Investigations had been investigating the issues presented by Judge Jack in MDL 1553, 
specifically examining doctors, screening companies, state regulators of radiological medicine, 
state medical boards, and law firms related to the MDL 1553 litigation, as a case study, to 
determine the public health issues arising from the use of mass tort screenings to identify 
claimants for a lawsuit.  Id. at 2-3. 
 229 Transcript of Status Conference at 58, MDL 1553, 398 F. Supp. 2d 563 (S.D. Tex. Aug. 22, 
2005).  
 230 Id. at 62-63. 
 231 Id. at 64; see also Jack the Ripper, WALL ST. J., Aug. 31, 2005, at A8. 
 232 See Editorial, Case of the Vanishing X-rays, WALL ST. J., Aug. 31, 2005, at A8. 
 233 Transcript of Status Conference, supra note 229, at 58-59. 
 234 Two O’Quinn clients stated to the staff of the Subcommittee on Oversight and 
Investigations that they were first diagnosed with asbestosis and, some time later, received a letter 
from the firm telling them that they also had silicosis.  MEMORANDUM FROM THE SUBCOMM. ON 
OVERSIGHT AND INVESTIGATIONS, supra note 228.  
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conjunction with the O’Quinn firm. 
In testimony before the House Subcommittee on Oversight and 
Investigations, the O’Quinn firm repeated the assertion that it did not 
retread asbestos claims as silicosis claims and indeed “did not have an 
asbestos docket.”235  Joseph Gibson, an attorney with the O’Quinn firm, 
previously stated in an affidavit that he was “aware that some of our 
clients had Asbestosis diagnoses because during the time our plaintiffs 
were being tested for Silicosis, some plaintiffs were found to have X-
ray findings that were consistent with Asbestosis.”236  He stated that this 
was the only exception to the O’Quinn firm’s general rule that the “law 
firm did not have in its possession any records relating to Asbestosis 
claims that its Silica MDL plaintiffs may or may not have had.”237  
When a firm sponsored litigation screening generated diagnoses of both 
asbestosis and silicosis for the same litigant, the firm referred the 
asbestosis claim to the Foster Law Firm, formerly known as Foster & 
Harssema,238 and shared in any fees generated by the asbestos case.239 
The Foster Law Firm is located at 440 Louisiana, Suite 2100, 
Houston, Texas.  The O’Quinn firm is located at 440 Louisiana, Suite 
2300, Houston, Texas.240  The O’Quinn firm had participated in the 
creation of the Foster firm.  It “initially financed the start-up of [the 
Foster] law firm” in 2001241 and two O’Quinn partners, Mr. O’Quinn 
and Mr. Laminack, were elected managers of the Foster firm.242 From 
 
 235 Abel Manji, an attorney with the O’Quinn Law Firm who assumed responsibility for 
O’Quinn’s silicosis cases after joining the firm in May 2005, was designated to be a witness at the 
Oversight and Investigations Hearing on July 26, 2006.  He testified that the O’Quinn Firm did 
not “engage in the practice of retreading old asbestos cases into new silicosis cases, in fact, the 
O’Quinn Firm did not have an asbestos docket.”  The Silicosis Story: Mass Tort Screening and 
the Public Health: Hearings Before the Subcomm. on Oversight and Investigations of the H. 
Comm. on Energy and Commerce, 109th Cong., at 384 (2006) (testimony of Abel Manji) 
[hereinafter Hearings]. 
 236 Affidavit of Joseph Gibson, MDL 1553, 398 F. Supp. 2d 563 (Mar. 9, 2005.)  
 237 Id. 
 238 Id.  Gibson further stated that the O’Quinn Law Firm had handled some asbestosis cases 
directly, but the vast majority were referred to Ryan Foster. Id. 
 239 Hearings, supra note 235, at 423-24 (testimony of Richard Laminack).  Laminack testified 
that the O’Quinn Firm and the Foster Firm had a “referral arrangement,” whereby the O’Quinn 
Firm earned a referral fee for every successful asbestosis claim they sent to the Foster firm.  Id. 
 240 TEXAS FRANCHISE TAX, PUBLIC INFORMATION REPORT OF RYAN A. FOSTER & ASSOC., 
PLLC (2004) (copy on file with Cardozo Law Review) [hereinafter FOSTER TEXAS FRANCHISE 
TAX REPORT].  According to a 2001 Texas secretary of state document, Foster & Harssema and 
John M. O’Quinn & Associates had their offices in the same building in Houston.  Mary Alice 
Robbins, The Big Grill: Plaintiffs Lawyers Raked Over the Coals Regarding Silica Suits, TEX. 
LAW., July 31, 2006, at 1. 
 241 Hearings, supra note 235, at 423 (testimony of Richard Laminack). 
 242 Id.  In response to a question from Rep. Walden, “[a]nd, are you an officer, or director, or 
have you ever been, of the Foster Law Firm?,” Laminack answered:  
Well, when it was originally set up, it was set up to have three managers, I was 
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2002 to 2005, two of three managers and directors of the Foster firm 
were members of the O’Quinn firm, including variously Mr. Laminack, 
Mr. O’Quinn, and Mr. Pirtle.243 
The relationship between the O’Quinn and Foster law firms is 
made manifest by the process the firms followed in generating litigants. 
For example, both the O’Quinn and Foster firms hired N&M, Inc.244 to 
perform screenings.  These screenings for the firms generated one X-ray 
and one physical examination per litigant.245  N&M hired Dr. Ray 
Harron246 to read the X-rays and perform the diagnosing.247 Dr. 
Harron’s typical X-ray impression read “bilateral interstitial fibrosis 
consistent with asbestosis, silicosis and coal workers 
pneumoconiosis.”248  Under instructions from the O’Quinn firm, where 
there were dual diagnoses, Dr. Harron then prepared two separate 
letters, one stating a diagnosis of asbestosis and the other of silicosis.249 
 
designated, along with Mr. O’Quinn, as a non-member manager—my understanding is, 
that was done primarily, to ensure, since Mr. O’Quinn had provided the money for the 
start-up of that firm, that Mr. Foster couldn’t spend or borrow money without Mr. 
O’Quinn’s approval, if you will, so, uh, I got elected to be one of the managers, to 
ensure that the vote was always 2 to 1.   
Id. 
 243 FOSTER TEXAS FRANCHISE TAX REPORT, supra note 240. Laminack disputed being a 
director in his testimony, saying that he was only a manager.  Hearings, supra note 235, at 424 
(testimony of Richard Laminack). 
 244 See supra note 35, and text at note 226.  Out of the 6,757 MDL plaintiffs for whom N&M 
generated a silicosis diagnosis, at least 4,031 had previously filed asbestosis claims with the 
Manville Trust.  In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 603 (S.D. Tex. 
2005).  The Campbell Cherry law firm paid N&M $750 for each litigant screened who was 
diagnosed with silicosis and signed a retainer agreement.  If the diagnosis was negative or the 
litigant did not sign up with the law firm, N&M was paid nothing by the firm. Transcript of 
Daubert Hearings at 301-03, 325, MDL 1553, 398 F. Supp. 2d 563 (Feb. 17, 2005)  N&M was 
likely paid approximately $3,192,000 by Campbell Cherry, which represented approximately 
4,256 plaintiffs in this MDL.  Id. at 363. The O’Quinn law firm paid $335 per positive diagnosis, 
which included the X-ray, a physical examination, and a PFT, for each of the over 2,000 plaintiffs 
they represented and $35 for an X-ray that was read negative.  Id. at 363-64.  Heath Mason, the 
principal of N&M, testified that “a lot” of firms did not pay N&M for negatives.  Hearings, supra 
note 235, at 135-36 (testimony of Heath Mason).  He has also testified that based on this fee 
structure, the emphasis was to generate positive diagnoses: “[F]rom a business standpoint of mine 
[sic], you had to do large numbers.” Id. at 282. 
 245 For an example, see N&M INVOICES (Mar. 13, 2002, Mar. 21, 2002, July 21, 2002, Jan. 15, 
2003, Dec. 4, 2002) (on file with the author). 
 246 See supra notes 216 and 224 for a description of Dr. Harron’s practices. 
 247 All but six out of over 300 of O’Quinn’s plaintiffs with concurrent claims for silicosis and 
asbestosis were diagnosed by Dr. Ray Harron.  Affidavit of Joseph Gibson at Exh. B, MDL 1553, 
398 F. Supp. 2d 563 (July 29, 2004). 
 248 For an example of Dr. Harron’s diagnosing letter filed int eh MDL see Diagnosing Letter 
of Ray A. Harron, M.D., MDL 1553, 398 F. Supp. 2d 563, SHOW-001538 (S.D. Tex. 2006) (on 
file with  author). 
 249 Hearings, supra note 235, at 423 (testimony of Richard Laminack).  (“[Rep. Walden:] So, 
can you explain why the asbestos letters don’t mention the silicosis and vice versa? Isn’t that a 
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The asbestosis diagnosis letter was sent to the Foster firm and the 
silicosis diagnosis letter was sent to the O’Quinn firm.250 As noted, the 
O’Quinn firm shared in the fees generated by the asbestosis claim.251  
As further noted, Laminack had testified that the O’Quinn firm’s 
silicosis claims were genuine even where there also had been a 
diagnosis of asbestosis for the same claimant because “the asbestosis 
diagnosis is wrong.”252 
 
V.     THE REFUSAL TO PROVIDE SCREENING RECORDS AS EVIDENCE OF 
PREDETERMINED PERCENTAGES OF POSITIVE X-RAY READINGS AND 
DIAGNOSES 
 
The evidence reviewed in this Article, including (1) the prevalence 
of radiographic findings of fibrosis and diagnoses of asbestosis found 
by litigation screenings as compared to clinical studies, (2) clinical re-
readings of litigation B Readers’ prevalence percentages, (3) the 
number of annual hospitalizations primarily because of asbestosis, and 
(4) the results of pulmonary function tests administered by screening 
companies, leads inexorably to the identical conclusion reached by 
Judge Jack in the silica MDL: the medical reports are manufactured for 
money. 
Moreover, the B Readers, diagnosing doctors and screening 
companies involved in litigation screenings appear to have 
predetermined percentages of “positive” findings irrespective of the X-
rays or files they are reviewing or PFT tests they are administering.  
Indeed, this appears to be the “product” they are selling to lawyers.253  If 
 
fairly significant fact to leave out of a diagnoses letter? [Mr. Laminack:] Well, with all due 
respect congressman, what you are looking at is a partial document, the letter your looking at was 
attached to a package of four documents that included the exact findings from the B-read and the 
exact medical history, and in the case where there was a dual diagnosis, that information was 
clearly stated in the B-read information and in the medical history.  So, if the implication is that 
somebody was trying to hide the fact, that’s simply not true.  That letter, the package contained 
all the details of the dual diagnosis.”).  Laminack stated that the O’Quinn Firm insisted that there 
be two letters separating the diagnoses because “our firm doesn’t handle asbestos cases.”  Id. 
 250 Id.  Heath Mason explained that the same law firm “had two sets of lawyers . . . for this 
particular thing—one to handle their silica exposure, one to handle their asbestos exposure.” 
Transcript of Daubert Hearings at 400, MDL 1553, 398 F. Supp. 2d 563 (Feb. 17, 2005). 
 251 See supra note 239. 
 252 See supra note 230. 
 253 There is also evidence that law firms have “signature” percentages of positive X-ray 
readings and diagnosis that they demand that doctors and screening companies adhere to.  In the 
audit undertaken by the Manville Trust, see Brickman, Asbestos Litigation, supra note 1, at 128, 
the failure rate of a given B Reader often varied significantly depending on which law firms were 
employing the B Reader.  See Houser Affidavit, supra note 98, ¶ 27.  In fact, biostaticians from 
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such a determination were to be made, it could be “smoking gun” 
evidence of fraud that would not only subject these doctors’ findings to 
challenge, but also expose them and the screening companies to 
possible criminal prosecution.  If “signature” percentages of fibrosis and 
asbestosis were the actual product that doctors and screening companies 
were selling to lawyers, we would expect that these doctors and 
screening companies would go to great lengths to avoid disclosing 
information that would enable computation of their positive rates of 
finding radiographic evidence of fibrosis and diagnosing asbestosis.  
This may explain why, outside of the silica MDL, where Judge Jack 
utilized the full powers of her office to overcome resistance to the 
production of the subpoenaed records, and MDL 875 where Judge Giles 
has allowed some discovery of RTS’s record, B Readers, and other 
doctors and screening company representatives who are deposed and 
subpoenaed to produce records of all of their X-ray readings, diagnoses, 
and PFT tests, and not just those for the litigants in that case—records 
which would enable a determination of their total percent “positives”—
move to quash subpoenas for these records and otherwise simply refuse 
to comply.254 In addition, leading plaintiffs’ law firms, understanding 
 
Pennsylvania State University and the University of Pennsylvania, who were commissioned by 
the Manville Trust to assist with the analysis of the audit data, concluded that the identity of the 
particular law firm that submitted any given claim was a “strikingly significant predictor” of 
whether that claim would fail the audit, and that those findings exhibited “huge levels of 
statistical significance.”  LOCALIO REPORT, supra note 99, at 18. 
 254 See, e.g., Response and Brief in Support of Response of Jay Segarra, M.D., to Defendants’ 
Combined Motion and Brief to Compel Response to Subpoena to Jay Segarra, M.D. and 
Combined Motion and Brief in Support of Motion of Jay Segarra, M.D., to Quash or, in the 
Alternative, Modify Subpoena to Jay Segarra, M.D., In re Asbestos Prods. Liab. Litig. (No. VI), 
MDL No. 875 (E.D. Pa. Sept. 13, 2006).  This motion requested that the court modify defendants’ 
subpoena for the records of all of Dr. Segarra’s X-ray readings and diagnoses done for asbestos 
litigation purposes, which defendants argue is needed “because analysis of Dr. Segarra’s pattern 
and practice will help the Court to determine whether his diagnoses . . . are reliable,” id. at 2, 
acknowledging that he has been the primary diagnosing doctor for 23,200 asbestos claims 
submitted to the Manville Trust, id. at 3-4, asserting that “[t]he one thing the Defendants do not 
have [and cannot have] are copies of Dr. Segarra’s negative reports,” id. at 4 (emphasis in 
original), and seeking to limit the subpoena to just the diagnoses in the cases before the MDL 
court.   Letter from Daniel J. Mulholland, Forman Perry Watkins Krutz & Tardy LLP, to X.M. 
Frascogna, Jr., Special Master, Fairley v. Pulmosan Safety Equip. Co., Civ. Action No. CI-2004-
001-SI (Miss. Cir. Ct. Feb. 8, 2006) (detailing Dr. Jay Segarra’s repeated and adamant refusals in 
one matter to produce subpoenaed data that he acknowledged that he kept that would allow 
calculation of his percent “positives”). 
Other litigation doctors similarly refuse to provide subpoenaed records that would allow 
calculation of their percent positives.  See, e.g., Defendants’ Brief in Response to Dr. Schonfeld’s 
Opposition to Motion for Evidentiary Hearing, In re All Asbestos Cases Special Docket No. 
073958 (Ohio C.P. Feb. 3, 2006) (detailing Dr. Schonfeld’s opposition to the defendants’ motion 
for an evidentiary hearing concerning the sufficiency of the medical evidentiary support offered 
by the plaintiffs pursuant to the court’s prior case management order dealing with 35,000 pending 
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what is at stake, vigorously oppose efforts to subpoena the records of 
the litigation doctors.255  Some of the litigation doctors as well as two 
screening company principals have pled their Fifth Amendment right 
against self-incrimination as a basis for refusing to testify and produce 
records.256  The implications of doctors refusing to testify about their X-
 
asbestos cases.)  Dr. Schonfeld argues, inter alia, that his production of certain requested 
documents would violate the Health Insurance Portability and Accountability Act (HIPAA).  Dr. 
Schonfeld has previously testified that the persons he examines, however, are not his “patients,” 
that he provides no treatment or follow-up care, and that he is not their doctor.  See also Certain 
Defandants’ Combined Motion and Brief to Compel Dr. Alvin J. Schonfeld’s Response to 
Subpoena, In re Asbestos Prods. Liab. Litig., (No. VI), MDL No. 875 (E.D. Pa. Oct. 27, 2006) 
(detailing the extensive history of Dr. Schonfeld’s opposition to producing his records pursuant to 
a prior court order authorizing discovery into the screening process); Motion to Quash Deposition 
Subpoena, or in the Alternative, Motion for Protective Order and Memorandum of Law in 
Support Thereof at 3-4, In re Deposition Subpoena Served upon James W. Ballard M.D., 
Lawrence v. Chesterton, Case No. CIV-2000-73-2 (Ala. Cir. Ct. Feb. 16, 2007) (seeking to quash 
a subpoena for Dr. Ballard’s testimony because it imposes a burden on him, as he will have to 
otherwise invoke his Fifth Amendment right against self-incrimination, which “could be the 
subject of adverse comment throughout further [civil] proceedings,” and thus reduce the 
commercial value of Dr. Ballards’ diagnoses, and acknowledging that Dr. Ballard is believed to 
be a subject of the grand jury investigation being conducted by the U.S. Attorney for the Southern 
District of New York); Additional Brief in Opposition to Dr. Ballard’s Motion to Quash the W.R. 
Grace Subpoena, In re Deposition Subpoena Served Upon James W. Ballard, M.D., In re W.R. 
Grace & Co., 315 B.R. 353 (Bankr. D. Del. Feb. 26, 2006) (No. 01-1139 (JFK)); see also 
Brickman, Asbestos Litigation, supra note 1, at 84-86. 
 255 See, e.g., Plaintiffs’ Motion to Quash the Subpoenas Served by Forman Perry Upon 
Various Diagnosing Physicians and Entities, In re Asbestos Products Liability Litigation (No. 
VI), MDL Docket No. 875 (E.D. Pa. March 23, 2007); Response to Defendants’ Motion for 
Production of Pulmonary Diagnoses and Evaluations, In re: Texas State Silica Prod. Liab., 
Master Docket No. 2004-7000 (Tex. Dist. Ct. Apr. 13, 2007).  
 256 Doctors Ray Harron, Andrew Harron and James Ballard, between them responsible for 
more than 4,000 diagnoses of silicosis, were subpoenaed to appear before the House Energy and 
Commerce Subcommittee on Oversight and Investigations; each invoked their Fifth Amendment 
rights in declining to respond to this question asked by Subcommittee Chairman Ed Whitfield: 
“Will you certify that each of these diagnoses and all others that you made in this litigation are 
accurate and made pursuant to all medical practices, standards and ethics?”  House Committee on 
Energy and Commerce, Press Release, Doctors Refuse to Testify at Silicosis Hearing; Others 
Recount Diagnoses ‘Manufactured for Money,’ Mar. 9, 2006, available at 
http://republicans.energycommerce.house.gov/108/News/03092006_1810.htm.  In addition, Dr. 
Todd Coulter, who was responsible for 237 diagnoses in MDL 1553, all done for Occupational 
Diagnostics, a screening company, “took the Fifth” and declined to testify before the House 
subcommittee.  Hearings, supra note 235, at 436 (testimony of Dr. H. Todd Coulter);  see also 
Silicosis Clam-Up, WALL ST. J., Mar. 13, 2006, at A18; supra note 107.  Dr. James W. Ballard 
also invoked his Fifth Amendment privilege and refused to answer a variety of questions about 
his medical opinion in a civil proceeding.  See Deposition of James W. Ballard,  In re W.R. Grace 
& Co., 315 B.R. 353 (Bankr. D. Del. Feb. 22, 2007) (Civ. Action No. 01-1139); see also supra 
note 107.  Charles Foster, the owner of Respiratory Testing Services, also “took the Fifth” before 
the House Subcommittee concerning the MDL 1553 silica cases.  Hearings, supra note 235, at 
264 (testimony of Charles Foster), and did so again during the entirety of his deposition on 
asbestos claims, in the W.R. Grace bankruptcy.  See Deposition of Charles Foster at 8, In re W.R. 
Grace & Co., 315 B.R. 353 (Oct. 27, 2006).  Health Mason, the co-owner of N&M, Inc., the 
screening company that accounted for the bulk of the silicosis claims that were included in the 
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ray readings and diagnoses on the grounds that that testimony may tend 
to incriminate them notwithstanding,257 the Fifth Amendment protection 
does not generally extend to doctors’ and screening company’s 
records.258  While it remains uncertain whether all of the records that 
have been subpoenaed will be produced, it is of critical importance for a 
full and final determination of whether hundreds of thousands of 
diagnoses have been “manufactured for money,” that these records be 
preserved.259 
 
silica MDL, see supra notes 35 and 226, invoked his Fifth Amendment privilege against self-
incrimination in response to each substantive question posed to him.  See Deposition of Charlie 
Health Mason, In re W.R. Grace et al., In re W.R. Grace & Co.315 B.R. 353 (Feb. 27, 2007). 
 257 Unlike in criminal cases, a witness “taking the Fifth” in a civil proceeding can give rise to a 
negative inference that the answer would be disadvantageous.  See, e.g., Baxter v. Palmigiano, 
425 U.S. 308, 318 (1976); LiButti v. United States, 107 F.3d 110, 120-25 (2d. Cir. 1997).  In 
addition, the invocation of the Fifth Amendment by the principals of two screening companies, 
N&M and RTS, has significant implications for the admissibility of the medical reports of the 
litigation doctors that these two screening companies used.  N&M and RTS have accounted for 
approximately 60,000-70,000 asbestos litigants.  The doctors they hired to read the X-rays and 
provide diagnoses include Ray Harron, Andrew Harron, George Martindale, Jay Segarra, Walter 
Allen Oaks, Jose Roman-Candelaria, Paul Venizelos, Dominic Gaziano, Robert Altmeyer and 
Alvin Schonfeld.  Just six of these doctors (Harron, Segarra, Venizelos, Gaziano, Altmeyer, and 
Schonfeld) have accounted for 206,794 medical reports submitted to the Manville Trust.  See 
CRMC Response, supra note 19, at ques. 14(a) and 14(c).  These litigation doctors relied on the 
X-rays and in many cases, the PFTs that the screening companies administered to provide their 
diagnoses.  Since the administrators of those X-rays and PFTs have “taken the fifth” with regard 
to all matters relating to their screening practices, that raises the issues of whether the medical 
reports can be properly authenticated for purposes of admission and whether the methodologies 
used by these doctors are reliable.  See FED. R. EVID 702 & 703, and their state counterparts.  
U.S. District Court Judge James Giles, presiding over MDL 875, has reached a similar 
conclusion, finding that the medical reports generated by asbestos litigation screenings “lack 
reliability and accountability” and are “inherent[ly] suspicious as to their reliability.” See supra 
note 8. 
 258 98 C.J.S. Witnesses § 543 (2006) (“The privilege is to protect against compulsory 
incrimination through one’s own testimony or personal records. . . . The privilege may not be 
based on incrimination resulting from the contents or nature of the thing demanded. [Moreover, 
r]ecords normally kept or required to be maintained by law or under professional rules are not 
privileged.”).  The U.S. Supreme Court has held that “[i]t is also clear that the Fifth Amendment 
does not independently proscribe the compelled production of every sort of incriminating 
evidence but applies only when the accused is compelled to make a Testimonial Communication 
that is incriminating.”  Fisher v. United States, 425 U.S. 391, 406 (1976); see also United States 
v. Hubell, 530 U.S. 27 (2000) (stating that a person cannot avoid producing subpoenaed 
documents merely because they contained incriminating evidence and defining communications 
that are “testimonial” in character and therefore are protected).  The issue of whether the Fifth 
Amendment protection against self-incrimination extends to records is complex and the very 
limited discussion in this footnote is not being offered as anything more than an introductory 
note. 
 259 See Certain Defendants’ Emergency Motion For Temporary Restraining Order And Any 
Other Relief The Court Deems Proper, In re Asbestos Prods. Liab. Litig. (No. VI), MDL Docket 
No. 875 (E.D. Pa. Jan. 9, 2007) (seeking an order prohibiting Dr. Alvin Schonfeld from 
continuing to periodically destroy his records).  It is undoubtedly the case that copies of at least 
most of the records of screenings including X-rays ILO reports and diagnoses are in the 
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CONCLUSION 
 
A review of the evidence emerging from a search of the files in the 
depository created by Judge Jack for documentary evidence obtained 
during the course of discovery in the silica MDL, as well as other 
evidence, permits an assessment of the reliability of X-rays readings and 
diagnoses of asbestosis and silicosis generated in the course of litigation 
screenings.  Litigation screenings have accounted for substantially all of 
the 585,000 nonmalignant claims filed with the Manville Trust between 
1988 and 2006.  Under the illegitimate “entrepreneurial” model, a 
comparative handful of doctors, numbering approximately 25, have 
accounted for the majority of the hundreds of thousands of medical 
reports generated by litigation screenings. 
Perhaps the single most important finding presented is the rate of 
positive readings of X-rays by these litigation doctors.  On the basis of 
the evidence reviewed in this Article, I estimate that the litigation 
doctors read 50%-90% of the X-rays generated by litigation screenings 
as indicating radiographic evidence of fibrosis graded 1/0 or higher on 
the ILO scale, which they find are “consistent with asbestosis.”  In 
addition, I estimate that 80% or more of this group are then diagnosed 
with asbestosis “within a reasonable degree of medical certainty.”  
Because “failed” X-rays and diagnoses are reread and rediagnosed by 
other litigation doctors, it is likely that the actual rates of positive X-ray 
readings and diagnoses are higher. 
A review of clinical studies indicates that the prevalence of 
radiographic evidence of fibrosis in populations occupationally exposed 
to asbestos is approximately 11.56%.  A number of reasons are 
advanced for why this prevalence range may overstate the percentage of 
radiographic findings fibroses identified in the clinical studies.  Even if 
the clinical studies’ prevalence range is not discounted for overreading, 
the prevalence range cannot be directly compared to that of the 
litigation doctors.  There are more than 100 possible causes of 
radiographic evidence of fibrosis other then exposure to asbestos, 
including old age, obesity, and smoking.  Moreover, most of the clinical 
studies did not specifically find that the opacities that they graded as 1/0 
or higher were “consistent with asbestosis.” 
Two clinical studies and one court ordered “study” indicate that 
15-23% of those occupationally exposed workers identified as having 
radiographic evidence of fibrosis were diagnosed with asbestosis.  
Litigation doctors, however, diagnose 80% or more of those with X-
 
possession of the plaintiffs’ lawyers who hired the screening companies and litigation doctors. 
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rays graded at 1/0 or higher with asbestosis.  Even this simple 
comparison does not fully capture the degree of disparity.  If litigation 
doctors had screened the 18,943 Finnish workers occupationally 
exposed to asbestos that were the subject of one of the clinical studies, 
they would likely have diagnosed approximately 7,500 to 10,500 with 
asbestosis, compared to the 124 actually diagnosed with asbestosis in 
the clinical setting, and compared to the approximately 560 that the 
review of the clinical studies suggests. 
Further evidence of the unreliability of the medical reports 
generated by litigation screenings is set forth in a review of seven 
clinical studies or their equivalent, which re-read X-rays initially read 
by litigation doctors as 1/0 or higher. Included in the seven studies is the 
Henry Study which confirmed the results of the Gitlin Study, finding 
that the litigation B Readers’ error rate was approximately 91%.260  In 
toto, the seven clinical re-readings or their equivalent indicated error 
rates for the initial readings ranging from 60-97%.   
Another comparison, which affords considerable insight into the 
validity of the medical reports generated by litigation screenings, is the 
ratio of pleural plaques to pulmonary fibrosis found in clinical studies 
(2:1 to 3:1) versus the 0.2:1 ratio found in litigation screenings after a 
global settlement significantly reduced the value of future pleural 
plaque claims. 
Evidence that the litigation doctors have a predetermined 
percentage of positive X-ray readings and diagnoses which they do not 
wish to disclose has also been reviewed.  This includes a detailed 
description of the repeated refusals of several of the litigation doctors to 
provide subpoenaed records including all of the medical reports they 
issued for persons who were recruited to attend litigation screenings.  
Providing these records, in some cases, would enable their percentage 
of positive X-ray readings and diagnoses to be determined.  These 
refusals are circumstantial evidence that their medical reports are at 
least suspect if not fraudulent.  So too is the invocation of the Fifth 
Amendment by four of the litigation doctors as the basis for refusing to 
testify about their diagnoses and communications with screening 
company principals.  Charles Foster, head of the RTS screening 
company and Health Mason, head of the N&M screening company, also 
invoked the Fifth Amendment and refused to testify in civil proceedings 
about the screenings they conducted.  These two screening companies 
have accounted for 60,000-70,000 asbestos claims and have principally 
used ten of the most prolific litigation B Readers to read X-rays and 
 
 260  See supra note 121.   
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issue diagnoses.261 
Pulmonary function test results have also been reviewed.  PFTs 
done in the course of litigation screenings are often under the 
supervision of one of the litigation doctors or for their use in issuing 
diagnoses.  A comparison of PFT results generated by litigation 
screenings and the results of clinical studies indicates an even greater 
disparity than that between clinical studies and the litigation doctors’ X-
ray readings and diagnoses of asbestosis. 
The reliability of the prevalence of radiographic evidence of 
fibrosis and of asbestosis found by the litigation doctors is further 
undermined by medical literature which states that by 1990, new cases 
of asbestosis had largely disappeared and by data assembled by the 
National Center for Health Statistics for the National Hospital 
Discharge Survey (NHDS).  The evidence reviewed is that in the 15-
year period between 1990 and 2004, the NHDS examined an 
approximately 1% sample of hospital discharges, amounting to 
approximately 4,500,000 hospital discharge records.  It found that of 
this number, a total of 57 patients had been hospitalized primarily 
because of asbestosis.  Because this number, which ranged from 0 to 8 
for each of the 15 years, is so small, the annual NHDS does not list any 
projections for asbestosis as a “First Listed Diagnoses.” 
Finally, I summarized some of the evidence that U.S. District 
Court Judge Janis Jack reviewed in her detailed opinion in the silica 
MDL. Judge Jack’s findings of a “phantom silicosis epidemic” and the 
methods of generating false medical reports largely corroborated my 
own findings that I had published a year earlier with regard to asbestos 
litigation.  Judge Jack found that the litigation doctors in the silica MDL 
had graded over 92% of the 6,510 B reads produced as part of the 
plaintiffs’ initial disclosures as positive.  Among the evidence that led 
Judge Jack to conclude that virtually all of the medical reports were 
unreliable was the revelation that 60-70% of the silicosis claimants had 
previously filed asbestosis claims.  Medical literature and testimony is 
that such a dual disease is a “clinical rarity” and virtually never seen by 
practicing pulmonologists.  Retreading asbestosis claims as silicosis is 
not only evidence that the diagnoses of silicosis were unreliable but also 
that diagnoses of asbestosis in these same cases were equally unreliable. 
Judge Jack’s conclusion is unprecedented in the annals of judicial 
decision-making: 
[I]t is apparent that truth and justice had very little to do with these 
diagnoses. . . . [Indeed,] it is clear that the lawyers, doctors and 
 
 261 See supra note 254. 
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screening companies were all willing participants. . . [in a] scheme 
. . . to manufacture . . . [diagnoses] for money.262 
The evidence reviewed in this Article indicates that Judge Jack’s 
findings with respect to silica litigation, applies with at least equal force 
to nonmalignant asbestos litigation: the diagnoses are mostly 
manufactured for money. 
 
 262 In re Silica Prods. Liab. Litig. (MDL 1553), 398 F. Supp. 2d 563, 635 (S.D. Tex. 2005). 
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 p
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ra
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at
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s 
en
-
ga
ge
d 
in
 th
e 
m
an
uf
ac
-
tu
re
 o
f s
pe
ci
al
ty
 a
nd
 
fi
lt
er
 p
ap
er
s 
 (
M
ix
in
g 
as
be
st
os
 w
it
h 
ce
llu
lo
se
, 
m
ak
in
g 
ci
ga
re
tt
e 
fi
l-
te
rs
);
 6
7 
pe
rs
on
s 
ex
-
po
se
d 
to
 c
hr
ys
ot
ile
; 
13
6 
pe
rs
on
s 
ex
po
se
d 
to
 
cr
oc
id
ol
it
e 
20
3 
 
77
 (
37
.9
%
) 
A
sb
es
to
s-
re
la
te
d 
ra
di
o-
gr
ap
hi
c 
ab
no
r-
m
al
it
ie
s 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
tw
o 
re
ad
er
s.
  
E
.A
. 
G
ae
ns
le
r 
et
 
al
.  
R
ad
io
gr
ap
hi
c 
P
ro
gr
es
si
on
 
of
 A
sb
es
to
si
s 
W
ith
 o
r 
W
ith
-
ou
t C
on
tin
ue
d 
E
xp
os
ur
e,
 in
 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 
V
II
T
H
 I
N
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 3
86
 (
19
90
) 
Si
x 
se
ts
 o
f w
or
ke
rs
 
w
er
e 
st
ud
ie
d:
 s
hi
py
ar
d;
 
fi
lt
er
 p
ap
er
 m
an
uf
ac
-
tu
ri
ng
 p
la
nt
; g
as
ke
t 
m
an
uf
ac
tu
ri
ng
 p
la
nt
; 
el
ec
tr
ic
al
 in
su
la
ti
on
 
m
an
uf
ac
tu
ri
ng
 p
la
nt
; 
in
su
la
ti
on
 b
oa
rd
 
m
an
uf
ac
tu
ri
ng
 p
la
nt
 
1,
76
4 
25
4 
(1
4.
4%
) 
Ir
re
gu
la
r 
sm
al
l 
op
ac
it
ie
s;
 “
pr
e-
su
m
ed
 a
sb
es
to
-
si
s”
 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
tw
o 
B
 R
ea
d-
er
s.
  
T
he
 a
ut
ho
rs
 c
on
cl
ud
ed
 th
at
 “
[t
]h
is
 s
tu
dy
 
co
nf
ir
m
ed
 o
ur
 im
pr
es
si
on
 th
at
 a
sb
es
to
-
si
s 
is
 a
 d
is
ap
pe
ar
in
g 
di
se
as
e.
 A
m
on
g 
pe
rs
on
s 
fi
rs
t e
xp
os
ed
 b
ef
or
e 
19
50
, 
47
.6
%
 h
ad
 d
ev
el
op
ed
 fi
br
os
is
. .
 . 
. [
T
hi
s 
nu
m
be
r]
 d
ec
re
as
ed
 to
 1
8.
0%
 fo
r 
19
50
-
19
59
, a
nd
 a
m
on
g 
th
os
e 
fi
rs
t e
xp
os
ed
 
af
te
r 
19
59
 o
nl
y 
2.
0%
 h
ad
 d
ev
el
op
ed
 a
s-
be
st
os
is
.”
  P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 
V
II
T
H
 I
N
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, a
t 
38
7.
 
M
. G
ar
ci
a-
C
lo
sa
s 
et
 a
l. 
 A
sb
es
to
s-
R
el
at
ed
 D
is
ea
se
s 
in
 C
on
st
ru
ct
io
n 
C
ar
pe
nt
er
s,
 
27
 A
M
. J
. I
N
D
U
S.
 M
E
D
. 1
15
 
(1
99
5)
 
C
on
st
ru
ct
io
n 
ca
rp
en
-
te
rs
 (
50
6)
; M
ill
w
ri
gh
ts
 
(5
5)
; o
th
er
 jo
bs
 s
uc
h 
as
 
w
el
di
ng
, p
ai
nt
in
g,
 a
nd
 
sh
ip
 r
ep
ai
r;
 a
ve
ra
ge
 
ti
m
e 
in
 tr
ad
e 
fo
r 
th
e 
20
 
in
di
vi
du
al
s 
w
it
h 
X
-r
ay
s 
gr
ad
ed
 a
t 1
/0
 o
r 
hi
gh
er
 
63
1 
20
 (
3.
2%
) 
Sm
al
l o
pa
ci
ti
es
; 
in
te
rs
ti
ti
al
 fi
-
br
os
is
 
R
es
ul
ts
 w
er
e 
ba
se
d 
on
 a
 c
on
se
ns
us
 
re
ac
he
d 
by
 tw
o 
re
ad
er
s.
 T
he
 s
tu
dy
 
gr
ou
p’
s 
X
-r
ay
s 
w
er
e 
m
ix
ed
 w
it
h 
1,
20
0 
ot
he
rs
 to
 b
lin
d 
th
e 
re
ad
er
s.
 I
nt
er
st
it
ia
l 
m
ar
ki
ng
s 
co
ns
is
te
nt
 w
it
h 
fi
br
os
is
, b
ut
 
no
t g
ra
de
d 
1/
0 
or
 h
ig
he
r 
ar
e 
no
t i
n 
th
e 
re
su
lt
in
g 
20
.  
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w
as
 3
1 
ye
ar
s;
 th
e 
av
er
-
ag
e 
fo
r 
th
os
e 
w
ho
 
w
er
e 
gr
ad
ed
 a
t 0
/0
 a
nd
 
ha
d 
no
 p
le
ur
al
 p
la
qu
es
 
w
as
 1
8.
4 
ye
ar
s 
J.
 G
it
lin
 e
t 
al
.  
C
om
pa
ri
so
n 
of
 ‘B
’ R
ea
de
rs
’ 
In
te
rp
re
ta
tio
ns
 o
f 
C
he
st
 
R
ad
io
gr
ap
hs
 f
or
 A
sb
es
to
s 
R
el
at
ed
 C
ha
ng
es
, 1
1 
A
C
A
D
. 
R
A
D
IO
L
O
G
Y
 8
43
 (
20
04
) 
C
he
st
 r
ad
io
gr
ap
hs
 
pr
ev
io
us
ly
 in
te
rp
re
te
d 
by
 p
hy
si
ci
an
s 
re
ta
in
ed
 
by
 a
tt
or
ne
ys
 r
ep
re
-
se
nt
in
g 
pe
rs
on
s 
al
le
g-
in
g 
re
sp
ir
at
or
y 
ch
an
ge
s 
du
e 
to
 e
xp
o-
su
re
 to
 a
sb
es
to
s 
49
2 
22
 (
4.
5%
) 
Sm
al
l o
pa
ci
ti
es
; 
pa
re
nc
hy
m
al
 
ab
no
rm
al
it
y 
Si
x 
re
ad
er
s 
re
ad
 e
ac
h 
of
 th
e 
49
2 
fi
lm
s 
(t
ot
al
 r
ea
di
ng
s:
 2
,9
52
).
 T
he
 n
um
be
r 
of
 
re
ad
in
gs
 g
ra
de
d 
at
 1
/0
 is
 c
al
cu
la
te
d 
fr
om
 
th
e 
4.
5%
 o
f t
he
 to
ta
l 2
,9
52
 r
ea
ds
 in
-
cl
ud
ed
 a
s 
1/
0 
or
 h
ig
he
r.
 4
72
 o
f t
he
 4
92
 
(9
5.
9%
) 
or
ig
in
al
 li
ti
ga
ti
on
 r
ea
ds
 w
er
e 
gr
ad
ed
 a
t 
≥ 1
/0
.  
B
. H
ilt
 e
t 
al
.  
C
he
st
 R
ad
io
gr
ap
hs
 in
 S
ub
-
je
ct
s 
w
ith
 A
sb
es
to
s-
R
el
at
ed
 
A
bn
or
m
al
iti
es
: C
om
pa
ri
so
n 
B
et
w
ee
n 
IL
O
 C
at
eg
or
iz
a-
tio
ns
 a
nd
 C
lin
ic
al
 R
ea
di
ng
, 
21
 A
M
. J
. I
N
D
U
S.
 M
E
D
. 8
55
 
(1
99
2)
 
E
xp
os
ed
 in
 n
on
- t
ra
di
-
ti
on
al
ly
 r
ec
og
ni
ze
d 
gr
ou
ps
; o
ut
 o
f t
he
 8
4 
w
it
h 
X
-r
ay
s 
gr
ad
ed
 a
t 
1/
0 
or
 h
ig
he
r,
 th
e 
m
os
t 
ex
po
su
re
 o
cc
ur
re
d 
at
 
el
ec
tr
oc
he
m
ic
al
 in
du
s-
tr
ie
s 
m
ai
nt
en
an
ce
 jo
bs
; 
fo
r 
m
en
 w
it
h 
lu
ng
 fi
-
br
os
is
 1
/0
 o
r 
hi
gh
er
, 
th
e 
m
ea
n 
ti
m
e 
si
nc
e 
th
ei
r 
fi
rs
t a
sb
es
to
s 
ex
-
po
su
re
 w
as
 4
3.
5 
ye
ar
s,
 
an
d 
th
e 
m
ea
n 
du
ra
ti
on
 
of
 e
xp
os
ur
e 
w
as
 4
.4
  
ye
ar
s 
43
0 
84
 (
19
.5
%
) 
Ir
re
gu
la
r 
op
ac
i-
ti
es
, m
os
t p
re
va
-
le
nt
 in
 th
e 
m
id
-
dl
e 
an
d 
lo
w
er
 
fi
el
ds
; l
un
g 
fi
-
br
os
is
; a
sb
es
to
s-
re
la
te
d 
ra
di
o-
gr
ap
hi
c 
ch
an
ge
s 
E
va
lu
at
io
n 
of
 m
ed
ic
al
 a
nd
 o
cc
up
at
io
na
l 
hi
st
or
y 
w
as
 c
on
du
ct
ed
 to
 d
et
er
m
in
e 
if
 
th
e 
ra
di
ol
og
ic
al
 c
ha
ng
es
 w
er
e 
to
 b
e 
re
-
ga
rd
ed
 a
s 
as
be
st
os
-r
el
at
ed
.  
R
es
ul
ts
 
w
er
e 
ba
se
d 
on
 a
 c
on
se
ns
us
 o
f o
ne
 B
 
R
ea
de
r 
an
d 
on
e 
ra
di
ol
og
is
t r
ea
di
ng
 s
id
e 
by
 s
id
e.
  T
hi
s 
st
ud
y 
re
cl
as
si
fi
ed
 X
-r
ay
s 
pr
ev
io
us
ly
 r
ea
d 
as
 h
av
in
g 
a 
co
nd
it
io
n 
co
ns
is
te
nt
 w
it
h 
an
 a
sb
es
ti
fo
rm
 m
in
er
al
 
ex
po
su
re
, u
si
ng
 th
e 
IL
O
 s
ys
te
m
. 
N
. 
H
is
an
ag
a 
et
 
al
. 
P
le
ur
al
 P
la
qu
es
 a
nd
 I
rr
eg
u-
la
r 
O
pa
ci
tie
s 
on
 C
he
st
 R
a-
di
og
ra
ph
s 
A
m
on
g 
C
on
-
C
on
st
ru
ct
io
n 
w
or
ke
rs
: 
ca
rp
en
te
rs
, p
la
st
er
er
s,
 
el
ec
tr
ic
ia
ns
, s
te
el
-
6,
86
4 
83
 (
1.
21
%
) 
32
 s
ho
w
ed
 ir
-
re
gu
la
r 
op
ac
i-
ti
es
, a
nd
 5
1 
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st
ru
ct
io
n 
W
or
ke
rs
, P
ro
-
ce
ed
in
gs
 o
f N
in
th
 I
nt
er
na
-
ti
on
al
 C
on
fe
re
nc
e 
on
 O
c-
cu
pa
ti
on
al
 R
es
pi
ra
to
ry
 
D
is
ea
se
s,
 K
yo
to
, J
ap
an
, 
28
6-
89
 (
19
97
) 
fr
am
e 
w
or
ke
rs
, 
pl
um
be
rs
, p
ai
nt
er
s,
 
ot
he
rs
 
sh
ow
ed
 
ro
un
de
d 
op
ac
i-
ti
es
  
J.
M
. 
H
ug
he
s 
&
 
H
. W
ei
ll 
P
ul
m
on
ar
y 
F
ib
ro
si
s 
as
 a
 
D
et
er
m
in
an
t o
f 
A
sb
es
to
s-
In
du
ce
d 
L
un
g 
C
an
ce
r 
in
 a
 
P
op
ul
at
io
n 
of
 A
sb
es
to
s 
C
em
en
t W
or
ke
rs
 in
 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 
V
II
T
H
 I
N
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 3
70
 (
19
90
) 
W
or
ke
rs
 in
 tw
o 
N
ew
 
O
rl
ea
ns
 a
sb
es
to
s 
ce
-
m
en
t p
la
nt
s;
 m
ea
n 
ag
e 
of
 th
os
e 
st
ud
ie
d 
w
as
 4
5 
ye
ar
s 
83
9 
79
 (
9%
) 
Sm
al
l o
pa
ci
ti
es
 
T
hi
s 
is
 a
 fo
llo
w
-u
p 
st
ud
y 
of
 a
 p
op
ul
at
io
n 
or
ig
in
al
ly
 e
xa
m
in
ed
 in
 1
96
9,
 w
hi
ch
 s
tu
d-
ie
d 
90
8 
in
di
vi
du
al
s.
  T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
th
re
e 
re
ad
er
s;
 th
e 
re
su
lt
s 
ar
e 
pr
es
en
te
d 
us
in
g 
th
e 
m
ed
ia
n 
of
 th
e 
th
re
e.
K
. J
a-
ko
bs
so
n 
et
 
al
. 
R
ad
io
lo
gi
c 
C
ha
ng
es
 in
 A
s-
be
st
os
 C
em
en
t W
or
ke
rs
, 5
2 
O
C
C
U
P
A
T
IO
N
A
L
 &
 E
N
V
T
L
. 
M
E
D
. 2
0 
(1
99
5)
 
B
lu
e 
co
lla
r 
as
be
st
os
 
ce
m
en
t p
la
nt
 w
or
ke
rs
; 
m
ed
ia
n 
ti
m
e 
si
nc
e 
fi
rs
t 
ex
po
su
re
 w
as
 2
3.
5 
ye
ar
s;
  m
ed
ia
n 
ti
m
e 
on
 
th
e 
jo
b 
w
as
 1
9.
7 
ye
ar
s;
 
M
ed
ia
n 
ye
ar
 o
f s
ta
rt
 o
f 
em
pl
oy
m
en
t w
as
 1
95
1 
(r
an
ge
 1
92
0-
19
67
) 
17
4 
36
 (
20
%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s,
 “
s”
 o
r 
“t
”;
 p
ar
en
ch
y-
m
al
 a
bn
or
m
al
it
y
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
fi
ve
 r
ea
de
rs
, 
an
d 
th
e 
m
ed
ia
n 
re
ad
in
gs
 w
er
e 
us
ed
.  
T
he
 s
tu
dy
 r
ep
or
te
d 
th
e 
re
su
lt
s 
of
 2
03
 X
-
ra
ys
; 1
74
 o
f t
he
se
 w
er
e 
ex
po
se
d 
w
or
k-
er
s.
 T
he
 r
es
ul
ts
 o
f 2
9 
un
ex
po
se
d 
w
or
k-
er
s 
ar
e 
co
ns
id
er
ed
 s
ep
ar
at
el
y 
in
 th
e 
“u
ne
xp
os
ed
” 
re
vi
ew
. 
J.
 J
an
ko
vi
c 
&
 R
. R
eg
er
 
H
ea
lth
 H
az
ar
d 
E
va
lu
at
io
n 
R
ep
or
t-
 U
ni
te
d 
R
ub
be
r 
W
or
ke
rs
’ I
nt
er
na
tio
na
l U
n-
io
n,
 N
IO
SH
 I
nv
es
tig
at
io
n,
 
M
H
E
T
A
 8
7-
01
7-
19
49
 
(1
98
9)
 
T
ir
e 
w
or
ke
rs
, p
ar
t o
f 
th
e 
U
ni
te
d 
R
ub
be
r 
W
or
ke
rs
’ I
nt
er
na
ti
on
al
 
U
ni
on
; a
ll 
st
ud
y 
pa
r-
ti
ci
pa
nt
s 
w
er
e 
ov
er
 4
0 
yr
s.
 o
ld
. 
98
7 
2 
(0
.2
0%
) 
Sm
al
l o
pa
ci
ti
es
 
ir
re
gu
la
r 
in
 
sh
ap
e 
an
d 
pr
e-
do
m
in
an
tl
y 
in
 
th
e 
lo
w
er
 lu
ng
 
zo
ne
s 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
th
re
e 
re
ad
er
s,
 
an
d 
th
e 
m
ed
ia
n 
re
ad
in
gs
 w
er
e 
us
ed
. 
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 S.
 K
a-
ga
m
im
or
i 
et
 a
l. 
St
ud
ie
s 
on
 C
ha
ng
es
 in
 
C
at
eg
or
ie
s 
fo
r 
P
ne
um
oc
o-
ni
os
is
 X
-r
ay
 C
la
ss
if
ic
at
io
n 
in
 J
ap
an
es
e 
W
or
ke
rs
 W
ith
 
O
cc
up
at
io
na
l E
xp
os
ur
e 
to
 
M
in
er
al
 D
us
ts
, P
ro
ce
ed
in
gs
 
of
  N
in
th
 In
t’
l C
on
fe
re
nc
e 
on
 O
cc
up
at
io
na
l R
es
pi
ra
-
to
ry
 D
is
ea
se
s,
 K
yo
to
, J
a-
pa
n,
 1
66
-1
69
 (
19
97
) 
M
in
er
al
 d
us
t w
or
ke
rs
 
in
 J
ap
an
 
3,
02
4 
81
 (
2.
68
%
) 
N
/A
 
T
he
 in
it
ia
l r
ea
di
ng
 o
f c
he
st
 X
-r
ay
s 
w
as
 
pe
rf
or
m
ed
 b
y 
ph
ys
ic
ia
ns
 in
 th
e 
he
al
th
 
ag
en
cy
.  
In
 th
e 
in
it
ia
l s
tu
dy
, c
on
du
ct
ed
 
in
 1
98
6 
th
er
e 
w
er
e 
4,
95
9 
pa
rt
ic
ip
an
ts
 
an
d 
th
e 
nu
m
be
r 
of
 s
ub
je
ct
s 
gr
ad
ed
 1
/0
 
or
 h
ig
he
r 
w
as
 6
7 
(1
.3
5%
).
  H
ow
ev
er
, 
be
ca
us
e 
of
 th
e 
cr
it
er
ia
 fo
r 
th
is
 r
ev
ie
w
, 
th
e 
re
su
lt
s 
of
 th
e 
re
ev
al
ua
ti
on
 a
re
 b
ei
ng
 
us
ed
. 
S.
M
. K
en
-
ne
dy
 e
t a
l. 
L
un
g 
F
un
ct
io
n 
an
d 
C
he
st
 
R
ad
io
gr
ap
h 
A
bn
or
m
al
iti
es
 
A
m
on
g 
C
on
st
ru
ct
io
n 
In
su
-
la
to
rs
, 2
0 
A
M
. J
.  
IN
D
U
S.
 
M
E
D
. 6
73
 (
19
91
) 
C
ur
re
nt
 a
nd
 r
et
ir
ed
 
co
ns
tr
uc
ti
on
 in
su
la
-
to
rs
, a
ge
d:
 5
0 
ye
ar
s 
or
 
ol
de
r 
 
88
 
16
 (
18
.2
%
) 
P
ar
en
ch
ym
al
 
fi
br
os
is
 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 in
de
pe
nd
en
tl
y 
by
 
tw
o 
re
ad
er
s.
 
K
.H
. K
il-
bu
rn
 e
t a
l. 
In
te
ra
ct
io
n 
of
 A
sb
es
to
s,
 
A
ge
, a
nd
 C
ig
ar
et
te
 S
m
ok
-
in
g 
in
 P
ro
du
ci
ng
 R
ad
io
-
gr
ap
hi
c 
E
vi
de
nc
e 
of
 D
if
fu
se
 
P
ul
m
on
ar
y 
F
ib
ro
si
s,
 8
0 
A
M
. J
. M
E
D
. 3
77
 (
19
86
) 
W
iv
es
 o
f s
hi
py
ar
d 
w
or
ke
rs
; t
he
 w
or
ke
rs
 
ha
d 
be
en
 e
m
pl
oy
ed
 a
t 
th
e 
sh
ip
ya
rd
 fo
r 
tw
en
ty
 y
ea
rs
 o
r 
m
or
e,
 
an
d 
th
is
 w
as
 p
ro
ba
bl
y 
th
ei
r 
in
it
ia
l c
on
ta
ct
 
w
it
h 
as
be
st
os
; t
he
 
w
om
en
 h
ad
 o
nl
y 
in
-
th
e-
ho
m
e 
ex
po
su
re
 to
 
as
be
st
os
 b
ro
ug
ht
 in
 b
y 
th
ei
r 
hu
sb
an
ds
 
26
9 
19
 (
7.
06
%
) 
Ir
re
gu
la
r 
op
ac
i-
ti
es
. 
D
if
fu
se
 p
ul
m
o-
na
ry
 fi
br
os
is
; 
lu
ng
 c
ha
ng
es
 
ty
pi
ca
l o
f a
sb
es
-
to
si
s.
 
F
or
 p
ur
po
se
s 
of
 th
is
 r
ev
ie
w
, t
he
 K
ilb
ur
n 
st
ud
y 
w
as
 b
ro
ke
n 
in
to
 fi
ve
 s
ep
ar
at
e 
st
ud
ie
s:
 o
ne
 o
f i
ns
ul
at
or
s,
 tw
o 
of
 u
ne
x-
po
se
d,
 a
nd
 tw
o 
of
 e
xp
os
ed
.  
A
n 
ar
it
h-
m
et
ic
 a
ve
ra
ge
 o
f t
hr
ee
 p
hy
si
ci
an
s 
w
as
 
us
ed
 to
 in
te
rp
re
t t
he
 X
-r
ay
s 
fo
r 
al
l 
gr
ou
ps
. 
K
.H
. K
il-
bu
rn
 e
t a
l. 
In
te
ra
ct
io
n 
of
 A
sb
es
to
s,
 
A
ge
, a
nd
 C
ig
ar
et
te
 S
m
ok
-
in
g 
in
 P
ro
du
ci
ng
 R
ad
io
-
gr
ap
hi
c 
E
vi
de
nc
e 
of
 D
if
fu
se
 
P
ul
m
on
ar
y 
F
ib
ro
si
s,
 8
0 
A
M
. J
. M
E
D
. 3
77
 (
19
86
) 
In
su
la
to
rs
 
41
9 
73
 (
17
.4
%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s 
T
he
 s
tu
dy
 u
se
s 
th
e 
te
rm
s 
“a
sb
es
to
si
s,
” 
“d
if
fu
se
 p
ul
m
on
ar
y 
fi
br
os
is
” 
an
d 
“d
if
-
fu
se
 in
te
rs
ti
ti
al
 fi
br
os
is
” 
in
te
rc
ha
ng
ea
-
bl
y.
 S
ee
, e
.g
.,  
80
 A
M
. J
. M
E
D
. 3
77
 
(“
T
yp
ic
al
 lu
ng
 c
ha
ng
es
 o
f a
sb
es
to
si
s 
(d
if
fu
se
 p
ul
m
on
ar
y 
fi
br
os
is
).
”)
. 
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 K.
H
. K
il-
bu
rn
 e
t a
l. 
In
te
ra
ct
io
n 
of
 A
sb
es
to
s,
 
A
ge
, a
nd
 C
ig
ar
et
te
 S
m
ok
-
in
g 
in
 P
ro
du
ci
ng
 R
ad
io
-
gr
ap
hi
c 
E
vi
de
nc
e 
of
 D
if
fu
se
 
P
ul
m
on
ar
y 
F
ib
ro
si
s,
 8
0 
A
M
. J
. M
E
D
. 3
77
 (
19
86
) 
M
al
e 
sh
ip
ya
rd
 w
or
k-
er
s;
 2
0 
ye
ar
s 
or
 m
or
e 
fr
om
 in
it
ia
l s
hi
py
ar
d 
em
pl
oy
m
en
t a
nd
 
pr
ob
ab
le
 in
it
ia
l c
on
-
ta
ct
 w
it
h 
as
be
st
os
; r
e-
cr
ui
te
d 
in
 1
98
1;
 o
f t
he
 
32
 a
ge
d 
71
-8
5,
 2
0 
(6
2.
5%
) 
ha
d 
1/
0 
or
 
hi
gh
er
 
26
0 
10
7 
(4
1.
2%
) 
Ir
re
gu
la
r 
op
ac
i-
ti
es
; p
ar
en
ch
y-
m
al
 a
sb
es
to
si
s 
of
 p
ro
fu
si
on
 1
/0
 
or
 m
or
e 
 
T
hi
s 
st
ud
y 
se
pa
ra
te
d 
th
e 
nu
m
be
rs
 a
ls
o 
by
 th
os
e 
w
ho
 e
ve
r 
sm
ok
ed
 a
nd
 n
ev
er
 
sm
ok
ed
.  
F
or
 a
ll 
ag
e 
gr
ou
ps
 e
xc
ep
t t
he
 
ol
de
st
 (
71
-8
5)
, a
 h
ig
he
r 
pe
rc
en
t o
f 
sm
ok
er
s 
ha
d 
X
-r
ay
s 
gr
ad
ed
 a
t 1
/0
 o
r 
hi
gh
er
, t
ha
n 
pe
op
le
 w
ho
 h
ad
 n
ev
er
 
sm
ok
ed
.  
T
he
 te
rm
 “
pa
re
nc
hy
m
al
 a
sb
es
to
si
s”
 is
 
us
ed
 in
te
rc
ha
ng
ea
bl
y 
w
it
h 
“d
if
fu
se
 p
ul
-
m
on
ar
y 
fi
br
os
is
.”
 
K
.H
. K
il-
bu
rn
 &
 R
. 
W
ar
sh
aw
 
A
ir
w
ay
 O
bs
tr
uc
tio
n 
in
 A
s-
be
st
os
is
 S
tu
di
ed
 in
 S
hi
py
ar
d 
W
or
ke
rs
, i
n 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 V
II
T
H
 
IN
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 4
08
 (
19
90
) 
B
oi
le
rm
ak
er
s 
em
-
pl
oy
ed
 m
os
tl
y 
in
 s
hi
p 
re
pa
ir
 a
nd
 s
om
e 
in
 
ne
w
 s
hi
p 
co
ns
tr
uc
ti
on
; 
of
 th
os
e 
st
ud
ie
d,
 th
e 
m
ea
n 
ag
e 
w
as
 5
2.
5 
ye
ar
s;
 th
e 
 
m
ea
n 
am
ou
nt
 o
f t
im
e 
of
 e
xp
os
ur
e 
to
 a
sb
es
-
to
s 
w
as
 2
7.
3 
ye
ar
s;
 to
 
be
 e
lig
ib
le
 fo
r 
th
e 
st
ud
y,
 th
e 
in
di
vi
du
al
 
ha
d 
to
 h
av
e 
be
en
 e
x-
po
se
d 
fo
r 
at
 le
as
t 1
5 
ye
ar
s 
29
6 
10
6 
(3
5.
8%
) 
P
ro
fu
si
on
 o
f 
ir
re
gu
la
r 
op
ac
i-
ti
es
 
T
he
 s
tu
dy
 r
ef
er
s 
to
 I
L
O
 r
ea
di
ng
s 
of
 1
/0
 
or
 h
ig
he
r 
as
 a
sb
es
to
si
s.
 
K
. K
os
ki
-
ne
n 
et
 a
l. 
 
R
ad
io
gr
ap
hi
c 
A
bn
or
m
al
i-
tie
s 
A
m
on
g 
F
in
ni
sh
 C
on
-
st
ru
ct
io
n,
 S
hi
py
ar
d 
an
d 
A
s-
be
st
os
 I
nd
us
tr
y 
W
or
ke
rs
, 2
4 
SC
A
N
D
IN
A
V
IA
N
 J
. W
O
R
K
 
E
N
V
’T
 &
. H
E
A
L
T
H
 1
09
 
(1
99
8)
 
17
,9
37
 c
on
st
ru
ct
io
n 
w
or
ke
rs
;  
45
6 
sh
ip
ya
rd
 
w
or
ke
rs
; 5
50
 a
sb
es
to
s 
in
du
st
ry
 w
or
ke
rs
; 
st
ud
y 
w
as
 li
m
it
ed
 to
 
th
os
e 
em
pl
oy
ed
 fo
r 
at
 
le
as
t 1
0 
ye
ar
s;
 in
 c
on
-
st
ru
ct
io
n 
an
d 
co
m
-
18
,9
43
 
53
4 
(2
.8
%
) 
Sm
al
l i
rr
eg
ul
ar
 
lu
ng
 o
pa
ci
ti
es
 
in
di
ca
ti
ve
 o
f 
in
te
rs
ti
ti
al
 p
ul
-
m
on
ar
y 
fi
br
os
is
 
T
he
 c
ri
te
ri
a 
fo
r 
te
st
in
g 
po
si
ti
ve
 w
as
 (
i)
 
op
ac
it
ie
s 
cl
ea
rl
y 
co
ns
is
te
nt
 w
it
h 
in
te
rs
ti
-
ti
al
 fi
br
os
is
 (
1/
1)
; (
ii)
 o
pa
ci
ti
es
 in
di
ca
t-
in
g 
m
ild
 in
te
rs
ti
ti
al
 fi
br
os
is
 (
1/
0)
, a
nd
 
fi
nd
in
gs
 c
on
si
st
en
t w
it
h 
un
ila
te
ra
l o
r 
bi
la
te
ra
l p
le
ur
al
 p
la
qu
es
; (
iii
) 
fi
nd
in
gs
 
in
di
ca
ti
ng
 m
ar
ke
d 
ab
no
rm
al
it
ie
s 
of
 th
e 
vi
sc
er
al
 p
le
ur
a 
no
t k
no
w
n 
to
 b
e 
ca
us
ed
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m
en
ce
d 
w
or
k 
be
fo
re
 
19
80
, o
r 
1 
ye
ar
 in
 s
hi
p-
ya
rd
 a
nd
 c
om
m
en
ce
d 
w
or
k 
be
fo
re
 1
98
0,
 o
r 
1 
ye
ar
 in
 a
sb
es
to
s 
in
du
s-
tr
y,
 a
nd
 c
om
m
en
ce
d 
w
or
k 
be
fo
re
 1
97
6;
 
m
ea
n 
da
te
 o
f o
ns
et
 o
f 
ex
po
su
re
 w
as
 1
96
0;
 
m
ea
n 
du
ra
ti
on
 o
f e
m
-
pl
oy
m
en
t w
as
 2
6 
ye
ar
s;
 
av
er
ag
e 
du
ra
ti
on
 o
f 
as
be
st
os
 e
xp
os
ur
e 
w
as
 
9 
ye
ar
s 
 
by
 in
fe
ct
io
n;
 a
nd
 (
iv
) 
fi
nd
in
gs
 c
on
si
st
en
t 
w
it
h 
bi
la
te
ra
l p
le
ur
al
 p
la
qu
es
.  
T
he
 
st
ud
y 
pr
es
en
te
d 
th
e 
re
su
lt
s 
in
 a
 w
ay
 th
at
 
re
qu
ir
ed
 c
al
cu
la
ti
on
s 
to
 d
et
er
m
in
e 
th
e 
nu
m
be
r 
of
 x
-r
ay
s 
re
ad
 a
s 
1/
0 
or
 g
re
at
er
.  
T
he
 c
al
cu
la
ti
on
s 
ar
e 
on
 fi
le
 w
it
h 
th
e 
au
-
th
or
.  
O
f t
he
 to
ta
l 4
,1
33
 in
di
vi
du
al
s 
w
ho
 
sc
re
en
ed
 p
os
it
iv
e,
 th
re
e-
qu
ar
te
rs
 w
er
e 
di
ag
no
se
d 
w
it
h 
an
 o
cc
up
at
io
na
l d
is
ea
se
, 
of
 w
hi
ch
 4
%
 (
12
4)
 w
as
 a
sb
es
to
si
s.
 
J.
 L
ef
an
te
 
et
 a
l. 
 
A
n 
A
na
ly
si
s 
of
 X
-r
ay
 
R
ea
de
r 
A
gr
ee
m
en
t: 
D
o 
F
iv
e 
R
ea
de
rs
 S
ig
ni
fi
ca
nt
ly
 I
n-
cr
ea
se
 R
ea
de
r 
C
la
ss
if
ic
at
io
n 
R
el
ia
bi
lit
y 
O
ve
r 
T
ha
t o
f 
T
hr
ee
 R
ea
de
rs
? 
in
 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 
V
II
T
H
 I
N
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 4
82
 (
19
90
) 
W
or
ke
rs
 e
m
pl
oy
ed
 in
 
th
e 
m
an
uf
ac
tu
re
 o
f 
m
an
-m
ad
e 
fi
be
rs
; 
m
ea
n 
ag
e 
w
as
 4
1 
(r
an
gi
ng
 fr
om
 1
9 
to
 
76
) 
11
68
 
19
 (
1.
62
%
) 
Sm
al
l o
pa
ci
ti
es
 
F
iv
e 
re
ad
er
s 
ea
ch
 r
ea
d 
al
l t
he
 X
-r
ay
s.
  
T
he
 s
tu
dy
 p
re
se
nt
ed
 th
e 
re
su
lt
s 
of
 e
ac
h 
of
 th
e 
re
ad
er
s,
 a
nd
 a
 m
ed
ia
n,
 w
hi
ch
 is
 
us
ed
 in
 th
is
 r
ev
ie
w
.  
O
f t
he
 fi
ve
 r
ea
de
rs
, 
th
e 
on
e 
w
ho
 r
ea
d 
th
e 
m
os
t p
os
it
iv
e 
re
ad
 
10
.4
%
 1
/0
 o
r 
hi
gh
er
 a
nd
 th
e 
on
e 
w
ho
 
re
ad
 th
e 
le
as
t p
os
it
iv
e 
re
ad
 0
.8
%
.  
S.
M
. L
ev
in
 
&
 I
.J
. S
e-
lik
of
f 
R
ad
io
lo
gi
ca
l A
bn
or
m
al
iti
es
 
an
d 
A
sb
es
to
s 
E
xp
os
ur
e 
A
m
on
g 
C
us
to
di
an
s 
of
 th
e 
N
ew
 Y
or
k 
C
ity
 B
oa
rd
 o
f 
E
du
ca
tio
n,
 3
1 
A
N
N
A
L
S.
 
N
.Y
. A
C
A
D
. S
C
I. 
65
3 
(1
99
1)
C
us
to
di
an
s 
of
 N
ew
 
Y
or
k 
C
it
y 
B
oa
rd
 o
f 
E
du
ca
ti
on
; 6
6%
 h
ad
 
be
gu
n 
cu
st
od
ia
l w
or
k 
be
fo
re
 1
96
5;
 e
xa
m
in
a-
ti
on
s 
w
er
e 
do
ne
 b
e-
tw
ee
n 
19
85
 a
nd
 1
98
7;
 
66
0 
10
5 
(1
6%
) 
P
ar
en
ch
ym
al
 
ch
an
ge
s,
 c
on
si
s-
te
nt
 w
it
h 
as
be
s-
to
s-
 
re
la
te
d 
sc
ar
ri
ng
 
X
-r
ay
 fi
lm
s 
w
er
e 
fi
rs
t r
ea
d 
at
 th
e 
si
te
 
m
ai
nl
y 
to
 a
ss
es
s 
qu
al
it
y,
 a
nd
 a
 fe
w
 
w
ee
ks
 la
te
r,
 r
e-
re
ad
 u
si
ng
 th
e 
IL
O
 s
ys
-
te
m
 b
y 
D
r.
 I
rv
in
g 
Se
lik
of
f. 
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th
es
e 
66
%
 h
ad
 a
t l
ea
st
 
20
 y
ea
rs
 s
in
ce
 o
ns
et
 o
f 
po
ss
ib
le
 e
xp
os
ur
e;
 
24
%
  h
ad
 b
eg
un
 w
or
k 
at
 le
as
t 3
0 
ye
ar
s 
ea
rl
ie
r
R
. L
ill
is
 e
t 
al
. 
R
ad
io
gr
ap
hi
c 
A
bn
or
m
al
i-
tie
s 
in
 A
sb
es
to
s 
In
su
la
to
rs
: 
E
ff
ec
ts
 o
f 
D
ur
at
io
n 
F
ro
m
 
O
ns
et
 o
f 
E
xp
os
ur
e 
an
d 
Sm
ok
in
g.
 R
el
at
io
ns
hi
ps
 o
f 
D
ys
pn
ea
 W
ith
 P
ar
en
ch
y-
m
al
 a
nd
 P
le
ur
al
 F
ri
br
os
is
, 
20
 A
M
. J
. I
N
D
U
S.
 M
E
D
. 1
 
(1
99
1)
 
A
ct
iv
e 
an
d 
re
ti
re
d 
as
-
be
st
os
 in
su
la
to
rs
; 
86
.8
%
 h
ad
 3
0 
ye
ar
s 
or
 
m
or
e 
fr
om
 o
ns
et
 o
f 
as
be
st
os
 e
xp
os
ur
e;
 
te
st
in
g 
w
as
 p
er
fo
rm
ed
 
in
 1
9 
ci
ti
es
 b
et
w
ee
n 
19
81
 a
nd
 1
98
3 
2,
79
0 
1,
68
3 
(6
0.
3%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s 
in
di
-
ca
ti
ng
 th
e 
pr
es
-
en
ce
 o
f i
nt
er
st
i-
ti
al
 p
ul
m
on
ar
y 
fi
br
os
is
 
St
ud
y 
al
so
 s
ho
w
ed
 th
at
 c
ig
ar
et
te
 s
m
ok
-
in
g 
co
nt
ri
bu
te
s 
to
 th
e 
pr
ev
al
en
ce
 a
nd
 
se
ve
ri
ty
 o
f i
nt
er
st
it
ia
l f
ib
ro
si
s.
 
O
. M
et
a-
di
lo
gk
ul
 &
 
P
. S
u-
pa
na
ch
ar
t 
O
cc
up
at
io
na
l A
sb
es
to
si
s 
an
d 
A
sb
es
to
s 
R
el
at
ed
 D
is
-
ea
se
s 
A
m
on
g 
W
or
ke
rs
 E
x-
po
se
d 
T
o 
A
sb
es
to
s,
 1
98
7,
 
T
ha
ila
nd
, i
n 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 V
II
T
H
 
IN
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 3
31
 (
19
90
) 
  
A
ll 
w
or
ke
rs
 in
 th
e 
24
 
fa
ct
or
ie
s 
re
gi
st
er
ed
 b
y 
M
in
is
tr
y 
of
 I
nd
us
tr
y 
th
at
 u
se
d 
as
be
st
os
 in
 a
 
pr
od
uc
ti
on
 p
ro
ce
ss
 
66
0 
34
 (
5.
2%
) 
w
er
e 
ei
th
er
 
≥ 1
/1
  o
r 
1/
0 
pl
us
 a
n-
ot
he
r 
cr
it
e-
ri
a.
 
N
/A
 
T
he
 s
tu
dy
 d
ef
in
es
 a
sb
es
to
si
s 
as
 a
n 
IL
O
 
re
ad
in
g 
gr
ad
ed
 1
/0
 o
r 
gr
ea
te
r,
 p
lu
s 
at
 
le
as
t o
ne
 o
th
er
 a
bn
or
m
al
it
y,
 o
r 
a 
re
ad
-
in
g 
of
 1
/1
 o
r 
gr
ea
te
r.
 T
hu
s 
th
e 
st
ud
y 
do
es
 n
ot
 id
en
ti
fy
 th
e 
nu
m
be
r 
of
 X
-r
ay
s 
gr
ad
ed
 1
/0
 o
r 
gr
ea
te
r 
w
it
ho
ut
 o
th
er
 a
b-
no
rm
al
it
ie
s;
 3
1 
of
 th
e 
34
 w
er
e 
“p
os
si
bl
e”
 
ca
se
s 
(t
he
 s
ub
je
ct
 h
ad
 a
n 
x-
ra
y 
of
 1
/0
 
pl
us
 a
no
th
er
 a
bn
or
m
al
it
y 
co
ns
is
te
nt
 
w
it
h 
pn
eu
nm
oc
on
io
si
s)
;  
3 
w
er
e 
“d
ef
i-
ni
te
” 
ca
se
s 
(t
he
 s
ub
je
ct
 h
as
 a
 r
ea
di
ng
 o
f  
≥ 1
/1
).
  T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
tw
o 
re
ad
er
s.
 
A
. M
ill
er
 e
t 
al
. 
R
el
at
io
ns
hi
p 
of
 P
ul
m
on
ar
y 
F
un
ct
io
n 
to
 R
ad
io
gr
ap
hi
c 
In
te
rs
tit
ia
l F
ib
ro
si
s 
in
 2
,6
11
 
L
on
g-
te
rm
 A
sb
es
to
s 
In
su
la
-
to
rs
, 1
45
 A
M
. R
E
V
. 
In
su
la
to
rs
 w
ho
 w
er
e 
en
ro
lle
d 
in
 th
e 
un
io
n 
on
 J
an
ua
ry
 1
, 1
96
7 
an
d 
w
ho
 h
ad
  a
t l
ea
st
 3
0 
yr
s 
fr
om
 o
ns
et
 o
f e
x-
26
11
 
15
57
 
(5
9.
63
%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s,
 c
on
-
si
st
en
t w
it
h 
in
-
te
rs
ti
ti
al
 p
ul
-
m
on
ar
y 
fi
br
os
is
 
A
ll 
fi
lm
s 
w
er
e 
re
ad
 b
y 
th
e 
sa
m
e 
B
 
R
ea
de
r 
(D
r.
 L
ili
s)
. 
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R
E
SP
IR
A
T
O
R
Y
. D
IS
E
A
SE
 
26
3 
(1
99
2)
 
po
su
re
. T
es
te
d 
in
 
19
81
-1
98
3.
 
ca
us
ed
 b
y 
as
-
be
st
os
  
J.
 M
ill
er
 
B
en
ig
n 
E
xp
os
ur
e 
to
 A
sb
es
-
to
s 
A
m
on
g 
P
ow
er
 P
la
nt
 
W
or
ke
rs
, (
19
90
) 
(u
np
ub
-
lis
he
d 
m
an
us
cr
ip
t o
n 
fi
le
 
w
it
h 
au
th
or
) 
P
ow
er
 p
la
nt
 w
or
ke
rs
; 
pa
rt
ic
ip
at
io
n 
w
as
 li
m
-
it
ed
 to
 th
os
e 
w
ho
 w
er
e 
ex
po
se
d 
fo
r 
20
 y
ea
rs
 
or
 m
or
e;
 s
ub
je
ct
s 
w
er
e 
id
en
ti
fi
ed
 in
 1
98
2;
 th
us
 
th
ey
 a
ll 
w
or
ke
d 
in
 
19
62
 o
r 
be
fo
re
; 8
0%
 o
f 
th
e 
11
4 
ha
d 
30
 o
r 
m
or
e 
ye
ar
s 
of
 la
te
nc
y.
 
11
4 
1 
(.
88
%
) 
N
o 
de
fi
ni
te
 
ca
se
s 
of
 a
sb
es
-
to
si
s;
 n
on
e 
of
 
th
e 
in
it
ia
l/ 
su
b-
se
qu
en
t f
ilm
s 
sh
ow
ed
 s
m
al
l 
ir
re
gu
la
r 
op
ac
i-
ti
es
 m
or
e 
th
an
 
1/
0 
R
ad
io
gr
ap
hs
 w
er
e 
in
te
rp
re
te
d 
by
 tw
o 
R
ea
de
rs
.  
R
ea
de
r 
O
ne
 fo
un
d 
tw
o 
(1
.7
5%
) 
an
d 
R
ea
de
r 
T
w
o 
fo
un
d 
ze
ro
 
(0
%
) 
w
it
h 
op
ac
it
ie
s 
gr
ad
ed
 m
or
e 
th
an
 
1/
0.
  T
he
 a
ve
ra
ge
 o
f t
he
se
 r
ea
di
ng
s 
w
as
 
us
ed
 fo
r 
th
is
 r
ev
ie
w
.  
 R
ea
de
r 
O
ne
 
fo
un
d 
pl
eu
ra
l p
la
qu
es
 in
 4
5 
(4
0%
) 
su
b-
je
ct
s,
 a
nd
 R
ea
de
r 
2 
fo
un
d 
pl
eu
ra
l 
pl
aq
ue
s 
in
 5
1 
(4
6%
) 
su
bj
ec
ts
.  
R
.L
. M
ur
-
ph
y 
Jr
. e
t 
al
. 
E
ff
ec
ts
 o
f 
L
ow
 C
on
ce
nt
ra
-
tio
ns
 o
f 
A
sb
es
to
s.
 C
lin
ic
al
, 
E
nv
ir
on
m
en
ta
l, 
R
ad
io
-
gr
ap
hi
c 
an
d 
E
pi
de
m
io
lo
gi
c 
O
bs
er
va
tio
ns
 in
 S
hi
py
ar
d 
P
ip
e 
C
ov
er
er
s 
an
d 
C
on
-
tr
ol
s,
 2
85
 N
. E
N
G
L
. J
. M
E
D
. 
12
71
 (
19
71
) 
P
ip
e 
co
ve
re
rs
 e
m
-
pl
oy
ed
 in
 th
e 
sh
ip
ya
rd
 
in
 N
ov
em
be
r 
19
65
; 
on
 a
ve
ra
ge
 e
ac
h 
in
di
-
vi
du
al
 w
as
 e
m
pl
oy
ed
 
fo
r 
17
.4
 y
ea
rs
; 4
5 
of
 
th
os
e 
st
ud
ie
d 
 
(4
4.
55
%
) 
ha
d 
be
en
 
ex
po
se
d 
fo
r 
m
or
e 
th
an
 
30
 y
ea
rs
 
10
1 
44
 
(4
3.
56
%
) 
In
 a
dd
it
io
n 
to
 
X
-r
ay
 r
ea
di
ng
s,
 
th
e 
st
ud
y 
di
d 
an
 
“e
pi
de
m
io
lo
gi
-
ca
l d
ia
gn
os
is
” 
of
 
as
be
st
os
is
 a
nd
 
fo
un
d 
th
at
 1
1 
of
 
th
e 
44
 h
ad
 a
s-
be
st
os
is
 
R
.L
. M
ur
-
ph
y 
Jr
. e
t 
al
.  
E
ff
ec
ts
 o
f 
L
ow
 C
on
ce
nt
ra
-
tio
ns
 o
f 
A
sb
es
to
s.
 C
lin
ic
al
, 
E
nv
ir
on
m
en
ta
l, 
R
ad
io
-
gr
ap
hi
c 
an
d 
E
pi
de
m
io
lo
gi
c 
O
bs
er
va
tio
ns
 in
 S
hi
py
ar
d 
P
ip
e 
C
ov
er
er
s 
an
d 
C
on
-
tr
ol
s,
 2
85
 N
. E
N
G
L
. J
. M
E
D
. 
12
71
 (
19
71
) 
P
ip
ef
it
te
rs
, o
n 
av
er
ag
e 
em
pl
oy
ed
 fo
r 
17
.1
 
ye
ar
s 
94
 
21
 
(2
2.
34
%
) 
P
er
 th
e 
ab
ov
e,
 
th
e 
st
ud
y 
di
d 
an
 
“e
pi
de
m
io
lo
gi
-
ca
l d
ia
gn
os
is
” 
of
 
as
be
st
os
is
 a
nd
 
fo
un
d 
th
at
 1
 o
f 
th
e 
21
 h
ad
 a
s-
be
st
os
is
 
R
es
ul
ts
 w
er
e 
co
de
d 
by
 n
um
be
r:
 1
=
no
ne
, 
2=
ab
no
rm
al
 n
ot
 c
on
si
st
en
t w
/ a
sb
es
to
-
si
s,
 3
=
qu
es
ti
on
ab
ly
 c
on
si
st
en
t w
it
h 
as
-
be
st
os
is
, 4
=
co
ns
is
te
nt
 w
it
h 
sl
ig
ht
 a
sb
es
-
to
si
s,
 5
=
co
ns
is
te
nt
 w
it
h 
m
od
er
at
el
y 
ad
va
nc
ed
 a
sb
es
to
si
s,
 a
nd
 6
=
co
ns
is
te
nt
 
w
it
h 
ad
va
nc
ed
 a
sb
es
to
si
s.
  W
he
n 
th
e 
IL
O
 s
ys
te
m
 w
as
 d
ev
el
op
ed
, t
he
 a
ut
ho
rs
 
ad
de
d 
a 
fo
ot
no
te
 o
f h
ow
 to
 c
on
ve
rt
 
th
ei
r 
re
ad
in
gs
 to
 th
e 
IL
O
 c
at
eg
or
ie
s:
 
1=
0/
0;
 3
=
0/
1;
 4
=
 1
/0
, 1
/1
, 1
/2
; 5
=
 2
/1
, 2
/2
, 
2/
3;
 a
nd
 6
=
 3
/2
, 3
/3
, 3
/4
 . 
 
 T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
th
re
e 
re
ad
er
s.
  
R
.T
. M
yi
nt
 
&
 S
. M
yi
nt
 
Sm
al
l A
ir
w
ay
 I
m
pa
ir
m
en
t 
F
in
di
ng
s 
at
 th
e 
Sc
re
en
in
g 
of
 
A
sb
es
to
s 
w
or
ke
rs
 in
 
di
ff
er
en
t t
ra
de
s—
sh
ee
t 
63
9 
18
3 
(2
9%
) 
w
er
e 
1/
1 
or
 
T
he
 a
ut
ho
rs
 
re
fe
r 
to
 th
e 
re
-
T
hi
s 
st
ud
y 
in
cl
ud
ed
 7
0 
in
su
la
to
rs
 b
ut
 th
e 
re
su
lt
s 
co
ul
d 
no
t b
e 
se
gr
eg
at
ed
 fo
r 
us
e 
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63
9 
A
sb
es
to
s 
W
or
ke
rs
 w
ith
 
E
xp
os
ur
e 
H
is
to
ry
 o
f 
20
 
yr
s.
, i
n 
P
R
O
C
E
E
D
IN
G
S 
O
F
 
T
H
E
 V
II
T
H
 
IN
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 
at
 3
75
 (
19
90
) 
m
et
al
 w
or
ke
rs
, p
ip
ef
it
-
te
rs
, i
ns
ul
at
or
s,
 b
oi
l-
er
m
ak
er
s,
 b
ri
ck
la
ye
rs
, 
ir
on
 w
or
ke
rs
 a
nd
 o
th
-
er
s;
 to
 b
e 
in
cl
ud
ed
, 
su
bj
ec
ts
 h
ad
 to
 h
av
e 
be
en
 e
xp
os
ed
 fo
r 
20
 o
r 
m
or
e 
ye
ar
s.
. 
hi
gh
er
 
su
lt
s 
as
 “
in
ci
-
de
nt
 o
f a
sb
es
to
-
si
s 
in
 c
he
st
 X
-
ra
y 
pr
of
us
io
n 
be
tw
ee
n 
1/
1-
3/
3.
” 
in
 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 V
II
T
H
 
IN
T
E
R
N
A
T
IO
N
A
L
 P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, 
at
 3
75
 
in
 th
e 
“i
ns
ul
at
or
” 
se
ct
io
n.
 
T
hi
s 
st
ud
y 
di
d 
no
t i
de
nt
if
y 
th
e 
nu
m
be
r 
of
 X
-r
ay
s 
re
ad
 a
s 
1/
0.
 
R
es
ul
ts
 s
up
po
rt
 th
e 
“s
yn
er
gi
st
ic
 a
ct
io
n”
 
of
 c
ig
ar
et
te
 s
m
ok
in
g 
an
d 
as
be
st
os
 e
xp
o-
su
re
. 
J.
 O
ha
r 
et
 
al
. 
C
ha
ng
in
g 
P
at
te
rn
s 
in
 A
s-
be
st
os
-I
nd
uc
ed
 L
un
g 
D
is
-
ea
se
, 1
25
 C
H
E
ST
 7
44
 (
20
04
) 
E
nt
ry
 c
ri
te
ri
a 
w
as
 a
 
do
cu
m
en
te
d 
w
or
k-
pl
ac
e 
as
be
st
os
 e
xp
o-
su
re
, l
at
en
cy
 o
f m
or
e 
th
an
 1
0 
ye
ar
s 
an
d 
an
 
ab
no
rm
al
 c
he
st
 X
-r
ay
 
co
ns
is
te
nt
 w
it
h 
th
e 
hi
s-
to
ry
 o
f a
sb
es
to
s 
ex
po
-
su
re
 
3,
38
3 
31
2 
(9
.2
%
) 
w
er
e 
1/
1 
or
 
hi
gh
er
 
N
/A
 
C
he
st
 r
ad
io
gr
ap
hs
 w
er
e 
re
ad
 b
y 
a 
re
ad
er
 a
nd
 r
ev
ie
w
ed
 b
y 
a 
ph
ys
ic
ia
n.
  
T
hi
s 
st
ud
y 
di
d 
no
t i
de
nt
if
y 
th
e 
nu
m
be
r 
of
 X
-r
ay
s 
re
ad
 a
s 
1/
0.
  T
he
 s
tu
dy
 fo
un
d 
th
at
 c
ig
ar
et
te
 s
m
ok
in
g 
is
 a
ss
oc
ia
te
d 
w
it
h 
gr
ea
te
r 
pr
ev
al
en
ce
 o
f p
ar
en
ch
ym
al
 
op
ac
it
ie
s.
 
P
. O
ks
a 
et
 
al
., 
 
P
ar
en
ch
ym
al
 a
nd
 P
le
ur
al
 
F
ib
ro
si
s 
in
 C
on
st
ru
ct
io
n 
W
or
ke
rs
, 2
1 
A
M
. J
. I
N
D
U
S.
 
M
E
D
. 5
61
 (
19
92
) 
C
on
st
ru
ct
io
n 
w
or
ke
rs
; 
of
 th
e 
43
7 
st
ud
ie
d,
 
81
%
 v
er
if
ie
d 
ex
po
su
re
 
to
 a
sb
es
to
s;
 th
e 
av
er
-
ag
e 
du
ra
ti
on
 o
f e
xp
o-
su
re
 w
as
 3
.7
 y
ea
rs
 
43
7 
70
 (
16
%
) 
w
er
e 
1/
1 
or
 
hi
gh
er
 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s 
99
%
 
of
 th
e 
ti
m
e 
an
d 
ap
pe
ar
ed
 p
re
-
do
m
in
an
tl
y 
in
 
th
e 
lo
w
 a
nd
 c
en
-
tr
al
 p
ar
ts
 o
f t
he
 
lu
ng
; “
in
te
rs
ti
-
ti
al
 lu
ng
 d
is
ea
se
, 
ty
pi
ca
l o
f a
sb
es
-
O
f t
he
 4
37
 in
di
vi
du
al
s 
in
 th
e 
st
ud
y,
 7
0 
(1
6%
) 
ha
d 
re
ad
in
gs
 o
f 1
/1
 o
r 
hi
gh
er
, 
an
d 
17
5 
(4
0%
) 
w
er
e 
in
 th
e 
0/
1-
1/
0 
ca
te
-
go
ry
.  
T
he
 s
tu
dy
 d
id
 n
ot
 d
is
ti
ng
ui
sh
 b
e-
tw
ee
n 
th
os
e 
w
it
h 
0/
1 
an
d 
1/
0 
an
d 
on
ly
 
th
e 
ca
te
go
ri
es
 1
/1
 o
r 
gr
ea
te
r 
ar
e 
in
-
cl
ud
ed
.  
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
on
e 
re
ad
er
.  
BRICKMAN.FINAL.VERSION.1 11/19/2007  4:17:47 PM 
2007] DISPARITIES  609 
 
 
to
s-
re
la
te
d 
di
s-
ea
se
.”
  2
1 
A
M
. 
J.
 I
N
D
U
S.
 M
E
D
. 
at
 5
64
  
R
.B
. R
eg
er
 
et
 a
l. 
 
C
as
es
 o
f 
A
lle
ge
d 
A
sb
es
to
s-
R
el
at
ed
 D
is
ea
se
: A
 R
a-
di
ol
og
ic
 R
e-
ev
al
ua
tio
n,
 3
2 
J.
 O
C
C
U
P
A
T
IO
N
A
L
 M
E
D
. 
10
88
 (
19
90
) 
T
ir
ew
or
ke
rs
; p
re
vi
-
ou
sl
y 
de
si
gn
at
ed
 a
s 
ha
vi
ng
 a
 c
on
di
ti
on
 
co
ns
is
te
nt
 w
it
h 
an
 a
s-
be
st
if
or
m
 m
in
er
al
 e
x-
po
su
re
 
43
9 
8 
(1
.8
2%
) 
N
/A
 
X
-r
ay
s 
w
er
e 
re
ad
 b
y 
th
re
e 
re
ad
er
s.
  T
hi
s 
st
ud
y 
w
as
 a
 r
e-
re
ad
in
g 
of
 4
39
 X
-r
ay
s 
th
at
 h
ad
 b
ee
n 
fo
un
d 
po
si
ti
ve
 fo
r 
as
be
s-
to
s-
re
la
te
d 
di
se
as
e 
as
 th
e 
ba
si
s 
fo
r 
fi
lin
g 
le
ga
l c
la
im
s 
fo
r 
an
 a
sb
es
to
s-
re
la
te
d 
in
-
ju
ry
;  
re
-r
ea
di
ng
s 
in
cl
ud
e 
al
l p
ro
fu
si
on
s 
th
at
 h
ad
 b
ee
n 
re
ad
 a
s 
gr
ea
te
r 
th
an
 0
/1
.  
T
he
 s
tu
dy
 d
id
 n
ot
 s
ep
ar
at
el
y 
id
en
ti
fy
 
th
os
e 
w
it
h 
re
ad
in
gs
 g
re
at
er
 th
an
 0
/1
; 
si
nc
e 
th
e 
to
ta
l p
os
it
iv
e 
re
ad
s 
is
 8
, t
he
 
nu
m
be
r 
w
it
h 
0/
1 
m
us
t h
av
e 
be
en
 v
er
y 
sm
al
l a
nd
 th
ei
r 
in
cl
us
io
n 
th
er
ef
or
e 
do
es
 
no
t a
ff
ec
t t
he
 v
al
id
it
y 
of
 th
e 
re
vi
ew
. 
A
.Z
. R
oc
-
sk
ay
 e
t a
l. 
 
R
es
pi
ra
to
ry
 H
ea
lth
 in
 A
s-
be
st
os
-E
xp
os
ed
 I
ro
nw
or
k-
er
s,
 2
9 
A
M
. J
. I
N
D
U
S.
 M
E
D
. 
45
9 
(1
99
6)
 
A
sb
es
to
s-
ex
po
se
d 
ir
on
w
or
ke
rs
 in
 M
ic
hi
-
ga
n;
 a
ve
ra
ge
 le
ng
th
 o
f 
ti
m
e 
si
nc
e 
jo
in
in
g 
th
e 
un
io
n 
w
as
 2
4.
5 
ye
ar
s.
 
(r
an
gi
ng
 fr
om
 0
.8
 to
 
51
.7
 y
ea
rs
);
 c
al
en
da
r 
ye
ar
s.
 in
 tr
ad
e 
sp
an
ne
d 
fr
om
19
37
 to
 1
99
0 
54
7 
38
 (
7.
5%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s 
 
T
w
o 
re
ad
er
s 
in
de
pe
nd
en
tl
y 
ev
al
ua
te
d 
th
e 
X
-r
ay
s.
  T
he
 lo
w
er
 o
f t
he
 tw
o 
w
as
 
se
le
ct
ed
.  
T
he
 o
pa
ci
ti
es
 w
er
e 
bi
la
te
ra
l i
n 
6.
6%
 (
of
 th
e 
7.
5%
 w
it
h 
an
 I
L
O
 r
ea
di
ng
 
of
 1
/0
 o
r 
hi
gh
er
),
 a
nd
 u
ni
la
te
ra
l i
n 
0.
9%
.  
A
ll 
7.
5%
 in
 th
e 
lo
w
er
 lu
ng
 z
on
es
, a
nd
 in
 
ha
lf
 th
e 
ca
se
s,
 w
er
e 
ex
te
nd
ed
 to
 th
e 
m
id
 
an
d 
up
pe
r 
zo
ne
s 
al
so
. 
L
. R
os
en
-
st
oc
k 
et
 a
l. 
T
he
 R
el
at
io
n 
A
m
on
g 
P
ul
-
m
on
ar
y 
F
un
ct
io
n,
 C
he
st
 
R
oe
nt
ge
no
gr
ap
hi
c 
A
bn
or
-
m
al
iti
es
, a
nd
 S
m
ok
in
g 
St
at
us
 in
 a
n 
A
sb
es
to
s-
E
xp
os
ed
 C
oh
or
t, 
13
8 
A
M
. 
P
lu
m
be
rs
, p
ip
ef
it
te
rs
, 
w
el
de
rs
, s
te
am
fi
tt
er
s,
 
re
fr
ig
er
at
io
n,
 a
nd
 o
th
-
er
s;
 th
e 
m
ea
n 
ag
e 
am
on
g 
pa
rt
ic
ip
an
ts
 
w
as
 4
2.
1 
ye
ar
s;
 th
e 
68
1 
13
2 
(1
9.
38
%
) 
P
ar
en
ch
ym
al
 
fi
br
os
is
 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
tw
o 
re
ad
er
s.
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R
E
V
. R
E
SP
IR
A
T
O
R
Y
 
D
IS
E
A
SE
 2
72
 (
19
88
) 
m
ea
n 
du
ra
ti
on
 in
 th
e 
tr
ad
e 
w
as
 1
7.
1 
ye
ar
s 
R
os
si
te
r,
 
C
.E
. &
 
H
ar
ri
es
, 
P
.G
. 
U
.K
. N
av
al
 D
oc
ky
ar
ds
 A
s-
be
st
os
is
 S
tu
dy
: S
ur
ve
y 
of
 
th
e 
Sa
m
pl
e 
P
op
ul
at
io
n 
A
ge
d 
50
-5
9 
Y
rs
., 
36
 B
R
IT
. 
J.
 I
N
D
U
S.
 M
E
D
. 2
81
 (
19
79
) 
Sh
ip
ya
rd
 w
or
ke
rs
 in
 
th
e 
U
K
 w
ho
 w
er
e 
50
-
59
 y
rs
. o
ld
; t
hi
s 
st
ud
y 
se
pa
ra
te
d 
w
ha
t t
he
y 
ca
lle
d 
th
e 
hi
gh
 e
xp
o-
su
re
 tr
ad
es
 fr
om
 th
e 
re
st
 
1,
11
7 
43
 (
3.
85
%
) 
w
er
e 
1/
1 
or
 
hi
gh
er
 
N
/A
 
T
hi
s 
st
ud
y 
di
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 in
 a
 N
ew
 Y
or
k 
un
io
n 
ch
ap
te
r;
  a
bo
ut
 
26
.4
%
 h
ad
  l
es
s 
th
an
 
15
 y
ea
rs
 la
te
nc
y 
(y
ea
rs
 
si
nc
e 
fi
rs
t e
xp
os
ur
e)
, 
30
.5
%
 h
ad
 1
6-
25
 y
ea
rs
  
la
te
nc
y,
 2
4%
 h
ad
 2
6-
35
 y
ea
rs
 la
te
nc
y;
 a
nd
 
19
%
  h
ad
 le
ss
 th
an
 3
5 
yr
s 
 
34
3 
42
 (
12
.2
%
) 
O
pa
ci
ti
es
 o
f s
iz
e 
“s
” 
or
 “
t”
 a
nd
 
pr
of
us
io
n 
1/
0 
or
 
gr
ea
te
r;
 p
ar
en
-
ch
ym
al
 c
ha
ng
e 
co
ns
is
te
nt
 w
it
h 
po
ss
ib
le
 a
sb
es
-
to
si
s 
O
f t
he
 7
97
 in
di
vi
du
al
s 
in
vi
te
d 
to
 p
ar
ti
ci
-
pa
te
; 3
43
 a
cc
ep
te
d.
  T
ho
se
 w
ho
 d
id
 n
ot
 
re
sp
on
d 
te
nd
ed
 to
 b
e 
ol
de
r,
 r
et
ir
ed
, a
nd
 
liv
in
g 
ou
t o
f s
ta
te
—
th
us
 th
e 
“s
tu
dy
 
gr
ou
p 
re
pr
es
en
te
d 
a 
yo
un
ge
r…
su
bs
et
.”
  
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 V
II
T
H
 
IN
T
E
R
N
A
T
IO
N
A
L
 P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, a
t 3
34
; t
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
on
e 
B
 R
ea
de
r.
 
W
ill
ia
m
 
W
ei
ss
 &
 
P
et
er
 A
. 
T
he
od
os
  
P
le
ur
op
ul
m
on
ar
y 
D
is
ea
se
 
A
m
on
g 
A
sb
es
to
s 
W
or
ke
rs
 
in
 R
el
at
io
n 
to
 S
m
ok
in
g 
an
d 
T
yp
e 
of
 E
xp
os
ur
e,
 2
0 
J.
 
O
C
C
U
P
A
T
IO
N
A
L
 M
E
D
. 3
41
 
(1
97
8)
 
E
m
pl
oy
ee
s 
in
 tw
o 
as
-
be
st
os
 m
an
uf
ac
tu
ri
ng
 
pl
an
ts
 a
ge
d 
40
 a
nd
 
ov
er
; 4
2 
(4
3%
) 
ha
ve
 
be
en
 w
or
ki
ng
 fo
r 
m
or
e 
th
an
 3
0 
ye
ar
s 
98
 
20
 (
20
%
) 
T
he
 ty
pe
s 
of
 
ir
re
gu
la
r 
op
ac
i-
ti
es
 w
er
e 
lim
-
it
ed
 to
 “
s”
 a
nd
 
“t
” 
in
 I
L
O
 c
la
s-
si
fi
ca
ti
on
 
A
lm
os
t a
ll 
th
e 
ca
se
s 
of
 X
-r
ay
 a
bn
or
-
m
al
it
ie
s 
ty
pi
ca
l o
f a
sb
es
to
si
s 
w
er
e 
fo
un
d 
in
 m
en
 o
ve
r 
40
 y
ea
rs
 o
ld
.  
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 jo
in
tl
y 
an
d 
cl
as
si
fi
ed
 b
y 
co
n-
se
ns
us
.  
L
.S
. W
el
ch
 
et
 a
l. 
 
T
he
 N
at
io
na
l S
he
et
 M
et
al
 
W
or
ke
r 
A
sb
es
to
s 
D
is
ea
se
 
Sc
re
en
in
g 
P
ro
gr
am
: 
:R
ad
io
lo
gi
c 
F
in
di
ng
s.
 N
a-
tio
na
l S
he
et
 M
et
al
 E
xa
m
i-
na
tio
n 
G
ro
up
, 2
5 
A
M
. J
. 
IN
D
U
S.
 M
E
D
. 6
34
 (
19
94
) 
Sh
ee
t m
et
al
 w
or
ke
rs
 
fi
rs
t e
m
pl
oy
ed
 in
 th
e 
tr
ad
e 
at
 le
as
t 2
0 
ye
ar
s 
be
fo
re
 th
e 
st
ud
y,
 e
x-
am
in
ed
 s
ta
rt
in
g 
in
 
19
86
;  
T
he
 a
ve
ra
ge
 
ti
m
e 
w
or
ke
d 
in
 th
e 
in
du
st
ry
 w
as
 3
2.
8 
ye
ar
s,
 a
nd
 th
e 
av
er
ag
e 
ti
m
e 
of
 b
ei
ng
 a
 s
he
et
 
m
et
al
 w
or
ke
r 
w
as
 3
5 
yr
s;
  a
m
on
g 
th
os
e 
w
it
h 
ov
er
 4
0 
ye
ar
s 
si
nc
e 
en
-
te
ri
ng
 th
e 
tr
ad
e,
 1
7.
3 
%
 h
ad
 X
-r
ay
s 
gr
ad
ed
 
at
 1
/0
 o
r 
gr
ea
te
r 
 
9,
60
5 
1,
17
8 
(1
2.
3%
) 
Sm
al
l o
pa
ci
ti
es
; 
P
ar
en
ch
ym
al
 
ab
no
rm
al
it
ie
s;
  
as
be
st
os
-r
el
at
ed
 
ab
no
rm
al
it
ie
s 
E
ac
h 
X
-r
ay
 w
as
 r
ea
d 
by
 o
ne
 r
ea
de
r.
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A
.J
. Z
it
ti
ng
 
R
ad
io
gr
ap
hi
c 
Sm
al
l L
un
g 
O
pa
ci
tie
s 
an
d 
P
le
ur
al
 A
b-
no
rm
al
iti
es
 a
s 
a 
C
on
se
-
qu
en
ce
 o
f 
A
sb
es
to
s 
E
xp
o-
su
re
 in
 a
n 
A
du
lt 
P
op
ul
at
io
n,
21
 
SC
A
N
D
IN
A
V
IA
N
 J
. W
O
R
K
 
E
N
V
’T
. &
 H
E
A
L
T
H
 4
70
 
(1
99
5)
 
R
ep
re
se
nt
at
iv
e 
sa
m
pl
e 
of
 F
in
ni
sh
 a
du
lt
 p
op
u-
la
ti
on
 
3,
60
1 
50
6 
(1
4.
05
%
) 
N
/A
 
T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
tw
o 
re
ad
er
s.
  
B
as
ed
 o
n 
a 
su
rv
ey
, t
he
 g
ro
up
 w
as
 d
i-
vi
de
d 
in
to
 th
re
e 
ca
te
go
ri
es
: (
1)
 p
ro
ba
bl
y 
ex
po
se
d,
 (
2)
 p
os
si
bl
y 
ex
po
se
d,
 a
nd
 (
3)
 
un
lik
el
y 
ex
po
se
d.
  T
ho
se
 in
 th
is
 s
tu
dy
 
ar
e 
lim
it
ed
 to
 th
os
e 
in
cl
ud
ed
 in
 c
at
eg
o-
ri
es
 (
1)
 a
nd
 (
2)
.  
C
at
eg
or
y 
(3
) 
is
 in
-
cl
ud
ed
 in
 th
e 
re
vi
ew
 o
f u
ne
xp
os
ed
 
po
pu
la
ti
on
s.
 
B
. 
14
 C
lin
ic
al
 S
tu
di
es
 o
f 
E
xp
os
ed
 P
op
ul
at
io
ns
 E
xc
lu
de
d 
fr
om
 th
e 
R
ev
ie
w
 
A
U
T
H
O
R
 
ST
U
D
Y
 
ST
U
D
Y
 G
R
O
U
P
 &
 
E
X
P
O
SU
R
E
 
D
E
T
A
IL
S 
N
 
1/
0 
O
R
 
H
IG
H
E
R
 
O
P
A
C
IT
Y
 
T
Y
P
E
;  
L
A
N
G
U
A
G
E
 
U
SE
D
 
D
E
T
A
IL
 
H
.E
. 
A
m
an
du
s 
et
 a
l. 
Si
gn
if
ic
an
ce
 o
f 
Ir
re
gu
la
r 
Sm
al
l O
pa
ci
tie
s 
in
 r
ad
io
-
gr
ap
hs
 o
f C
oa
lm
in
er
s 
in
 th
e 
U
SA
, 3
3 
B
R
IT
. J
. I
N
D
U
S.
 
M
E
D
. 1
3 
(1
97
6)
 
C
oa
lm
in
er
s 
6,
16
6 
80
1 
(1
3%
) 
N
/A
 
T
he
 a
ut
ho
rs
 s
tu
di
ed
 c
oa
lm
in
er
s 
w
ho
 
ha
d 
no
 a
sb
es
to
s 
ex
po
su
re
.  
T
hi
s 
st
ud
y 
is
 n
ot
 in
cl
ud
ed
 in
 th
e 
ex
po
se
d 
re
vi
ew
 
be
ca
us
e 
m
in
er
s 
ar
e 
ex
cl
ud
ed
, a
nd
 it
 is
 
no
t i
nc
lu
de
d 
in
 th
e 
un
ex
po
se
d 
re
vi
ew
 
be
ca
us
e 
of
 in
te
ns
iv
e 
ex
po
su
re
 to
 c
oa
l 
du
st
 a
nd
 p
os
si
bl
y 
si
lic
a.
  T
o 
be
 e
lig
ib
le
 
fo
r 
th
e 
st
ud
y,
 th
e 
su
bj
ec
t h
ad
 to
 h
av
e 
a 
pr
ev
io
us
 X
-r
ay
 th
at
 w
as
 r
ea
d 
as
 s
ho
w
-
in
g 
sm
al
l o
pa
ci
ti
es
 1
/0
 o
r 
gr
ea
te
r.
  
T
ho
se
 w
it
h 
ei
th
er
 m
as
si
ve
 fi
br
os
is
 o
r 
w
it
h 
a 
cl
ea
r 
X
-r
ay
 w
er
e 
ex
cl
ud
ed
.  
H
. A
nt
on
-
C
ul
ve
r 
et
 
al
. 
A
n 
E
pi
de
m
io
lo
gi
c 
St
ud
y 
of
 
A
sb
es
to
s-
R
el
at
ed
 C
he
st
 X
-
ra
y 
C
ha
ng
es
 to
 I
de
nt
if
y 
W
or
k 
A
re
as
 o
f 
H
ig
h 
R
is
k 
in
 
Sh
ip
ya
rd
 w
or
ke
rs
 e
m
-
pl
oy
ed
 in
 a
 W
es
t C
oa
st
 
sh
ip
ya
rd
, w
it
h 
a 
 m
e-
di
an
 a
ge
 o
f  
49
 y
ea
rs
; 
3,
90
3 
51
5 
ab
nr
m
l.
N
/A
 
T
he
 5
15
 in
di
vi
du
al
s 
in
 th
e 
fi
rs
t c
at
e-
go
ry
 in
cl
ud
e 
m
ul
ti
pl
e 
pl
eu
ra
l p
la
qu
es
, 
m
ar
ke
dl
y 
in
cr
ea
se
d 
bi
la
te
ra
l p
le
ur
al
 
th
ic
ke
ni
ng
 a
nd
 in
te
rs
ti
ti
al
 d
is
ea
se
.  
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a 
Sh
ip
ya
rd
 P
op
ul
at
io
n,
 4
 
A
P
P
L
IE
D
 I
N
D
U
S.
 H
Y
G
E
IN
E
. 
11
0 
(1
98
9)
 
m
ed
ia
n 
ag
e 
at
 fi
rs
t e
m
-
pl
oy
m
en
t w
as
 3
3;
 m
e-
di
an
 d
ur
at
io
n 
of
 e
m
-
pl
oy
m
en
t: 
13
 y
rs
. 
T
he
re
 is
 n
o 
w
ay
 to
 te
ll 
ho
w
 m
an
y 
ar
e 
1/
0 
or
 h
ig
he
r.
  T
he
 r
es
ul
ts
 a
re
 p
re
-
se
nt
ed
 a
s 
(1
) 
pr
ob
ab
ly
 a
sb
es
to
s 
re
la
te
d 
 
(1
3.
2%
);
 (
2)
 p
os
si
bl
y 
as
be
st
os
 r
el
at
ed
 
(7
.5
%
);
 (
3)
 p
ro
ba
bl
y 
no
t r
el
at
ed
 to
 a
s-
be
st
os
 e
xp
os
ur
e 
(1
2%
);
 a
nd
  (
4)
 n
o 
ab
no
rm
al
it
y 
(6
7.
3%
).
  T
he
re
 is
 n
o 
di
s-
cu
ss
io
n 
of
 th
e 
IL
O
 c
at
eg
or
ie
s.
 
A
.C
. 
F
ri
ed
m
an
 
et
 a
l. 
A
sb
es
to
s-
R
el
at
ed
 P
le
ur
al
 
D
is
ea
se
 a
nd
 A
sb
es
to
si
s:
 A
 
C
om
pa
ri
so
n 
of
 C
T
 a
nd
 
C
he
st
 R
ad
io
gr
ap
hy
, 1
50
 
A
M
. J
. R
O
E
N
T
G
E
N
O
L
O
G
Y
 
26
9 
(1
98
8)
 
M
en
 w
it
h 
a 
hi
st
or
y 
of
 
oc
cu
pa
ti
on
al
 e
xp
os
ur
e 
to
 a
sb
es
to
s;
 
at
 le
as
t o
ne
 y
ea
r 
of
 o
c-
cu
pa
ti
on
al
 e
xp
os
ur
e 
to
 
as
be
st
os
; 5
5 
of
 th
e 
60
 
in
cl
ud
ed
 h
ad
 a
sb
es
to
s 
re
la
te
d 
pl
eu
ra
l d
is
ea
se
, 
th
e 
ot
he
rs
 w
er
e 
su
s-
pe
ct
ed
 o
f h
av
in
g 
m
es
o-
th
el
io
m
a,
 a
st
hm
a 
fr
om
 
ex
po
su
re
, a
nd
 lu
ng
 
ca
nc
er
 
60
 
21
 (
35
%
) 
N
/A
 
T
hi
s 
st
ud
y 
of
 6
0 
m
en
 is
 e
xc
lu
de
d 
be
-
ca
us
e 
th
e 
su
bj
ec
ts
 w
er
e 
se
le
ct
ed
 b
as
ed
 
on
 p
re
vi
ou
s 
ch
es
t X
-r
ay
s 
in
te
rp
re
te
d 
as
 
in
di
ca
ti
ng
 a
sb
es
to
s-
re
la
te
d 
pl
eu
ra
l a
nd
 
pa
re
nc
hy
m
al
 d
is
ea
se
 o
r 
a 
m
al
ig
na
nc
y.
  
T
hi
s 
st
ud
y 
di
ag
no
se
d 
21
 o
f t
he
 6
0 
su
b-
je
ct
s 
w
it
h 
as
be
st
os
is
; 1
9 
w
er
e 
di
ag
-
no
se
d 
w
it
h 
pa
re
nc
hy
m
al
 a
sb
es
to
si
s 
an
d 
pl
eu
ra
l d
is
ea
se
, a
nd
 2
 h
ad
 p
ar
en
ch
ym
al
 
as
be
st
os
is
 w
it
ho
ut
 p
le
ur
al
 d
is
ea
se
. 
P
.G
. H
ar
-
ri
es
 e
t a
l. 
 
R
ad
io
lo
gi
ca
l S
ur
ve
y 
of
 M
en
 
E
xp
os
ed
 to
 A
sb
es
to
s 
in
 N
a-
va
l D
oc
ky
ar
ds
, 2
9 
B
R
IT
. J
. 
IN
D
U
S.
 M
E
D
. 2
74
 (
19
72
) 
U
.K
. N
av
al
 d
oc
ky
ar
ds
 
w
or
ke
rs
 fr
om
 fo
ur
 
po
rt
s;
 s
tu
dy
 in
cl
ud
es
 
th
e 
re
su
lt
s 
of
 th
e 
19
66
 
Sh
ee
rs
 s
tu
dy
 o
f D
av
-
en
po
rt
 a
nd
 a
dd
s 
th
re
e 
po
rt
s 
3,
85
6 
N
/A
 
N
/A
 
T
hi
s 
st
ud
y 
is
 e
xc
lu
de
d 
be
ca
us
e 
it
 d
oe
s 
no
t p
ro
vi
de
 I
L
O
 s
co
re
s 
th
ou
gh
 it
 d
oe
s 
lis
t t
he
 n
um
be
r 
fo
un
d 
w
it
h 
“c
on
fi
rm
ed
 
pu
lm
on
ar
y 
fi
br
os
is
.”
  H
ow
ev
er
, t
hi
s 
de
te
rm
in
at
io
n 
is
 b
as
ed
 o
n 
X
-r
ay
 r
ea
d-
in
gs
, l
un
g 
fu
nc
ti
on
 te
st
in
g,
 a
nd
 c
lin
ic
al
 
ex
am
in
at
io
ns
.  
B
as
ed
 o
n 
th
is
 c
ri
te
ri
a,
 
of
 3
,8
56
 te
st
ed
, 1
2 
(0
.3
%
) 
w
er
e 
fo
un
d 
to
 h
av
e 
th
e 
co
nd
it
io
n 
lis
te
d 
th
at
 a
p-
pe
ar
s 
to
 b
e 
th
e 
eq
ui
va
le
nt
 o
f a
 d
ia
gn
o-
si
s 
of
 a
sb
es
to
si
s.
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 S.
 K
a-
ga
m
im
or
i e
t 
al
. 
St
ud
ie
s 
on
 C
ha
ng
es
 in
 C
at
e-
go
ri
es
 f
or
 P
ne
um
oc
on
io
si
s 
X
-r
ay
 C
la
ss
if
ic
at
io
n 
in
 
Ja
pa
ne
se
 W
or
ke
rs
 W
ith
 O
c-
cu
pa
tio
na
l E
xp
os
ur
e 
to
 
M
in
er
al
 D
us
ts
, P
ro
ce
ed
in
gs
 
of
 N
in
th
 In
te
rn
at
io
na
l C
on
-
fe
re
nc
e 
on
 O
cc
up
at
io
na
l 
R
es
pi
ra
to
ry
 D
is
ea
se
s,
 
K
yo
to
, J
ap
an
 a
t 1
66
-6
9 
(1
99
7)
 (
re
pr
od
uc
in
g 
or
ig
i-
na
l 1
98
6 
st
ud
y)
 
W
or
ke
rs
 e
xp
os
ed
 to
 
m
in
er
al
 d
us
ts
 in
 J
ap
an
 
4,
95
9 
67
 (
1.
35
%
) 
N
/A
 
T
he
se
 w
er
e 
ev
al
ua
te
d 
by
 a
n 
of
fi
ci
al
 
pa
ne
l o
n 
pn
eu
m
oc
on
io
si
s.
  T
hi
s 
pa
rt
 o
f 
th
e 
st
ud
y 
is
 e
xc
lu
de
d 
be
ca
us
e 
th
e 
re
-
su
lt
s 
of
 th
e 
re
-e
va
lu
at
io
n 
w
hi
ch
 in
di
-
ca
te
 a
 h
ig
he
r 
pr
ev
al
en
ce
 o
f f
ib
ro
si
s 
is
 
be
in
g 
us
ed
 in
 th
e 
re
vi
ew
. 
L
an
gl
an
ds
, 
J.
H
.M
. e
t 
al
. 
In
su
la
tio
n 
W
or
ke
rs
 in
 B
el
-
fa
st
. 2
. M
or
bi
di
ty
 in
 M
en
 
St
ill
 a
t W
or
k,
 2
8 
B
R
IT
. J
. 
IN
D
U
S.
 M
E
D
. 2
17
 (
19
71
) 
In
su
la
to
rs
 
16
2 
N
/A
 
N
/A
 
T
hi
s 
st
ud
y 
di
d 
no
t u
se
 th
e 
IL
O
 c
la
ss
if
i-
ca
ti
on
 s
ys
te
m
.  
T
he
 a
ut
ho
rs
 e
va
lu
at
ed
 
th
e 
ca
us
es
 o
f d
ea
th
s 
as
 th
e 
su
bj
ec
ts
 
di
ed
.  
 S
om
e 
of
 th
e 
su
bj
ec
ts
 o
f t
hi
s 
st
ud
y 
w
er
e 
re
-e
va
lu
at
ed
 in
 C
am
pb
el
l 
19
82
, w
hi
ch
 is
 in
cl
ud
ed
, s
up
ra
. 
L
id
de
ll,
 
F
.D
.K
. e
t 
al
. 
R
ad
io
lo
gi
ca
l C
ha
ng
es
 a
nd
 
F
ib
re
 E
xp
os
ur
e 
in
 C
hr
y-
so
til
e 
W
or
ke
rs
 A
ge
d 
60
-6
9 
Y
rs
. a
t T
he
tf
or
d 
M
in
es
, 2
6 
A
N
N
A
L
S 
O
C
C
U
P
A
T
IO
N
A
L
 
H
Y
G
IE
N
E
 8
89
 (
19
82
) 
  
A
sb
es
to
s 
m
in
e 
w
or
ke
rs
 
ag
ed
 6
0 
ye
ar
s 
or
 o
ld
er
 
51
5 
13
6 
(2
6.
4%
) 
N
/A
 
T
hi
s 
st
ud
y 
is
 e
xc
lu
de
d 
be
ca
us
e 
th
e 
su
b-
je
ct
s 
w
er
e 
no
t u
si
ng
 a
sb
es
to
s 
co
nt
ai
n-
in
g 
pr
od
uc
ts
, w
er
e 
no
t i
n 
pr
ox
im
it
y 
to
 
ot
he
rs
 u
si
ng
 s
uc
h 
pr
od
uc
ts
, a
nd
 w
er
e 
no
t i
nv
ol
ve
d 
in
 th
e 
m
an
uf
ac
tu
ri
ng
 o
f 
as
be
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 p
ro
du
ct
s.
  I
n 
ad
di
ti
on
, m
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at
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at
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. d
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 c
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 E.
R
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t o
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 m
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 p
ra
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 p
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r 
be
tw
ee
n 
15
 a
nd
 1
9 
ye
ar
s,
 8
4 
fo
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ad
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 b
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 d
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 d
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 d
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e.
 
L
.C
. O
liv
er
 
et
 a
l. 
A
sb
es
to
s-
R
el
at
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l C
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l p
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at
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 d
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ad
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m
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 o
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R
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R
N
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ra
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 p
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os
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 p
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l c
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ad
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os
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 r
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 p
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 o
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 D
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 m
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 c
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 c
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 C
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R
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P
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O
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P
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. C
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ad
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C
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 D
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 C
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R
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at
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 p
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 r
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-
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w
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 r
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re
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re
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 d
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re
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ra
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 r
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R
O
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re
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os
e 
un
ex
po
se
d.
  O
nl
y 
th
e 
un
ex
po
se
d 
po
pu
la
ti
on
 is
 u
se
d 
in
 th
is
 r
ev
ie
w
.  
T
hi
s 
st
ud
y 
al
so
 c
or
re
la
te
d 
op
ac
it
ie
s 
w
it
h 
sm
ok
in
g.
  T
he
 X
-r
ay
s 
w
er
e 
re
ad
 b
y 
th
re
e 
re
ad
er
s.
 
B
jo
rn
 H
ilt
 
et
 a
l. 
A
sb
es
to
s-
R
el
at
ed
 R
ad
io
-
gr
ap
hi
c 
C
ha
ng
es
 b
y 
IL
O
 
C
la
ss
if
ic
at
io
n 
of
 1
0 
x 
10
 c
m
 
C
he
st
 X
-r
ay
s 
in
 a
 S
cr
ee
n-
in
g 
of
 th
e 
G
en
er
al
 P
op
ul
a-
tio
n,
 3
7 
J.
 E
N
V
T
L
. M
E
D
. 
18
9 
(1
99
5)
  
T
hi
s 
st
ud
y 
de
sc
ri
be
s 
a 
 
pr
ev
io
us
 s
cr
ee
ni
ng
 o
f 
21
,4
53
 m
al
es
 a
ge
d 
40
 
or
 o
ld
er
 in
 th
e 
co
un
ty
 
of
 T
el
em
ar
k,
 N
or
w
ay
   
13
88
 
25
 (
1.
8%
) 
N
/A
 
T
he
 s
tu
dy
 fo
un
d 
th
at
 1
8.
1%
 w
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io
lo
gi
ca
l C
ha
ng
es
 in
 
A
sb
es
to
s 
C
em
en
t W
or
ke
rs
, 
52
 O
C
C
U
P
A
T
IO
N
A
L
 
E
N
V
N
T
L
. M
E
D
. 2
0 
(1
99
5)
 
W
hi
te
 c
ol
la
r 
w
or
ke
rs
 
fr
om
 a
n 
as
be
st
os
 c
e-
m
en
t p
la
nt
, i
n 
Sw
ed
en
 
29
 
2 
(6
.8
%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s,
 “
s”
 o
r 
“t
” 
P
ar
t o
f t
hi
s 
st
ud
y 
is
 s
ep
ar
at
ed
 o
ut
 a
nd
 
in
cl
ud
ed
 in
 th
e 
ex
po
se
d 
re
vi
ew
, b
e-
ca
us
e 
it
 a
ls
o 
ex
am
in
ed
 1
74
 b
lu
e 
co
lla
r 
w
or
ke
rs
.  
X
-r
ay
s 
w
er
e 
re
ad
 in
de
pe
nd
-
en
tl
y 
by
 fi
ve
 r
ea
de
rs
. 
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K
.H
. K
il-
bu
rn
 e
t a
l. 
 
In
te
ra
ct
io
n 
of
 A
sb
es
to
s,
 
A
ge
, a
nd
 C
ig
ar
et
te
 S
m
ok
-
in
g 
in
 P
ro
du
ci
ng
 R
ad
io
-
gr
ap
hi
c 
E
vi
de
nc
e 
of
 D
if
-
fu
se
 P
ul
m
on
ar
y 
F
ib
ro
si
s,
 
80
 A
M
. J
. M
E
D
. 3
77
 (
19
86
) 
Sa
m
pl
es
 o
f p
op
ul
at
io
n 
in
 M
ic
hi
ga
n 
an
d 
sa
m
-
pl
e 
of
 c
en
su
s 
tr
ac
t i
n 
C
al
if
or
ni
a 
25
14
 
32
 (
1.
27
%
) 
Ir
re
gu
la
r 
op
ac
i-
ti
es
; 
di
ff
us
e 
pu
lm
on
ar
y 
fi
br
os
is
; l
un
g 
ch
an
ge
s 
ty
pi
ca
l o
f 
as
be
st
os
is
. 
T
hi
s 
st
ud
y 
ha
d 
fi
ve
 c
at
eg
or
ie
s 
of
 
po
pu
la
ti
on
s:
 tw
o 
w
er
e 
un
ex
po
se
d;
 o
ne
 
w
as
 a
n 
in
su
la
to
r 
st
ud
y;
 a
nd
 tw
o 
w
er
e 
ex
po
se
d.
  O
nl
y 
th
e 
tw
o 
un
ex
po
se
d 
gr
ou
ps
 a
re
 in
cl
ud
ed
 h
er
e.
 T
he
re
 w
er
e 
th
re
e 
ph
ys
ic
ia
ns
 u
se
d 
to
 in
te
rp
re
t t
he
 
X
-r
ay
s 
an
d 
an
 a
ri
th
m
et
ic
 a
ve
ra
ge
 w
as
 
us
ed
. 
R
. S
ai
to
 e
t 
al
. 
A
 S
tu
dy
 O
n 
A
sb
es
to
s-
A
ss
oc
ia
te
d 
L
un
g 
D
is
ea
se
s 
A
m
on
g 
F
or
m
er
 U
.S
. N
av
al
 
Sh
ip
ya
rd
 W
or
ke
rs
, i
n 
P
R
O
C
E
E
D
IN
G
S 
O
F
 T
H
E
 
V
II
T
H
 I
N
T
E
R
N
A
T
IO
N
A
L
 
P
N
E
U
M
O
C
O
N
IO
SE
S 
C
O
N
F
E
R
E
N
C
E
, D
H
H
S 
(N
IO
SH
) 
P
U
B
. N
O
. 9
0-
10
8,
 a
t 3
62
 (
19
90
) 
T
hi
s 
w
as
 a
n 
un
ex
po
se
d 
co
nt
ro
l g
ro
up
 in
 th
e 
st
ud
y 
of
 U
S 
N
av
al
 
ya
rd
 w
or
ke
rs
 in
 J
ap
an
; 
m
ea
n 
ag
e 
of
 6
7.
2 
ye
ar
s 
40
 
22
 (
57
%
) 
Sm
al
l i
rr
eg
ul
ar
 
op
ac
it
ie
s 
an
d 
sm
al
l n
od
ur
al
 
op
ac
it
ie
s 
N
o 
ex
pl
an
at
io
n 
is
 o
ff
er
ed
 fo
r 
th
e 
re
la
-
ti
ve
ly
 h
ig
h 
pr
ev
al
en
ce
 o
f p
ne
um
oc
o-
ni
os
is
 in
 th
e 
co
nt
ro
l g
ro
up
 o
f p
er
so
ns
 
no
t o
cc
up
at
io
na
lly
 e
xp
os
ed
 to
 a
sb
es
-
to
s.
  
A
.J
. Z
it
ti
ng
 
et
 a
l. 
R
ad
io
gr
ap
hi
c 
Sm
al
l L
un
g 
O
pa
ci
tie
s 
an
d 
P
le
ur
al
 A
b-
no
rm
al
iti
es
 a
s 
a 
C
on
se
-
qu
en
ce
 o
f 
A
sb
es
to
s 
E
xp
o-
su
re
 in
 a
n 
A
du
lt 
P
op
ul
at
io
n,
 2
1 
SC
A
N
D
IN
A
V
IA
N
 J
. W
O
R
K
 
E
N
V
’T
. &
 H
E
A
L
T
H
 4
70
 
(1
99
5)
 
R
ep
re
se
nt
at
iv
e 
sa
m
pl
e 
of
 a
du
lt
 F
in
ni
sh
 p
op
u-
la
ti
on
 
3,
49
4 
40
8 
(1
1.
7%
) 
N
/A
 
T
w
o 
ra
di
ol
og
is
ts
 r
ea
d 
th
e 
X
-r
ay
s.
 
B
as
ed
 o
n 
a 
su
rv
ey
, t
he
 g
ro
up
 w
as
 d
i-
vi
de
d 
in
to
 th
re
e 
ca
te
go
ri
es
: (
1)
 p
ro
ba
-
bl
y 
ex
po
se
d,
 (
2)
 p
os
si
bl
y 
ex
po
se
d,
 a
nd
 
(3
) 
un
lik
el
y 
ex
po
se
d.
 T
ho
se
 in
cl
ud
ed
 
in
 th
is
 r
ev
ie
w
 a
re
 li
m
it
ed
 to
 c
at
eg
or
y 
(3
).
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D
. 
2 
C
lin
ic
al
 S
tu
di
es
 o
f 
U
ne
xp
os
ed
 P
op
ul
at
io
ns
 E
xc
lu
de
d 
fr
om
 th
e 
R
ev
ie
w
 
A
U
T
H
O
R
 
ST
U
D
Y
 
ST
U
D
Y
 G
R
O
U
P
 &
 
E
X
P
O
SU
R
E
 
D
E
T
A
IL
S 
N
 
1/
0 
O
R
 
H
IG
H
E
R
 
O
P
A
C
IT
Y
 
T
Y
P
E
;  
L
A
N
G
U
A
G
E
 
U
SE
D
 
D
E
T
A
IL
 
W
ill
ia
m
 
W
ei
ss
 
C
ig
ar
et
te
 S
m
ok
in
g 
an
d 
D
if
fu
se
 P
ul
m
on
ar
y 
F
ib
ro
-
si
s,
 9
9 
A
M
. R
E
V
. 
R
E
SP
IR
A
T
O
R
Y
 D
IS
E
IS
E
 6
7 
(1
96
9)
  
Sc
re
en
in
g 
of
fe
re
d 
to
 
al
l a
du
lt
s 
w
ho
 c
am
e 
to
 
th
e 
P
hi
la
de
lp
hi
a 
T
u-
be
rc
ul
os
is
 a
nd
 H
ea
lt
h 
A
ss
oc
ia
ti
on
’s
 C
en
tr
al
 
X
-r
ay
 U
ni
t a
nd
 h
ad
 a
 
pr
iv
at
e 
ph
ys
ic
ia
n 
  
2,
82
5 
40
 (
1.
4%
) 
N
/A
 
T
hi
s 
st
ud
y 
is
 e
xc
lu
de
d 
be
ca
us
e 
th
e 
re
-
su
lt
s 
ar
e 
no
t p
ro
vi
de
d 
us
in
g 
th
e 
IL
O
 
cl
as
si
fi
ca
ti
on
 s
ys
te
m
.  
In
st
ea
d,
 th
e 
te
rm
 “
pu
lm
on
ar
y 
fi
br
os
is
” 
is
 u
se
d.
  
T
he
 s
tu
dy
 fo
un
d 
th
at
 th
e 
pr
ev
al
en
ce
 
of
 d
if
fu
se
 p
ul
m
on
ar
y 
fi
br
os
is
 w
as
 
th
re
e 
ti
m
es
 h
ig
he
r 
in
 c
ig
ar
et
te
 s
m
ok
-
er
s 
th
an
 in
 n
on
-s
m
ok
er
s.
 
W
ill
ia
m
 
W
ei
ss
 
C
ig
ar
et
te
 S
m
ok
in
g 
an
d 
D
if
fu
se
 P
ul
m
on
ar
y 
F
ib
ro
-
si
s,
 1
4 
A
R
C
H
IV
E
S 
E
N
V
T
L
. 
H
E
A
L
T
H
 5
64
 (
19
67
) 
A
du
lt
s 
un
de
rg
oi
ng
 
ro
ut
in
e 
ch
es
t p
ho
to
-
fl
uo
gr
am
s 
at
 th
e 
P
hi
la
de
lp
hi
a 
T
ub
er
cu
-
lo
si
s 
an
d 
H
ea
lt
h 
A
ss
o-
ci
at
io
n,
 b
et
w
ee
n 
M
ar
ch
 1
1,
 1
96
6 
an
d 
A
pr
il 
12
, 1
96
6 
99
9 
31
 (
3.
1%
) 
N
/A
 
T
hi
s 
st
ud
y 
is
 e
xc
lu
de
d 
be
ca
us
e 
th
e 
re
-
su
lt
s 
ar
e 
no
t p
ro
vi
de
d 
us
in
g 
th
e 
IL
O
 
cl
as
si
fi
ca
ti
on
 s
ys
te
m
.  
In
st
ea
d,
 th
e 
te
rm
 “
pu
lm
on
ar
y 
fi
br
os
is
” 
is
 u
se
d.
 
 
